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The va scular endothelium i s c ontinuously s ubjected t o a  v ariety o f m echanical and c hemical 
stresses w hile it pe rforms its  dut ies in the maintenance of  vascular pe rmeability, tone, 
hemostasis, inflammation, and remodeling in health a nd di sease.  T he m echanism by w hich 
endothelial c ells r espond t o m echanical f orces, or  m echanotransduction, i s not  c ompletely 
understood a nd i s t he s ubject of  on going d ebate.   S everal t heories i nvolving proteins a nd 
reactive oxygen species have been proposed as components of the mechanotransduction process, 
however t he r ole of  t he lipid m icroenvironment a nd l ipid s ignaling r emains l argely unknow n.  
We h ypothesize that m echanical, uniaxial c yclic s train results in an increase in intracellular 
ceramide i n vascular en dothelial cel ls, which participates i n signaling ne cessary t o propagate 
mechanotransduction r esponses, pot entially contributing t o early events i n t he f ormation of  
atherosclerotic lesions.   
To evaluate t his h ypothesis, we used el ectrospray mass spectrometry t o study the lipid 
microenvironment, particularly w ith regards to  c eramide s ignaling, in e ndothelial cells in  
response t o c yclic s train w ithin a nd be yond t he ph ysiological r ange, s o a s t o g ain a be tter 
understanding of  t he events t hat may ul timately contribute to endothelial d ysfunction.  The 
findings of  t hese s tudies ha ve elucidated t he t ime s cale of  t he c eramide r esponse a nd t he 
ceramide bi osynthetic a nd m etabolic pa thways that oc cur dur ing the early response t o c yclic 
strain.  C eramide s ignaling r esults from  distinct s ignaling e vents a ssociated with nSMase, 
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 v 
aSMase, and de novo ceramide synthesis.  The nSMase signaling event appears to be necessary 
for t he l ater de novo event t o oc cur.  T he endothelial r esponse t o cyclic s train is sensitive to 
strain magnitude, resulting in ceramide elevation at levels both above and below physiological 
strain magnitudes, suggestive of a wide variety of arterial pathological states.   
These findings help to elucidate the early events in the mechanotransduction response to 
cyclic strain and represent a step towards bridging our understanding of the relationship between 
mechanotransduction and inflammation as it relates to endothelial cell activation and dysfunction 
and vascular disease.  Establishment of the involvement of the ceramide biosynthetic pathway in 
endothelial cells and the vascular environment provides us with new biomarkers and therapeutic 
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1.0  INTRODUCTION 
1.1 VASCULAR ENDOTHELIAL FUNCTION AND CARDIOVASCULAR DISEASE 
The vascular endothelium forms the lining of blood vessels and the heart, separating blood from 
the i ntimal a nd m edial l ayers of  a rteries and ve ins, a nd ve ry i mportantly, r egulates ve ssel 
permeability to leukocytes a nd inflammatory me diators [1].  F urthermore, t he v ascular 
endothelium is responsible for maintaining vascular tone and for regulating platelet aggregation, 
thrombogenesis, and proliferation and remodeling of  blood vessels, in response to biochemical 
and mechanical s ignaling [2].  D ysfunction or  l oss of  i ntegrity o f t he vascular endothelium, 
consequently, m ay c ompromise va soregulation, i ncrease bl ood c oagulation, a nd pr omote 
leukocyte and inflammatory cytokine infiltration into the intima and increase smooth muscle cell 
(SMC) m igration a nd pr oliferation, pot entially contributing t o t he f ormation of  a therosclerotic 
lesions [1, 3-5]. 
Atherosclerosis is a pr ogressive disease characterized by the formation of lesions within 
the ar terial w all cha racterized by i nflammation, l ipid a ccumulation, c ell de ath, a nd f ibrosis.  
Progressing l esions de velop i nto m ature pl aques, w hich can cause ve ssel oc clusion or  can 
rupture, leading to acute thrombotic occlusion of the vessel.  Depending on the arteries affected 
by a therosclerosis, the c linical out come ma y m anifest a s an acute m yocardial inf arction, heart 
failure, ischemic stroke, hypertension, or organ or limb ischemia and functional impairment [6-
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8].  Endothelial dysfunction, a precursor to the onset of atherosclerosis, has been implicated in 
the clinical manifestation and disease pathogenesis of most cardiovascular diseases [9-11]. 
1.1.1 Cardiovascular disease and atherosclerosis: incidence and impact on health care 
Cardiovascular disease i s the primary cause of  35.3% of  deaths each year in the United States 
and contributes to as many as 56% of all deaths.  Furthermore, as many as 80 million American 
adults ha ve at l east one  f orm of  cardiovascular disease m anifesting as h ypertension, coronary 
heart di sease s uch as m yocardial i nfarction or ang ina pe ctoris, heart f ailure, or s troke.  T aken 
together, these patients accounted for more than 7 million hospital di scharges in 2006  and the 
total c ost of  care f or cardiovascular di sease in 2009 i s pr ojected t o be  $475.3  bi llion.  
Atherosclerosis, w hether of  t he c oronary or pe ripheral arteries, is responsible f or n early three 
fourths of  a ll de aths f rom cardiovascular di sease i n t his country, i ncluding d eaths from s troke 
and myocardial infarction [8].  Atherosclerotic vascular disease remains a major cause of death 
worldwide in both developed and developing countries [4, 7, 8 ].  Thus, atherosclerotic vascular 
disease represents a serious clinical problem worldwide. 
Owing t o t he pr ofound impact of  a therosclerosis a s a  global h eath c risis, s ubstantial 
efforts ha ve be en m ade to e ducate t he publ ic a bout r isk f actors f or c ardiovascular di sease [8]  
and to improve diagnostic methods to monitor endothelial dysfunction and to detect subclinical 
vascular disease before patients become outwardly symptomatic of cardiovascular disease [5, 10, 
12].  A lthough t raditional m ethods of  de termining va scular d ysfunction ha ve focused on  
measures of vasomotion of arteries, whether by the administration of an endothelium-dependent 
vasodilator such as acetylcholine or  br ief occlusion of  a  peripheral a rtery to s tudy the vessel’s 
response t o t he r esulting flow-mediated va sodilation, e fforts a re now  b eing m ade t o i dentify 
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surrogate biochemical markers of vascular health in an effort to provide a more specific analysis 
of t he und erlying m echanisms of  a  p atient’s v ascular d ysfunction, r esponse t o t herapy, a nd 
prognosis [4, 12]. 
1.1.2 Vascular anatomy 
The vascular wall, whether that of an artery or a vein, contains three distinct layers: the intima, 
the media, and the adventitia.  The int ima, or tunica int ima, consists of  the  endothelial lining, 
which di rectly i nteracts w ith t he bl ood, s upported b y a ba sement m embrane a nd t hin 
extracellular ma trix ove rlying the  int ernal e lastic la mina.  T he s tructure of  the  int ernal e lastic 
lamina is an open meshwork that allows movement of cells between the intima and media as well 
as exchange of soluble factors between the endothelium and cells of the media.  This aspect is of 
particular note in the development of atherosclerotic lesions [13-15].   
The media, or tunica media, is comprised of smooth muscle cells and collagen, bounded 
by an external elastic lamina on t he opposite side.  T he smooth muscle cells provide the tonus 
that allows arteries to dampen pulsatile blood flow from the heart, and together with the elasticity 
of the various elastic laminae contributes to a relatively smooth flow of blood through the arterial 
system.  O wing t o t his pr operty, t he m edia i n a rteries i s ge nerally t hicker t han i n ve ins, a nd 
varies in thickness corresponding to the pressure head in the artery [13, 14] .  T he internal and 
external elastic laminae are also absent in the typical vein [14, 16].  In elastic arteries such as the 
aorta, which sees i ncreased pressures and pulsatility ac ross t he cardiac c ycle, the m edia i s 
comprised of  s everal l ayers of  l amellae, w hich a re l ayers o f s mooth m uscle c ells bounde d on  
each side by a thin elastic lamina and the number of lamellae increases a long the artery in the 
cephalad direction [13].   
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The outermost layer on the abluminal surface of the artery is the adventitia, or the tunica 
externa.  T he tunica externa consists pr imarily o f collagen, some e lastin, some smooth muscle 
cells, fibroblasts, macrophages, lymphocytes, a system of nerves, and the arterioles, capillaries, 
and venules of the vasa vasorum, which nourishes cells across the outer thickness of arteries.  In 
thicker arteries such as the aorta, the vasa vasorum also extends into the media of the vessel  [13, 
14, 16, 17] .  The adventitial vasa vasorum has also been implicated as the source of intraplaque 
vasculature i n advanced at herosclerotic l esions, correlating w ith increased inflammation and 
propensity for intraplaque rupture [17, 18]. 
The largest arteries, such as the aorta, pulmonary t runk, and their major branch arteries 
including the pulmonary, common carotid, subclavian, and common iliac arteries, are classified 
as elastic or conducting arteries and can have a diameter up to approximately 2.5cm [14].  These 
arteries have a highly organized medial structure that reduces oscillation and dampens pulsatility 
as blood flow progresses towards the arterioles.  This alleviates pulsatile stresses on the perfused 
organs [13, 14, 19] .  Medium di ameter a rteries, know n a s m uscular or di stribution a rteries, 
typically have a  l uminal di ameter of  0.5mm to 0.4cm and a re characterized b y a  t hick, highly 
cellular media.  Examples of muscular arteries include the external carotid, brachial, mesenteric, 
and femoral a rteries.  A rterioles te nd to have a lum inal di ameter of  l ess t han 30 µm, have a 
relatively thin media, and have a  poorly defined adventitia [14].  Atherosclerotic lesions occur 
primarily in large elastic arteries and medium muscular arteries [13]. 
 5 
1.1.3 Function of the healthy endothelium 
The vascular endothelium consists of a single, continuous monolayer of endothelial cells lining 
the blood vessels and the heart, thus separating the blood f rom underlying layers of  the vessel 
intima and media of arteries and veins [1, 20, 21].  Under conditions of laminar flow, endothelial 
cells elongate and align in the direction of flow/ shear stress, but retain a polygonal cobble-stone-
like morphology in regions of  di sturbed f low where flow may be s luggish or  characterized b y 
eddying [13, 22] .  T here i s e vidence t hat t he e ndothelium of  a rteries a nd ve ins a re distinct 
entities w ith i nherently different r esponses t o s timuli, r eflective o f e nvironmental i nputs a nd 
differential gene ex pression [16, 22, 23 ].  I n i ts uni que l ocation, t he e ndothelium ha s be en 
described a s a bi ophysical s ensor, c apable of  releasing num erous a utocrine, endocrine, a nd 
paracrine factors i n r esponse t o c hanges i n t he ph ysical, m etabolic, a nd i nflammatory 
environment to maintain vascular hom eostasis [4, 5, 9, 10 ].   I n a ddition t o r esponding t o 
changes in blood flow and blood composition, the endothelium is capable of reacting to signaling 
from the other cells of the vessel wall and extracellular matrix components [22-24].   
One of the most notable functions of the endothelium is the regulation of vascular tone in 
response t o c hanges i n he modynamic f orces a nd bl ood-borne c hemical s ignals t hrough t he 
release of  va soactive substances, i ncluding vasodilators l ike ni tric ox ide, pr ostacyclin, 
endothelium-derived h yperpolarizing factor, br adykinin, adrenomedullin, a nd C -natriuretic 
peptide; and vasoconstrictors like endothelin-1, angiotensin-II, thromboxane A2, prostaglandins, 
hydrogen peroxide and free r adicals [9, 21, 25] .  T he ba lance of  t hese f actors i s cr ucial t o 
vascular hom eostasis a nd i mpacts t he s ystemic blood c irculation [4, 9, 16].  N itric ox ide in 
particular is crucial in the maintenance of vascular tone and vascular reactivity and as such, is the 
subject of extensive study [4, 9].   
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The function of the endothelium goes beyond regulation of vascular tone.  Under normal 
physiological conditions, e ndothelial c ells r egulate t he bi directional t ransport of  gases a nd 
macromolecules from t he bl ood b y w ay o f receptor-mediated and receptor-independent 
transcytosis a nd e ndocytosis [4, 20]  and bi osynthesis of  num erous f actors t hat i nfluence 
hemostasis and angiogenesis [13, 16, 20, 21, 25 ].  T he endothelium also plays a critical role in 
trafficking of leukocytes, modification of lipoproteins from the plasma, and vessel permeability 
[13, 16, 23, 25]. 
The e ndothelium i s hi ghly d ynamic and he terogeneous, allowing f or l ocal a daptations 
necessary to maintain the health and function both of the vasculature and the tissues and organs it 
services.  In the disease state, its ability to optimally adapt to changes in environmental stimuli is 
compromised.  N ot s urprisingly, e ndothelial f unction i s a ssociated not  onl y w ith t raditional 
vascular disease like atherosclerosis, but with most diseases, ranging from cancer to renal failure 
to sepsis to chronic inflammatory disease, and may play a role in disease causality or may exist 
in a state of dysfunction secondary to the initial disease pathology [23]. 
1.1.4 Endothelial cell activation 
Under nor mal c onditions, t he qui escent e ndothelial c ells e xpress a phe notype tha t is  
anticoagulant, a nti-inflammatory, antiadhesive, and va sodilatory.  W hen e xposed t o c ertain 
environmental f actors i ndicative of  damage o r da nger, such as  TNF-α, IL -1, or  e ndotoxin, 
endothelial c ells c hange t heir ph enotype t o one  t hat i s m ore pr ocoagulant, pr oadhesive, and 
vasoconstrictive with increased antigen-presenting capacity.  This broad set of changes occurs as 
a normal part of both physiological and pathophysiological conditions [23, 24]. 
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One of  the  e arliest e vents of  e ndothelial c ell a ctivation, occurring within minutes of  
activation, is the exocytosis of Weibel-Palade bodies (WPBs) into both the apical and basolateral 
spaces.  W PBs release numerous proteins responsible for regulating hemostasis, vascular tone, 
inflammation, and angiogenesis [22, 25-27].  The major component of WPBs is von Willebrand 
factor (vWF), which is involved in platelet adhesion to the activated endothelial cell [22, 26, 27].  
P-selectin, a r eceptor t hat mediates a dhesion of  platelets a nd l eukocytes to t he e ndothelium i s 
present in the membranes of WPBs and fuses with the plasma membrane of the endothelial cell 
upon exocytosis.  W PBs have also been reported to contain endothelin (vasoconstrictor), tissue 
plasminogen a ctivator ( thrombolytic), os teoprotegerin ( bone r emodeling), a ngiopoietin-2 
(vascular r emodeling, inflammation), and even coagulation factor V III [22, 28] .  W PBs of  the 
microvasculature a nd t hose pr oduced du ring a ctive i nflammation c ontain t he proinflammatory 
chemokine IL-8, which is involved in chemotaxis of target leukocytes.  IL-8 is retained in WPBs 
even a fter reversal of  e ndothelial a ctivation, a rguing t hat t his pr operty h elps t he pr e-activated 
endothelium mount a more robust inflammatory response upon reactivation [29, 30]. 
While WPB exocytosis represents a  rapid and general response to inflammation dur ing 
activation, there are also a number of signaling events and changes in gene expression occurring 
over t he pe riod of  t he f irst f ew hour s t hat r efine the i mmune r esponse.  N umerous a dhesion 
molecules, including VCAM-1 and E-selectin are upregulated, which, combined with cytokines 
like IL-6 and chemokines l ike IL-8, p romote leukocyte adhesion prior to t rafficking across the 
endothelium.  The combination of cytokines, chemokines, and adhesion molecules necessary for 
leukocyte adhesion, rolling, a ctivation, and t ransendothelial m igration va ries depending on t he 
type of  t arget l eukocyte ( i.e. T  l ymphocyte, ne utrophil, or  m onocyte) [22, 25, 27] .  TNF-α 
activation of endothelial cells has also been shown to decrease endothelial nitric oxide synthase 
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(eNOS), thereby promoting a vasoconstrictive state [31].  Activation of endothelial cells by pro-
inflammatory cytokines has also been shown to upregulate production of Tissue Factor, a major 
initiator of the extrinsic coagulation cascade, thus promoting a pro-coagulant state [25]. 
Signaling through NF-κB, which has been studied best in response to the inflammatory 
cytokines T NF-α and I L-1, but  i s a lso know n t o be  t riggered b y Toll-like r eceptors on t he 
endothelial c ell s urface, l eads t o e xpression of  an a ssortment of  ge nes for pr o-inflammatory 
adhesion m olecules i ncluding E-selectin, ICAM-1, a nd V CAM-1; c ytokines s uch a s IL-6; 
chemokines such as IL-8; cyclooxygenase-2; and inducible nitric oxide synthase (iNOS) as well 
as a  num ber of  ot her pr otective ge nes, w hich pr otect a gainst a poptosis and exert ant i-
inflammatory e ffects, pr oviding s ome de gree of  pr otection t o t he e ndothelium a gainst da mage 
during activation [25, 32].  The high degree of regulatory feedback mechanisms assure that NF-
κB t ranscriptional pr oducts a re onl y t ransiently activated du ring a ctivation, a lthough t here i s 
evidence that enhanced NF-κB signaling occurs during aging and in some inflammatory diseases 
like r heumatoid arthritis a nd Crohn’s di sease [25, 33] .  Additionally, the M APK s ignaling 
pathways – including ERK, J NK, a nd p38 MAPK pa thways – are a lso a ctivated dur ing 
endothelial cel l act ivation, which have be en implicated in a va riety o f c ellular out comes f rom 
proliferation, and differentiation to apoptosis, stress responses, and inflammation [25]. 
Another interesting, but less understood facet of endothelial activation is the generation 
of microparticles, which are submicron vesicles shed from the plasma membrane in response to 
cellular activation, injury, o r apoptosis [20, 34, 35] .  Microparticles of  p latelet, leukocyte, and 
endothelial cell origin have been identified under both healthy and pathological conditions and 
their composition with regards to surface markers and lipid content depends on t he cell type of 
origin and disease state.  Endothelial microparticles, which are particularly rich in Tissue Factor 
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at their plasma membrane, have been shown to decrease nitric oxide-dependent vasodilation and 
to promote arterial stiffness, inflammation, and thrombogenesis [34]. 
Thus, t he br oad va riety of  s ignaling, c ellular r ecruitment, a nd t ranscriptional c hanges 
present dur ing a ctivation de monstrates not  onl y t he c omplex a nd m ultifaceted f unctionality of  
the e ndothelial c ell, but a lso suggests the  ma ny potential w ays in which a n imbalance of  thi s 




Figure 1.1.  The vascular endothelium undergoes many changes contributing to the onset of vascular disease. 
 
 10 
1.1.5 Endothelial cell dysfunction 
Endothelial dysfunction is believed to be one of the earliest events contributing to the onset of 
atherosclerotic cardiovascular disease (Figure 1.1), and has been described in patients with risk 
factors for vascular disease such as diabetes, hyperlipidemia, hypertension, and smoking, as well 
as in patients without traditional risk factors [4, 5, 10, 24].  Endothelial dysfunction has also been 
associated w ith m echanical r emoval of  or  t rauma t o t he e ndothelium or  w hen t he e ndothelial 
continuity is compromised [24, 35].  Whereas endothelial activation describes the presence of a 
specific endothelial phe notype, endothelial d ysfunction describes t he d anger of  t he endothelial 
phenotype to the host and may exist even in the absence of  endothelial activation.  U nlike the 
healthy e ndothelium, w hich i s hi ghly h eterogeneous i n i ts phe notype a nd f unctionality, t he 
dysfunctional phe notype l oses c omplexity a nd be comes m ore uni form i n i ts r esponse t o 
stimulation a s e ndothelial c ells a pproach qui escence [23].  C ellular s enescence, whether 
associated with age o r with disease s tates, pa rticularly under condi tions t hat r equire a  hi gh 
degree of cell turnover, has also been implicated in the progression of endothelial dysfunction as 
part of many vascular pathologies [36].   
While e ndothelial d ysfunction i s be lieved t o be  r eversible pr ior t o t he development of  
advanced, l esional, s tructural c hanges t o t he va scular w all, m ethods t o s creen f or i ts pr esence 
have not been widely utilized at the clinical level.  Likewise, guidelines for the identification of 
appropriate s creening populations i n ot herwise c linically a symptomatic pa tients w ithout 
traditional risk factors remain vague, since most patients do not present until they have clinically 
significant endpoint events, such as myocardial ischemia [4, 24].  The ability to effectively detect 
early e ndothelial d ysfunction a nd t o m onitor s ubclinical va scular di sease ha s t he pot ential t o 
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improve our  unde rstanding of  c onventional r isk f actors a nd t o e xpand t he e fficacy a nd us e o f 
preventative pharmacological and medical therapies [10, 37]. 
The traditional definition of endothelial dysfunction is a reduction in the bioavailability 
of vasodilators, and more specifically nitric oxide (NO), relative to the increase in endothelium-
derived va soconstrictors a nd r eactive ox ygen s pecies, l eading t o a n i mpaired e ndothelium-
dependent vasodilatory response [9, 10] .  A s such, conventional methods to assess endothelial 
dysfunction rely on detection of a paradoxical failure of vasodilation or even vasoconstriction in 
response to administration of an endothelium-dependent vasodilator like acetylcholine followed 
by a brief period of mechanical vascular occlusion [12].  Other methods like pulse wave velocity 
assess the overall stiffness of an artery and may represent a cause or an effect of vascular disease 
depending on t he unde rlying e tiology w ithout a ssessing t he a ctual he alth of  t he e ndothelium 
[19]. 
As our  unde rstanding o f t he c omplexity of  nor mal endothelial f unction a nd va scular 
disease p rogression improves, it be comes clear that thi s limite d definition of endothelial c ell 
dysfunction does not properly take into account the numerous contributions of the endothelium 
to the vascular milieu, nor  does it ta ke into account the potential detriment of their loss or the 
systemic n ature of  endothelial d ysfunction a s a s yndrome.  A s s uch, s ome s cholars ha ve 
suggested a n expanded vi ew of  endothelial d ysfunction t o a lso i nclude a ssessment o f t he 
antithrombotic, metabolic, platelet and leukocyte adhesion, and anti-inflammatory properties of 
the e ndothelial c ells a s w ell a s the  a bility to regulate the  move ment of  f luid volume a nd 
electrolytes in  the intra- and extravascular spaces to provide a m ore finely tuned evaluation of  
the e xtent of  e ndothelial d ysfunction a nd c apacity t o pr edict t he pot ential c ourse of  di sease 
progression [12, 19, 23,  24].  O thers note that endothelial dysfunction is characterized not only 
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by the loss of functionality of the endothelial cells present, but  also by a reduced ability of the 
endothelium to repair desquamation whether through proliferation or recruitment of circulating 
endothelial progenitor cells (EPCs) [24].  The relatively young field of biomarkers of endothelial 
dysfunction stands to provide the greatest benefit to this broader view of endothelial dysfunction. 
1.1.6 Atherosclerosis 
The f ormation of  t he a therosclerotic l esion i s c omplex a nd m ultistep.  D ue t o e xposure t o 
oxidized lipoproteins or oxidized LDL resulting from diet or inflammation, activated endothelial 
cells ( ECs) upr egulate s urface m arkers r esponsible f or r ecruitment a nd i ntravisation of  
circulating monocytes i nto t he subendothelial space where t hey di fferentiate i nto macrophages 
and t ake up ox idized L DL and ot her l ipids, l eading t o t he f ormation of  f oam c ells which 
comprise t he e arly l esion, know n a s t he “ fatty s treak.”  T he de veloping a therosclerotic l esion 
consists of foam cells of macrophage and smooth muscle cell origin, extracellular pools of lipids, 
apoptotic cells, and other immune cells such as T cells and mast cel ls, and is accompanied by 
SMC m igration a nd pr oliferation.  In t he l ate s tages of  pl aque de velopment, t he lesion also 
contains foam cells of endothelial cell origin.  As the lesion progresses, it becomes increasingly 
fibrotic and calcified, making it more susceptible to plaque rupture, leading to thrombosis, which 
can cause vessel occlusion or embolization or can contribute to further growth of the lesion and 
increased vessel stenosis, all with the potentially catastrophic outcome of stroke, myocardial or 
other organ infarction, or peripheral vascular occlusion [3, 6, 20].   
Similarly, loss of integrity of the endothelium due to endothelial apoptosis, as may also 
occur in the pr ocess of  vascular graft oc clusion, i s also believed to cause increased vascular 
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permeability, SMC proliferation, a nd bl ood c oaguability, potentially c ontributing t o l ipid, 
monocyte, and SMC deposition in the intimal space leading to plaque development [1, 38]. 
1.1.7 Transplant vasculopathy 
Transplant vasculopathy remains one of the most significant limitations in solid organ allograft 
transplantation.  A pproximately 50%  of  tr ansplant pa tients e xhibit s ignificant a llograft 
vasculopathy w ithin f ive years a nd 90 % e xhibit s ignificant di sease w ithin ten years.  During 
transplant vasculopathy, the vasculature of  t he a llograft or gan d evelops s evere, di ffuse i ntimal 
hyperplasia, leading to stenosis and eventual graft ischemia [15].   
Within the first year, a phenomenon of vessel shrinkage in transplanted organs has been 
observed and i s be lieved t o be  due  t o a  t ransient a dventitial h yperplasia c haracterized b y 
increased adventitial s carring and contraction due to initial pe rivascular inflammation.  Later, 
vascular stenosis in transplanted organs tends to be characterized by intimal hyperplasia, which 
involves the recruitment and proliferation of smooth muscle cells into the intima.  Regardless of 
whether int imal, medial, or a dventitial h yperplasia is  ini tiated, the ne t e ffect on the ve ssel 
without compensatory remodeling, is often increased vascular stiffness [15].   
Unlike conventional a therosclerotic l esions, a reas of  t ransplant vasculopathy t end to be  
concentric around t he graft r ather t han f ocal.  A lthough t he c omposition of  t he m edia a cross 
these lesions is somewhat different from a traditional atherosclerotic plaque, the initiating events 
of l esion f ormation a re still be lieved t o be  l oss, i mpaired r emodeling, and d ysfunction of  t he 
endothelium.  A lso, as w ith c onventional a therosclerosis, i nflammation a nd i ts i mpact on t he 
endothelium are also believed to be  a ve ry i mportant f actor i n t he early stages of  lesional 
development [1, 15]. 
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1.1.8 Vascular graft occlusion 
Annually, m ore t han 35 0,000 pa tients i n t he U nited S tates a nd m ore t han 800,000 pa tients 
worldwide undergo coronary artery bypass grafting for revascularization therapy due to coronary 
artery disease.  Graft occlusion following gradual graft stenosis remains a daunting challenge to 
bypass grafting and grafts of venous origin (i.e. saphenous vein) have a substantially higher rate 
of oc clusion b y t en years pos t-operative t han do arterial g rafts ( i.e. internal m ammary ar tery).  
Studies also show that even when the graft remains patent, vascular disease of the graft is often 
present [39, 40]. 
 Vein g raft oc clusion ha s be en e xtensively do cumented t o be  t he r esult of  e xcessive 
intimal h yperplasia o r at herosclerosis, often occurring at t he ar tery-vein anastomotic s ite [41].  
Experimental ve in grafts may s ee as  much as 140 times the ci rcumferential s train encountered 
compared t o that en countered at t he h arvest s ite.  A dditionally, the anastomotic s ite, due  t o 
ballooning of the graft because of compliance mismatch, is frequently exposed to eddying shear 
flow c onditions [42].  H istological e valuation of  t he ve in grafts ne ar the  a nastomotic s ite ha s 
shown that they experience intimal hyperplasia as well as loss of the endothelial layer across this 
region [41].  T his phe nomenon ha s a lso be en o bserved a long t he e ntire l ength of  t he graft in 
experimental ve in graft m odels, w ith a nd w ithout r eduction i n e ddying s hear flow [38, 4 2].  
There i s also evidence that in arterial and vein grafts in which the bypassed coronary a rtery i s 
“too patent,” that increased stenosis, due to reduced arterial flow in the graft, may occur [40]. 
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1.2 VASCULAR ENDOTHELIAL BIOMECHANICS AND MECHANOBIOLOGY 
Blood vessels experience a variety of mechanical forces due to blood f low, mainly hydrostatic 
pressure, acting radially; c yclic s train, acting ci rcumferentially; a nd f luid s hear s tress, a cting 
longitudinally in the direction of blood flow [43], as shown in Figure 1.2.  Together, these forces 
influence t he e ndothelium a nd i ts r ole i n maintaining pr oper bl ood f low, va scular t one, 
remodeling, inflammation, and thrombosis.  During mechanical injury and disease, blood vessels 
may encounter abnormal levels of these forces, which have been shown to affect the function of 









The pr ocess b y w hich applied m echanical f orces a re t ransformed i nto c ellular bi omolecular 
responses, i s know n a s m echanotransduction [46].  S everal pos sible m echanisms ha ve b een 
proposed for mechanotransduction including ion channels, G-proteins, mitogen-activated protein 
kinases (MAPKs), integrins and focal adhesions, the cytoskeleton, and reactive oxygen species 




Figure 1.3.  Several possible mechanisms for mechanotransduction have been proposed. 
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Upon a ctivation, s tretch-activated (SA) c ation channels al low a non -selective i nflux of  
K+, Na+, a nd C a2+ ions i nto t he c ell f ollowed b y membrane d epolarization.  T his r esponse i s 
blocked by the removal of extracellular Ca2+ or addition of the stretch-activated channel inhibitor 
gadolinium, but  not  by the addition of  Ca2+ channel blockers.   S A cation channels have been 
identified i n E Cs a nd S MCs of  va rious s pecies a nd va scular or igins a nd a re i nvolved i n c ell 
differentiation, p roliferation, morphological changes, and superoxide production in response to 
cyclic s train.  SA cat ion channels have also been known to signal through a number of second 
messenger pathways, including ERK1/2.  S pecific mechanosensitive K+ ion channels have also 
been reported in ECs and SMCs [44, 48]. 
Heterotrimeric G-proteins on t he apical surface of endothelial cells have been proposed 
as m echanosensors of  s tretch and shear s tress, in i solated m embranes and w hole cell m odels, 
suggesting a n i nitiating r ole f or c hanges i n m embrane f luidity i n r esponse t o m echanical 
perturbation.  Cyclic strain-induced p38 phosphorylation can be blocked by addition of G protein 
agonists and the level of activation has been show to be sensitive to both the magnitude and rate 
of strain [44, 48]. 
Mitogen-activated protein kinases ( MAPKs), including E RK1/2, J NK, a nd p38, ha ve 
been implicated in the process of mechanotransduction, but it is unclear whether they function in 
direct m echanosensing, second messenger s ignaling, or  both.  A lthough the i ntermediate s teps 
are not  w ell und erstood, m echanotransduction d ue t o S A cation channels, a nd actin f ilaments 
have be en s hown t o a ctivate E RK1/2.  Cyclic s train i nduces J NK a ctivation i n a n integrin-
independent manner, but it is unclear whether reactive oxygen species may be the cause of JNK 
activation.  Activation of p38 by cyclic stretch, which is time- and stretch-dependent, appears to 
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occur as  a s econd messenger pa thway m ediated by r eactive oxygen s pecies or  ot her s ignaling 
pathways like PKC-ras/rac1 [44]. 
Mechanical s tretch i s k nown t o r einforce i ntegrin adhesions and pr oduce i ntegrin-
dependent s ignaling, ob served i n bot h E Cs and S MCs [48].  In mos t cases, the cytoplasmic 
domain of integrins is functionally linked to cytoskeletal proteins and kinases like focal adhesion 
kinase, placing them in an optimum location for initiation of mechanotransduction [45, 47].  It is 
speculated that the α subunit acts as the mechanosensor and that subsequent signal transduction 
occurs t hrough t he cytoplasmic dom ain of  t he β1 integrin.  A dditionally, β1 i ntegrin pr otein 
expression and activity are observed in rat aortic SMCs in response to mechanical stress, further 
supporting this argument [44].  The specific signaling response appears to vary between species 
and vascular b eds, reflecting a s pecificity f or e xtracellular ma trix c omposition and integrin 
combination [44, 45, 48]. 
Owing to the complex and interconnected structural elements of the cell cytoskeleton, it 
has been proposed that the stresses applied locally are distributed globally through movement of 
the c ytoskeletal s tructure t hroughout t he cell.  T hus, t hrough t he cytoskeletal s tructure of  
microfilaments, intermediate f ilaments, internal mic rotubule s truts, and extracellular ma trix 
adhesions, s urface f orces c ould be  t ransmitted a long t he cytoskeleton deep into the cel l, 
potentially causing s patial a ssociations of  ot herwise s eparated enzymes and substrates t o 
promote signaling events.  This process is generally known as the tensegrity concept [44, 47]. 
Another possible route for sensing of mechanical forces, particularly shear stress, is the 
glycocalyx.  The glycocalyx covers the luminal surface of the blood vessel and provides a barrier 
to shear s tress s uch t hat t he s hear s tress a cting on the a ctual api cal pl asma m embrane of  t he 
endothelial cells is essentially zero.  In theory, mechanical forces would be transmitted along the 
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glycosaminoglycan chains of the glycocalyx to transmembrane anchors, and enzymatic digestion 
of the glycocalyx has been shown to negate certain shear-induced outcomes like NO production, 
but the specificity of such models is unclear [46, 48, 49].   
Reactive ox ygen s pecies ( ROS), which are capable of  s ignaling t hrough a  va riety of  
signaling pathways in the endothelium have also been proposed as an initial signaling event for 
mechanotransduction, most notably because ROS can activate FAK, which has been implicated 
in m echanotransduction due  t o i ts l ocation a t focal c ontacts a nd a bility to s ignal t hrough a 
number of downstream signaling p athways.  R OS a ppear t o b e i nvolved i n e ndothelial c ell 
expression of MCP-1 on endothelial cel ls exposed to mechanical strain, but  the source of ROS 
and whether it is the initial signal remains unclear [47]. 
The t rue m echanism of  m echanosensing i s ho tly de bated, but  i t s eems l ikely t hat 
endothelial cel ls em ploy a va riety of  s uch mechanisms with pot ential for ove rlap o f s econd 
messenger signaling pathways. 
1.2.2 Cyclic strain and the vasculature 
In pa rticular, cyclic s train is of  int erest to this study b ecause of  i ts clinical r elevance t o 
hypertension, ve in grafting, b alloon a ngioplasty ove r-stretch inj ury and pos sibly i ntra-aortic 
balloon pum ping, t issue e ngineering, a nd atherosclerotic l esions.  Cyclic s train influences a 
variety of vascular cell functions including proliferation, migration, apoptosis, morphology, and 
production and secretion of a variety of soluble molecules inherent to EC function [44].  C yclic 
strain appears to affect EC proliferation biphasically, with lower levels of strain causing reduced 
proliferation a nd hi gher levels of  s train c ausing enhanced pr oliferation.  E C m igration, on t he 
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other ha nd, a ppears t o vary di rectly w ith cyclic s train m agnitude, such that i ncreased s train 
causes an increase in the rate of migration [44].  One of the hallmarks of cyclic uniaxial strain in 
vascular cells is the phenomenon of cellular alignment perpendicular the direction of strain [44, 
50].  T his pe rpendicular al ignment i s b elieved to cause a r eduction of net i ntracellular s tress 
during l ong-term e xposure t o c yclic uni axial s train a nd i s a bsent in r esponse t o c yclic bi axial 
stress [50].  With increasing magnitude of uniaxial stretch, actin stress fibers align more closely 
perpendicular t o s train, w ith s ignificant a lignment a t a nd a bove ~5% s train [44, 50] .  
Microfilament r earrangement is  a lmost c omplete b y 15 minutes a fter the  ons et of  s train and 
cellular alignment is complete within 12 to 48 hours [44]. 
 Spontaneous atherosclerotic lesions tend to develop in regions of  elevated cyclic s train, 
including sites of vein to artery grafting [42, 51].  Not surprisingly, vein grafts used in coronary 
artery b ypass grafting are m ore pr one t o atherosclerosis t han arterial g rafts i n the s ame 
application [40].  Interestingly, in both ECs and SMCs, physiological levels of cyclic strain (~6-
10%) do not increase apoptosis, whereas in both cell types, superphysiological levels (15-20%) 
promote apoptosis [44, 52, 53].  Moreover, physiological cyclic strain in ECs inhibits TNF-α and 
serum s tarvation i nduced a poptosis i n bot h hum an a nd bovi ne a ortic E Cs [52].  Furthermore, 
cyclic strain has been shown to increase ROS production in aortic and venous ECs and in SMCs 
[51, 54, 55] .  It is theorized that high biomechanical stress results in elevated oxidative damage 
and c ell de ath, c ontributing t o i nflammation a nd SMC h yperplasia ultimately resulting in  
atherogenesis [38, 42, 44, 51, 55]. 
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1.2.3 Shear stress and the vasculature 
Although not the focus of this study, it is worth noting that of the forces acting on blood vessels, 
shear stress has been studied the most in the context of vascular endothelial cells, as this is the 
only cell t ype of  the vascular wall exposed to shear s tress associated with blood f low [56-59].  
Very notably, laminar shear stress is associated with a protective induction of eNOS expression 
and N O r elease, w hereas i n a reas of  di sturbed s hear s uch a s a t bi furcations, l ow e NOS 
expression occurs in a manner that makes the vessel more prone to atherosclerosis [56, 60]. 
1.3 CERAMIDE AND SPHINGOLIPIDS 
1.3.1 Ceramide 
Ceramide is a sphingolipid with diverse activity relevant to atherosclerosis and vascular biology.  
As such, ceramide is produced in response to a multitude of cellular stressors including cytokines 
(TNF-α, IL-1β, etc.), h ypoxia/reperfusion, l ipopolysaccharide, a nd o xidized LDL, growth 
factors, and other stimuli present in the vascular environment [2, 61].  Depending upon t he site 
and source of synthesis, ceramide can participate directly in signaling or can assist in signaling 
through its involvement in lipid rafting [2, 62].  Lipid rafts are regions of the plasma membrane 
that a re e nriched i n s phingomyelin a nd c holesterol.  U pon h ydrolysis of  s phingomyelin t o 
ceramide, these l ipid rafts s elf-associate t o form l arger c eramide-enriched membrane domains, 
thereby assisting in the aggregation and clustering of receptor molecules and contributing to the 
reorganization of int racellular s ignaling mol ecules to allow s ignal pr opagation within the c ell 
 22 
[62].  Depending on t he source and type of ceramide involved, ceramide signaling may lead to 
cell proliferation, differentiation, growth, or apoptosis [61].   
This diversity of outcomes is evident within the vascular setting.  In bovine aortic ECs, 
TNF-α, U V, he at s hock, H 2O2, a nd γ-irradiation all s ignal thr ough ceramide, resulting in 
apoptosis.  Conversely, in vascular SMCs, oxidized LDL signals through ceramide to cause SMC 
proliferation, LDL aggregation, a nd f oam c ell f ormation.  IL-1, on  t he other h and, p romotes 
differentiation of human dendritic cells and E-selectin upregulation in human umbilical vein ECs 
(HUVECs) by way of ceramide signaling [63]. 
1.3.2 Ceramide biosynthesis and signaling 
Ceramide is central to sphingolipid biosynthesis and may be generated de novo, or may 
be produced during the hydrolysis of sphingomyelin and other complex sphingolipids [63, 64], 
as s hown i n Figure 1.4. Ceramide can  a ct d irectly, or  can  be  f urther m etabolized into 
sphingomyelin ( SM), c eramide-1-phosphate, glucosylceramide a nd hi gher gangliosides or  
glyclolipids, or to sphingosine, which can be further processed into sphingosine-1-phosphate (S-
1-P) [63-66].  S tressors such as γ-irradiation or T NF-α stimulate s everal of  the se pa thways 
simultaneously [63, 65].  Thus, it is believed that the fate of a cell is determined by the net effect 
of the activity of all of these pathways in response to stresses [65].  Known targets of ceramide 
include ce ramide-activated pr otein ki nase (CAPK), pr otein ki nase C ζ (PKCζ), and ceramide-
activated pr otein phos phatase ( CAPP) [63, 65, 67] .  A dditionally, ceramide int eracts w ith 
MAPK, JNK, caspase, and m itochondrial s ignaling p athways [63, 67] .  T he num erous 
downstream targets of ceramide have been reviewed excellently by others [68, 69]. 
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Figure 1.4.  Ceramide is central to sphingolipid biosynthesis. 
 
 
As a  s phingolipid, c eramide i s s tructurally characterized b y a s phingosine ba se w ith a  
fatty acid attached to the car bon-2 pos ition b y a n a mide bond [64] (Figure 1.5).  T he 
predominant physiological forms of ceramide contain fatty acids of C16 to C26 chain length [62, 
70].  C 16 and C24 ceramides specifically have been implicated in apoptosis [70].  A  hydrophilic 
head gr oup c an be  a ttached t o t he O H-group i n t he c arbon-1 pos ition t o yield m ore c omplex 
sphingolipids.  F or e xample, a ddition of  a  s ugar yields g lycosphingolipids, i ncluding 





Figure 1.5.  Sphingolipids l ike c eramide, s phingosine-1-phosphate, an d s phingomyelin ar e ch aracterized by a  
sphingosine base. 
 25 
SM i s t he pr edominant s phingolipid i n bi ological m embranes and i s hy drolyzed i nto 
ceramide by sphingomyelinase (SMase).  Several forms of secreted or membrane-bound SMases 
have been identified and they a re cha racterized by their pH  optima – acidic (aSMase), neutral 
(nSMase), or ba sic [62, 65] .  nS Mase i s f ound pr imarily i n t he pl asma m embrane w hereas 
aSMase i s l ocated i n t he l ysosomes and e ndosomes, w here i t i s h ypothesized t hat i t m ay be  
rapidly mobilized to the extracellular membrane upon stimulation [65, 66, 71].  Basic SMase has 
been identified in the intestinal mucosa and bile, where it may be involved in digestion [63].   
Stress s timuli ma y tr igger c eramide a ccumulation from e ither de novo synthesis, S M 
hydrolysis, or both, and both pathways have been implicated in the same cellular outcomes.  SM 
hydrolysis into ceramide has been observed in response to numerous stimuli including TNF-α, 
Fas ligand, vitamin D3, IFN-γ, various chemotherapeutic agents, ionizing irradiation, heat stress, 
ischemia/reperfusion, nitric oxide, and IL-1 [63, 65, 72] .  Potentially interesting in the vascular 
setting is the observation that ceramide signaling due to aSMase-mediated hydrolysis of SM is 
necessary for eNOS activation by some cytokines and growth factors in various cell types and a 
coregulatory role f or ceramide and NO h as be en s uggested [73, 74] .  De novo synthesis of  
ceramide has b een obs erved in r esponse t o TNF-α, i onizing i rradiation, and chemotherapeutic 
agents [63, 65, 70, 75] .  Sphingomyelin hydrolysis occurs rapidly and transiently within minutes 
as an early ceramide response, although prolonged SMase act ivity has been observed, whereas 
de novo synthesis usually occurs over a period of several hours as a late response [63, 65, 70]. 
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1.3.3 Ceramide metabolites 
Both ceramide and its many metabolites are biologically active [2, 61, 64].  Of particular note in 
the vascular s etting is  the  metabolite sphingosine-1-phosphate (S-1-P) (Figure 1.5).  C eramide 
may be degraded to sphingosine by ceramidase and sphingosine can then be converted to S-1-P 
by sphingosine kinase (Figure 1.4).  S-1-P can either be converted back to sphingosine or can be 
further degraded b y S-1-P lyase to e thanolamine phosphate and hexadecanal for removal f rom 
the sphingolipid biosynthetic pathway [64, 76].  Platelets store and release S-1-P upon activation 
[76, 77].  Normal plasma and serum contain S-1-P at concentrations of 200-500nM [77].  S-1-P 
acts a s a n autocrine a ctivator of  pl atelets a nd he lps to synergistically amplify aggregation 
induced by weak platelet agonists [76].  As such, S-1-P may play a s trong role in accelerating 
hemostasis a nd t hrombosis [76, 77 ].  In H UVECs, S -1-P bi nds t o c ertain endothelial 
differentiation gene ( EDG) receptors t o e nhance m orphogenic di fferentiation, f ormation of  
adherens junctions and cortical actin, and chemotactic migration in angiogenic models [78].  In 
human a ortic S MCs, S -1-P i nhibits actin f ilament a ssembly a nd formation of  f ocal adhesions, 
thus inhibiting SMC spreading and migration. [79]. 
Since S-1-P tends to enhance growth, whereas ceramide tends to promote cell death and 
cell cycle arrest, it has been hypothesized that the relative amounts of  ceramide and S-1-P in a 
cell balance each other and serve as a sphingolipid rheostat [80].  Addition of S-1-P is capable of 
preventing exogenous ceramide-induced apoptosis i n HUVECs [78].  T his further und erscores 
the importance of understanding the balance of ceramide and its metabolites within the cellular 
setting. 
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1.3.4 Ceramide and its metabolite in atherosclerosis 
Ceramide ha s be en directly implicated in atherosclerotic le sions.  S ections of  a therosclerotic 
aorta contain substantially higher levels of ceramide by wet tissue weight than similar segments 
of he althy tis sue [2].  L actosylceramide i s pr evalent i n atherosclerotic l esions at al l s tages o f 
formation [81] and macrophages present in atherosclerotic lesions have been found to produce a 
soluble s phingomyelinase c apable of  d egrading sphingomyelin a ssociated w ith ox idized L DL 
into ceramide [2, 81].  Endothelial cells at the site of lesions have also been found to secrete a 
soluble form of  acidic sphingomyelinase [71].  F urthermore, in vitro, exogenous ceramide and 
exogenous neutral sphingomyelinase have been shown to cause Weibel-Palade body exocytosis 
from human aortic ECs, which may trigger inflammation and thrombosis [26].  Thus, ceramide 
may pl ay a  s ignificant r ole in the pr opagation of c ellular a nd molecular e vents c ritical to the 
formation of atherosclerotic lesions. 
1.4 SUMMARY AND LIMITATIONS OF PREVIOUS RESEARCH 
The vascular endothelium is continuously subjected to a variety of mechanical forces including 
cyclic s train, shear s tress, and pressure from pulsatile blood flow, as well as  chemical s tresses.  
Together, these factors influence t he endot helium's ability t o maintain appr opriate v ascular 
permeability, v ascular t one, a nd he mostasis, and to regulate inf lammation and remodeling in  
health and disease.  During mechanical injury or disease, blood vessels may encounter abnormal 
levels of mechanical forces, which can affect the function of endothelial cells and may contribute 
to formation of atherosclerotic lesions [43-45].   
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The m echanism by which e ndothelial c ells r espond t o m echanical f orces, or  
mechanotransduction, i s not  c ompletely unde rstood a nd i s the s ubject of  ong oing de bate.  
Several pos sible mechanisms i ncluding G -protein-linked r eceptors, mitogen-activated protein 
kinases ( MAPKs), i ntegrins a nd f ocal a dhesions, t he c ytoskeleton, ion c hannels, and reactive 
oxygen species (ROS) have been proposed as components of  the mechanosensing p rocess and 
likely, several of  these processes are activated concurrently [44, 45, 47] .  H owever, the role of 
the l ipid microenvironment a nd l ipid signaling, and m ore pa rticularly ceramide s ignaling, i n 
mechanotransduction, remains largely unknown.   
While, ceramide has be en s tudied in r esponse t o numerous molecular s tressors [2, 61] , 
almost no w ork ha s been done  t o e xplore t he r ole t hat c eramide m ight pl ay du ring 
mechanotransduction in response t o mechanical s tresses on cells, in particular in the va scular 
endothelium.  E xogenous c eramide generation ha s be en s hown t o cause i ncreased c ell 
proliferation as well as apoptosis in the walls of an experimental in vivo vein graft model [38].  
In an elevated pressure/flow model in isolated rat lung, transient activation of neutral SMase in 
the cell membrane has also been observed to generate ceramide, suggesting that it is a possible 
step in mechanosensing [82, 83].  Another study has shown that exogenously added ceramide or 
hydrolysis of  SM t o ceramide b y e xogenously added SMases is capa ble of  caus ing 
vasorelaxation in SMCs of phenylephrine-contracted rat aortic rings in vitro [84].  However, the 
role of ceramide and its metabolites remains unexplored in the model of cyclic strain. 
In our  s tudies, w e examined the vi rtually un explored a nd c ritical r ole of  t he l ipid 
microenvironment, particularly w ith regards to  c eramide s ignaling, in e ndothelial cells in  
response t o cyclic s train w ithin a nd be yond t he ph ysiological r ange, s o a s t o g ain a  be tter 
understanding of  t he events w hich m ay ul timately contribute t o e ndothelial d ysfunction and 
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eventual at herosclerosis.  T his research specifically f ocused on t he ceramide bi osynthetic 
pathway because we hypothesize that these lipid pathways play a critical role in endothelial cell 
mechanotransduction at several levels, as shown in Figure 1.6: 
1. Ceramide plays a critical role in plasma membrane dynamics
 
.  The involvement of G-
proteins, MAPKs, and other plasma membrane proteins in mechanotransduction 
pathways within endothelial cells has been demonstrated.  However, the influence and 
function of the ceramide and sphingolipid component of the plasma membrane must be 
considered because these lipids serve as membrane anchors for many of these proteins 
and function in the formation of lipid rafts to aid in the coalescence of membrane proteins 
and receptors into caveolae, which is necessary for efficient signaling [62]. 
2. Ceramide is required for activation of some protein kinases
 
.  While various protein 
kinases appear to be associated with the mechanotransduction response, it should be 
noted that some kinases require ceramide for activation, directly or indirectly [63, 65, 
67], suggesting a further potential role of ceramide and sphingolipids. 
3. Ceramide can form channels in membranes
 
.  Protein-based ion channels have been 
proposed as endothelial cell mechanosensors.  Again, ceramide and the sphingolipid 
component must be considered because of its necessity in proper ion channel formation, 
as well as for ceramide’s ability to self-form channels in lipid membranes without protein 
involvement [62, 85]. 
4. Ceramide can generate ROS and ROS can generate ceramide.  Ceramide has been shown 
to promote ROS generation and the correlation between ROS formation and ceramide 
signaling has been observed in numerous models [62, 67, 86].  Furthermore, ROS 
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production promotes ceramide generation.  Together, this perpetuating relationship would 
provide an efficient mechanism of signal amplification in ECs during 
mechanotransduction. 
 
5. The ceramide-sphingomyelinase pathway has been suggested as a mechanosensor
 
.  Rapid 
generation of ceramide due to neutral SMase activity in caveolae in a pressure/flow 
model has been observed, suggesting its potential role in mechanosensing [82, 83].  The 
ceramide-sphingomyelinase pathway has also been implicated in vasodilation, 




Figure 1.6.  Ceramide signaling may play a critical role in endothelial cell mechanotransduction at several levels. 
 31 
Thus, a detailed study of the role of the lipid microenvironment, and more particularly the 
role of  ceramide and its me tabolites, during c yclic s train will pr ovide n ew oppor tunities f or 
manipulation and monitoring of  endothelial he alth and function.  S uch manipulation s trategies 
could have di rect t ranslational appl ications i n pr otective t herapies for c ompromised o r 
pathophysiological s tates s uch a s a therosclerosis, hypertension, following ve in gr afting, or  t o 
enhance vascular tissue engineering efforts. 
1.5 HYPOTHESIS AND SPECIFIC AIMS  
The presented experiments were designed to test the following hypothesis:  
Mechanical, uniaxial cyclic strain results in an increase in intracellular ceramide in 
vascular endothelial cells, which participates in signaling necessary to propagate 
mechanotransduction responses to cyclic strain, potentially contributing to early events in 
the development of endothelial dysfunction and the formation of atherosclerotic lesions.   
The specific aims that we established to test this hypothesis are as follows: 
Specific Aim 1
a. Identify the major species of phosphatidyl choline (PC), phosphatidyl ethanolamine (PE), 
phosphatidyl inositol (PI), phosphatidyl serine (PS), and phosphatidyl glycerol (PG) 
present in human and bovine aortic endothelial cells. 
:  Determine the profile of phospholipids and sphingolipids present in aortic 
endothelial cells. 
b. Identify the major species of ceramide and sphingomyelin (SM) present in human and 
bovine aortic endothelial cells. 
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c. Determine whether aortic endothelial cells in static culture respond similarly to 
exogenous C8 and C16 ceramides, representing species of nonphysiological and 
physiological fatty acid chain lengths respectively. 
Specific A im 2
a. Identify the molecular forms of ceramide generated in response to cyclic strain. 
:  Determine whether aortic endothelial cell ceramide levels are altered in 
response to uniaxial, cyclic mechanical strain. 
b. Determine whether ceramide signaling in response to cyclic strain involves an early 
response within minutes, suggesting membrane sphingomyelin as the source of ceramide 
generation; a late response after several hours, suggesting de novo ceramide generation; 
or both. 
c. Determine if the duration, frequency, and intensity of cyclic strain affects the magnitude 
and molecular forms of ceramide generated. 
 
Specific A im 3
a. Determine if levels of sphingomyelin, sphingosine, and sphingosine-1-phosphate are 
altered in response to cyclic strain. 
:  Determine which ceramide biosynthetic pathways are activated upon 
exposure of aortic endothelial cells to cyclic, uniaxial strain and determine the 
abundance of ceramide metabolites. 
b. Determine the effects of inhibitors of de novo ceramide synthesis and hydrolysis of 
sphingomyelin to ceramide, on cyclic strain-induced ceramide levels. 
To summarize the  e xperimental de sign, we b egan by d efining the  lipi d environment of  aortic 
endothelial cells to establish the foundation for a more in-depth study of ceramide signaling.  We 
then set out to t horoughly e valuate how  c eramide a nd i ts m etabolites c hange i n r esponse t o a  
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panel of  ph ysiological and pa thological s train c onditions w ith r egards t o m agnitude a nd 
frequency ov er t ime.  Then, t o further de fine t he pl ace of  ceramide s ignaling w ithin t he 
mechanotransduction r esponse t o c yclic s train, w e e valuated w hich biosynthetic pa thways 
appeared to be activated i n response to strain and the accumulation of s elect matabolites with 
known biological activity in the vascular microenvironment.  T he findings of these studies will 
help t o e lucidate t he e arly e vents i n t he m echanotransduction r esponse t o c yclic s train a nd t o 
bridge our  unde rstanding be tween t he r elationship be tween m echanotransduction a nd 
inflammation as it relates to endothelial cell activation and dysfunction and vascular disease. 
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2.0  DETERMINATION OF THE LIPID PANEL FOR AORTIC ENDOTHELIAL 
CELLS 
2.1 INTRODUCTION  
Before examining the modulation of a single lipid species – ceramide -- and its metabolites, it is 
helpful t o f irst de fine t he e ntire p anel o f phos pholipids a nd s phingolipids pr esent i n a ortic 
endothelial cells and to identify variations between the lipid profiles of bovine aortic endothelial 
cells ( bAECs) a nd hum an a ortic e ndothelial c ells ( hAECs).  Many bi ologically a ctive lipi d 
species s uch as  sphingosine-1-phosphate, di acylglycerols, pl atelet-activating f actor, 
lysophosphatidic acid, and eicosanoids can be derived f rom the degradation or  modification of  
other phos pholipids a nd s phingolipids [87, 88 ].  L oss of  a ppropriate l ipid bi osynthesis ha s 
extensive implications in disease [87].  Thus, one must look at the entire lipid panel of the cell to 
properly understand the signaling potential of the cell.  
Lipids play important roles not only in the structures and metabolic functions of cells and 
organelles, but  also in signal transduction directly, as second messengers, or indirectly through 
lipid rafting [87, 89, 90] .  In addition to the functional specificity of the polar head-group of a  
lipid, the f atty acid side-chain c omposition, c hain-length, and bond characteristics can affect 
membrane f luidity a nd rigidity – characteristics ne cessary f or m aintaining pr oper m embrane 
structure/function and signaling [91, 92] .  Sphingolipids, as a part of  l ipid rafts, are critical for 
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facilitating and amplifying r eceptor signaling w ithin cells [62].  To da te, t here have be en no  
thorough evaluations of the specific lipid composition of aortic endothelial cells, particularly by 
mass spectrometry.   
Electrospray ioni zation tandem ma ss s pectrometry (ESI-MS/MS) ha s b een used by a 
number of groups including our own to identify the specific composition of lipids from whole-
cell lipid extractions, alone or  following HPLC or thin-layer chromatography purification [89, 
93-96]. 
This chapter will specifically address the first specific aim: 
Determine the profile of phospholipids and sphingolipids present in aortic endothelial cells. 
1. Identify the major species of phosphatidyl choline (PC), phosphatidyl ethanolamine 
(PE), phosphatidyl inositol (PI), phosphatidyl serine (PS), and phosphatidyl glycerol 
(PG) present in human and bovine aortic endothelial cells. 
2. Identify the major species of ceramide and sphingomyelin (SM) present in human and 
bovine aortic endothelial cells. 
3. Determine whether a ortic e ndothelial cells in static c ulture r espond s imilarly to 
exogenous C 8 and C 16 ceramides, representing s pecies of  nonph ysiological and 
physiological fatty acid chain lengths respectively. 
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2.2 METHODS 
2.2.1 Cell culture 
Cryopreserved s tocks of  pr imary culture hA ECs a nd bA ECs w ere obt ained from L onza 
Walkersville (Walkersville, M D).  P urchased hA ECs w ere obt ained f rom s ingle donor s a nd 
frozen in t he t hird passage following i solation.  Purchased bAECs w ere obtained pooled f rom 
three t o f ive donor s and f rozen i n t he f irst pa ssage following i solation.  P ooled bovi ne 
endothelial cells were chosen to reduce donor variation in endothelial cell phenotype.  Cells were 
expanded i n e ndothelial c ell g rowth m edium ( EGM, Lonza W alkersville), obtained as a 
BulletKit containing proprietarily protected concentrations of bovine brain extract with heparin, 
hydrocortisone, GA-100, human endothelial growth factor (hEGF), and a final concentration of 
2% s erum.  U pon r econstitution, hA ECs a nd b AECs w ere expanded a nd f rozen a s s tocks, a s 
described b elow, s o t hat a  f resh vi al of  cells c ould be  us ed f or e ach experiment a nd e ach 
experiment within a set of experiments would be done using cells in the same passage from the 
same c ell lot .  B y doi ng s o, all e xperiments c ould be  done  a t t he s ame pa ssage f ollowing 
isolation, within the number of guaranteed passages for endothelial cell phenotype and variation 
from donor to donor could be eliminated within the same set of experiments. 
2.2.1.1 Thawing of frozen aortic endothelial cells 
Prior t o t hawing frozen A ECs, 5m L complete EGM was a dded t o e ach of  f our T -25 
vented polystyrene t issue cul ture f lasks (BD Biosciences, S an J ose, C A) a nd warmed for 30  
minutes in a tissue culture incubator at 37oC, 5% humidity to condition the flasks.  Immediately 
upon removal from liquid nitrogen storage, the cryopreserved AECs (Lonza Walkersville) were 
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thawed quickly in a 37oC water bath before sterile transfer to the pooled, warmed medium from 
the preconditioned f lasks.  T he di luted cells were gently aspirated for mixing and then equally 
distributed across the T-25 flasks at a distribution of approximately 4000 cells/cm2).  The flasks 
were quickly returned to the 37oC incubator where they were allowed to adhere overnight.  O n 
the following day, the initial thawing medium was removed by aspiration and replaced with fresh 
EGM medium warmed t o 37 oC.  Media was r eplaced every t wo days t hereafter unt il pa ssage.  
All cell culture manipulations were performed using aseptic technique. 
2.2.1.2 Aortic endothelial cell passage and stocking 
When cells reached approximately 80% confluence, they were passed into new flasks at a 
distribution of 5000 cells/cm2 to prevent growth inhibition due to cell-cell contact.  As described 
previously (Section 2.2.1.1), 1 m L/5 cm2 EGM was added to the new flasks and conditioned at 
37oC prior to use in passage. 
For p assage, m edia w as ge ntly aspirated.  5 mL phos phate buf fered s aline ( PBS, 
Invitrogen, C arlsbad, C A) w as t hen a dded pe r 25 c m2 of c ulture a rea, r ocked gently, a nd 
removed b y a spiration t o r emove r esidual s erum f rom t he c ell m onolayer s urface.  1 m L of  
0.25% t rypsin-EDTA ( Invitrogen) pe r 25 cm2 of cul ture ar ea was i mmediately added t o the 
flasks and cell detachment was monitored closely using an inverted light microscope (Olympus, 
Center Valley, PA).  W hen cells were 80% rounded, the f lasks were gently tapped to dislodge 
the cells.  The trypsin was immediately diluted with room temperature EGM at a ratio of at least 
1:4.  Cells were counted on a hemacytometer (Fisher Scientific) and viability was determined by 
trypan bl ue e xclusion ( Sigma, S t. Louis, M O).  C ells w ere t hen centrifuged i n a be nchtop 
centrifuge at  1500  rpm f or 5 m inutes a t 4 oC to pellet the  c ells.  C ells w ere imme diately 
resuspended i n f reezing m edium c onsisting o f 10% F BS ( Invitrogen), 80% E GM, and 10%  
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DMSO (Fisher Scientific, Pittsburgh, PA) at a density of 1x106 live cells/mL.  Cells were quickly 
aliquotted into 2 mL round-bottom cryopreservation vials (Fisher Scientific), distributing 1x106 
cells pe r vi al.  V ials w ere i nsulated i n a s tyrofoam r ack and f rozen immediately i n a  -80oC 
freezer.  T he n ext m orning, c ells w ere t ransferred t o a  l iquid ni trogen freezer f or l ong-term 
storage.   
Approximately 50-70 vials of frozen AECs were obtained from each initial cryovial.  U pon 
stocking of  a ne w l ot of  A ECs, t he l ipid pr ofile of  t he ne w cells a t 80 % c onfluence i n s tatic 
culture was determined by electrospray mass spectrometry (ESI-MS) as described below (section 
2.2.2 t hrough 2.2.4 ) and compared to that of  previous lot s to ensure s imilarity of the  baseline 
lipid profile across donors.  For all experiments, cells were used in the first passage after thawing 
(fourth passage following receipt of initial primary culture and within seven passages following 
isolation). 
2.2.2 Preparation of AECs for ESI-MS Lipid Profile Determination 
Two vials (2x106 total l ive cells) were thawed (Section 2.2.1.1) and transferred into three T-75 
vented pol ystyrene t issue c ulture f lasks ( BD B iosciences), e ach pr econditioned w ith E GM at  
37oC.  Cells were cultured before passage (Section 2.2.1.2) into 6-well polystyrene tissue culture 
plates (BD Biosciences) at a density of approximately 5-8000 cells/cm2 in 2 mL EGM per well.  
The m edium was replaced with 2 m L EGM on the f irst da y following p assage and every two 
days thereafter.   
When cells reached 80% confluence, they were non-sterilely harvested, combining two wells per 
sample.  T he m edia f rom bot h wells w as t ransferred to a 15 mL conical cent rifuge t ube ( BD 
Biosciences).  Both wells were washed with 2 m L PBS and the wash was added to the conical 
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tube.  To induce cell detachment, 600 µL 0.25% t rypsin-EDTA was added to each well.  The 
cells were dislodged by aspiration with the pooled media/wash and returned to the conical tube.  
The wells were then washed to remove any remaining cells with 2 mL PBS per well, adding the 
wash to the same tube.  The harvested cells were centrifuged for five minutes at 1500 rpm, 4oC 
to pellet t he cel ls.  T he s upernatant w as t hen decanted and the c ells w ere r esuspended b y 
aspiration in 10 m L PBS.  T he cells were centrifuged again for 5 m inutes at 1500 r pm, 4oC to 
pellet the cells and the supernatant was discarded.  The cells were then resuspended in 1 m L of 
PBS, they were counted on a  hemacytometer, and the viability was determined by trypan blue 
exclusion. 
2.2.3 Lipid extraction 
Two wells of  a 6 -well pl ate grown t o 80% confluence generally yielded 5-10x105 cells, 
corresponding to an appropriate total lipid content for analysis by our ESI-MS techniques. 
Lipid extractions w ere p erformed in 13x100 m m borosilicate g lass tube s ( VWR, West 
Chester, PA) t hat ha d been pr epared b y w ashing t hem f irst w ith H PLC gr ade m ethanol 
(Spectrum, G ardena, C A) f ollowed b y chloroform ( EMD, G ibbstown, N J).  T he t ubes w ere 
allowed to air dry in a ventilated chemical fume hood. 
After cell counts and viability were determined, the endothelial cells were transferred to a 
prepared glass t ube, w hich w as t hen pl aced i nside a  ne w 15 c c pol ypropylene c onical and 
capped.  The cells were then centrifuged for 5 minutes at 1500 rpm, 4oC to pellet the cells.  The 
supernatant was decanted in a  s ingle pour to avoid dislodging the pelleted cells.  Immediately, 
500 µL of methanol containing butylated hydroxytoluene (BHT, Sigma) was added to the glass 
tube using a polypropylene pipette tip and the tube was briefly centrifuged.  1 mL of chloroform 
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was t hen a dded us ing a  g lass s erological pi pet pr ewashed w ith c hloroform t o r educe 
contamination of  t he e xtraction a nd t he t ube was a gain br iefly vor texed.  T he f inal e xtraction 
concentration of methanol:chloroform was 1:2.  The glass extraction tube was then replaced in 
the pol ypropylene t ube, the t ube w as f lushed w ith a  s tream of  ni trogen ga s, a nd t he t ube w as 
capped and sealed with Parafilm.  Extraction was allowed to occur in the dark, overnight, at 4oC. 
To separate the aqueous and organic phases, 300 µL of 0.15 M NaCl (Sigma) was added 
to the glass extraction tube.  The tube was vortexed for 5 seconds followed by centrifugation for 
5 m inutes a t 1500r pm, 4oC.  T he o rganic l ayer, c ontaining t he l ipids f rom t he c ell s ample 
partitions at the bottom of the tube below the NaCl.  T he bottom 90% of the organic layer was 
carefully removed using a glass Pasteur pipette and transferred to a  fresh glass ex traction tube 
prepared as described earlier in this section and untouched without clean latex gloves to reduce 
contamination from oils on the fingers.  T he organic layer was then evaporated under a s teady 
stream of ni trogen gas over a warm water bath, leaving the isolated lipids as a dry film on the 
bottom of the tube.  The glass tube containing the dried lipid extract was then replaced in the 15 
mL polypropylene conical, the conical was f lushed with ni trogen gas, capped, and sealed with 
Parafilm.  The lipid extracts were then stored in the dark at -20oC until ESI-MS analysis. 
2.2.4 ESI-MS analysis of lipids 
2.2.4.1 Principles of electrospray mass spectrometry 
Electrospray mass spectrometry (ESI-MS) works by solubalizing the sample molecules in 
a compatible running solution which is passed through a high voltage capillary tube into a strong 
electrostatic field (positive or  n egative) at a tmospheric pr essure, r esulting in a f ine aerosol of  
highly charged droplets containing the sample.  The running solvent evaporates leaving a stream 
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of sample ions that are then passed through a focusing lens and on into the first set of quadrupole 




Figure 2.1.  Electrospray mass spectrometry (ESI-MS) works by creating a stream of sample ions that are passed 
through a  focusing l ens ( upper l eft o f e xpanded view) a nd t hrough a  first s et o f q uadrupole a nalyzers ( MS1), 
yielding a spectrum of the relative intensity of each of the detected ions.  F or further structural characterization of 
the sample, the sample ions can then be passed through a h exapole collision cell (center of expanded view) where 
they are bombarded with argon gas to induce fragmentation.  The fragmented ions are then passed through a second 
set o f q uadrupole an alyzers (MS2).  T he r esulting s pectrum r eveals t he mass/charge of an y r esulting c harged 
fragments.  C omparison o f th e r esulting f ragments yields in formation th at c an b e u sed to  id entify the s tructural 
composition of the parent ion.  See the text for a detailed description of ESI-MS and ESI-MS/MS analysis.  F igure 




This first detector produces the MS1 analysis, providing a spectrum of relative intensity 
of signal at each mass/charge (m/z) in total ion counts.  A  single ion may hold several charges.  
The m/z  r eflects the  r atio of the  ion’ s mol ecular m ass to t he num ber of  its charges us ing t he 
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formula (m+n)/n where m is the molecular mass and n is the number of charges on the molecule.  
As such, the total population of a molecule of 900 Da that can hold up to three charges may be 
distributed across the spectrum with peaks at 901 for the m+1 ion, 451 for the m+2 ion, and 301 
for the m+3 ion. 
For s tructural de termination (MS/MS), t he s ample i ons can then be  passed through the 
hexapole c ollision c ell w here t hey are bom barded w ith a rgon gas t o i nduce m olecular 
fragmentation.  T he f ragments a re t hen p assed t hrough t he s econd s et o f qua drupoles a nd t he 
second analyzer where t he M S2 analysis oc curs.  T he r esulting s pectrum r eveals pe aks 
corresponding t o t he m /z of  a ny c harged f ragments.  F ragment m asses of  know n s tructural 
components and mass differences corresponding to the masses of known structural components 
(i.e. amino acids for protein determination) can be used to identify the structural composition of 
the parent ion. 
 
2.2.4.2 MS/MS analysis of lipids 
Determination of  l ipid structure r elies upon t he a bilities of  phos pholipids t o ho ld a  
negative charge on the phosphate group, allowing for their detection in the negative ion mode by 
ESI-MS.  O ccasionally, a  l ipid doe s not  hol d its ow n ne gative c harge, a s i s t he cas e w ith 
sphingolipids like ceramide, but will form a negatively charged adduct by associating with free 
Cl- ions ( a c hloride a dduct) w hich c an a lso be  detected i n t he ne gative m ode or  N a+ ions ( a 
sodium adduct) which can be detected in the positive mode.   T he abundance of such adducts is 
strongly affected by the abundance of Cl- or Na+ ions in the sample preparation and the variable 
sensitivity of the instrument under different operating conditions.   
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Typically, a lipid molecule may fragment within the head group, between the head group 
and the phosphate group, between the phosphate group and the glycerol backbone, or between 
the glycerol backbone and the side-chains.  Individual fragments may form adducts with Cl- or 
Na+, or  may gain or  lose a  water molecule and the resulting f ragmentation spectrum reflects a 
mixture of  t hose f ragments t hat hold a  charge i n t he chosen ion mode.  Not a ll f ragments are 
detectable.  T ypically, in the negative ion mode, certain lipid head groups, the phosphate group 
with or without the glycerol backbone, and the fatty acid side chains will carry a charge. 
There a re a va riety of  MS/MS ope rating s cans.  T he t hree t ypes of  M S-MS s cans that 
were utilized in this study are the daughter ion scan, a parent ion scan, or a constant neutral loss 
scan (Figure 2.2).  In a daughter ion scan, MS1 is used to scan for a single parent mass and only 
ions of  t hat m /z a re a llowed t o p ass i nto t he s econd qu adrupole, M S2, w hich s cans f or t he 
daughter ions that result after suffering fragmentation in the collision cell.  In a parent ion scan, 
the MS2 scans for a single daughter ion while the first quadrupole is used to scan for all parent 
ions tha t w ill f ragment to the pr oduct selected as t he da ughter i on.  O nly t hose pa rent i ons 
producing the specified daughter ion are reported in the spectrum.  In a neutral loss scan, both 
quadrupoles are scanning in synchrony, such that the any parent ion that loses a specified mass 
between the first quadrupole and the second quadrupole will be detected at the final detector and 





Figure 2.2.  Three types of ESI-MS/MS operating scans were utilized in this study.  In a daughter ion scan, MS1 is 
used to scan for a single parent mass and only ions of that m/z are allowed to pass into the second quadrupole, MS2, 
which scans for the daughter ions that result after suffering fragmentation in the collision cell.  In a parent ion scan, 
the M S2 s cans for a  s ingle daughter i on while t he f irst quadrupole is  u sed to  s can f or a ll parent io ns th at will 
fragment to the product selected as the daughter ion.  Only those parent ions producing the specified daughter ion 
are reported in the spectrum.  In a neutral loss scan, both quadrupoles are scanning in synchrony, such that the any 
parent ion that loses a specified mass between the first quadrupole and the second quadrupole will be detected at the 
final detector and reported in the spectrum.  Figure adapted from [97]. 
 
 
2.2.4.3 MS/MS determination of bAEC and hAEC lipid profiles 
All ESI-MS analysis was performed on a Fisons VG Quattro II t riple quadrupole mass 
spectrometer ( formerly Fisons I nstruments/Micromass, Inc.; c urrently Waters C orp., M ilford, 
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MA) w ith a n e lectrospray s ource, us ing t he M assLynx s oftware s ystem ( Fisons).  A ll l ipid 
analysis w as pe rformed us ing a  chloroform:methanol solvent s ystem a t a  r atio of 1: 2.  
Fragmentation was inducted by argon gas.  In all discussion of lipid species, to denote the fatty 
acid composition, the notation of Cn:m is used whereby “n” represents the carbon chain length of 
the fatty acid and “m” represents the number of double bonds in the fatty acid. 
Techniques f or i dentifying l ipid s pecies f or a c ell popul ation us ing E SI M S/MS ha ve 
been establish previously by our group and others [89, 93-96].  
To establish the appropriate t arget s pecies o f cer amide and sphingomyelin, it w as 
necessary to first determine the major species present.  bAECs were used for these experiments 
because t hey ar e t he cell t ype us ed for t he m ajority of  cyclic s train experiments in this s tudy.  
Ceramide doe s not  f ragment i nto a  de finitive f ragmentation pa ttern i n o ur s ystem, de spite t he 
ease and reliability of detection of chloride adducts of ceramide by our technique.  Our group has 
previously v erified t he fragmentation of c eramide s pecies us ing alternate m ass s pectrometry 
techniques [96].   
Likewise, s phingomyelin, due  t o i ts s tructural properties, poses s imilar cha llenges for 
fragmentation.  Sphingomyelin is detectable alone and as a sodium adduct in the positive mode, 
and t o a  m uch l esser extent a s a  c hloride a dduct i n t he ne gative m ode, m aking s tandard 
fragmentation in the negative mode less practical.  Sphingomyelin and PC have the same choline 
head group, which, due  to the pos itive charge held by the ni trogen, means that both l ipids are 
easily detectable in the positive mode and are the overwhelming majority of lipids detectable in 
the positive mode. Attempts to identify species of sphingomyelin by a neutral loss scan based on 
the pr operties of  t he choline he ad group would a lso r eveal s pecies of  PC.  B ecause of  t he 
sphingosine side chain, sphingomyelin typically runs at an odd m/z value while PC typically runs 
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as an even m/z value.  Unfortunately, t he f atty acid s ide c hains do not  charge i n t he pos itive 
mode and true verification of composition would need to be performed in the negative mode by 
doing a  da ughter i on s can of  t he c orresponding c hloride a dduct.  H owever, t his c ould be  
complicated by the wide acquisition window necessary for fragmentation in that some species of 
sphingomyelin and PC differ b y only a s ingle Da, meaning th at it is  like ly tha t bot h w ould 
fragment together, complicating the identification process.  Our group has previously verified the 
structure of several sphingomyelin species that had previously been isolated by TLC separation 
to eliminate PC [95]. 
Because ou r group has ve rified t he s tructures of  ph ysiological cer amide an d 
sphingomyelin s pecies previously, t hat w ork was not  r epeated.  T o e xamine t he r elative 
abundance of ceramide species in bAECs, a standard negative ion scan over the range of 400-950 
m/z w as pe rformed for six s eparate lipi d extractions f rom statically cul tured control bA ECs 
extracted at app roximately 80%  conf luence as d escribed in Sections 2.2.2 a nd 2.2.3 .  Natural 
species o f c eramide con tain a C 18:1 sphingosine base ( Figure 2.3) .  Because t his group i s not  
variable, ceramide species w ill he reafter b e d escribed only b y t heir fatty aci d side-chain.  For 
simplicity, when the number of double bonds is not specified, all bonding combinations analyzed 
for that species are being described (i.e. C16 refers to both the C16:0 and C16:1 forms).  The total 
ion counts (TIC) of peaks corresponding to the m/z appropriate for chloride adducts of ceramides 
with unsaturated or singly saturated fatty acid chain lengths from C2 through C28 were recorded 
and normalized in relationship to the (TIC) of a chloride adduct of PC at a m/z of 794 for each 
sample.  This particular species of PC has C16:0 and C18:1 fatty acid side chains and is a structural 





Figure 2.3.  C16:0 ceramide denotes a n aturally occurring ceramide containing a C 18:1 sphingosine base and a C 16:0 
fatty acid side-chain. 
   
 
To e xamine t he r elative a bundance of  s phingomyelin s pecies i n bA ECs, a  s tandard 
positive s can of  400 -950 m/z w as pe rformed for lipi d extractions f rom the  s ame s ix c ontrol 
bAEC lipi d extractions.  T he pos itive s can for e ach sample was p erformed imme diately 
following the negative ion scan and all pairs of scans were timed identically to assure consistent 
MS analysis.  Natural s pecies of  s phingomyelin cont ain a C 18:1 sphingosine ba se ( Figure 2.4) .  
Because t his gr oup i s n ot va riable, s phingomyelin s pecies w ill hereafter be  de scribed onl y by 
their f atty acid side-chain.  The t otal i on c ounts ( TIC) of  p eaks c orresponding t o t he m /z 
appropriate for sodium adducts of sphingomyelins with unsaturated or singly saturated fatty acid 
chain lengths from C2 through C28 were recorded and normalized in relationship to the (TIC) of a 
sodium adduct of PC at a m/z of 782 for each sample.  PC at a m/z of 782 in the positive mode is 






Figure 2.4.  C16:0 sphingomyelin denotes a naturally occurring sphingomyelin containing a  C 18:1 sphingosine base 
and a C16:0 fatty acid side-chain. 
  
 
By nor malizing T IC of  the  lipi d species of  int erest against tha t of  a  s ingle na turally 
occurring l ipid of  relatively constant abundance instead of  to cell count, there i s be tter control 
against variations in cell handling and isolation techniques prior to extraction as well as control 
against s ome a mount of  geometric mor phological va riation in cells w ith treatment or  g rowth.  
Use of the same species of PC for normalization in both the positive and negative mode assures 
that variation of levels in ceramide and sphingomyelin are compared against the same standard.  
This normalization strategy is employed in all MS analysis discussed in this study. 
The ba seline of  reliable de tection f or our  M S a nalysis s ystem i s approximately 1x 105 
TIC, he reafter called the threshold.  B elow this threshold, i t i s di fficult to di stinguish between 
signal noi se a nd de tection a nd t he s ignal i s not  s trong e nough t o a llow f or f ragmentation t o 
determine s tructure.  S tatistical s ignificance of t he r elative abunda nce of cer amide and 
sphingomyelin species was de termined by pe rforming a pa ired t-test using P rism V ersion 4 
(GraphPad S oftware, S an D iego, C A) relative to the thr eshold normalized against the  
corresponding PC C16:0, C18:1 Cl
- TIC for each sample. 
Determination of PC, PE, PI, PS, and PG profiles was performed using lipid extractions 
of s tatically cultured control hA ECs ex tracted at 80%  conf luence, prepared as de scribed in 
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Section 2.2.2 a nd 2.2.3.  Figure 2.5 s hows the structural properties of the typical phospholipids 
we pr ofiled i n t his s tudy.  hAECs w ere chos en f or t his s et of  ex periments due  t o anticipated 




Figure 2.5.  A typical phospholipid -- in this example C16:0/C18:1 phosphatidyl choline (PC) --  is characterized by a 
glycerol back-bone with two fatty acid s ide-chains a t the C1 and C 2 positions and a  phosphate l inked to the head 
group at the C3 position.  In all discussion of phospholipid species, to denote the fatty acid composition, the notation 
of Cn:m is used whereby “n” represents the carbon chain length of the fatty acid and “m” represents the number of 
double bonds in the fatty acid. 
 
 
The profile of major species of PE was determined by performing a negative mode parent 
ion s can of  a ll i ons pr oducing a  f ragment w ith a  m /z of  196, c orresponding t o a  l oss of  the 
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glycerol-ethanolamine head group with the loss of one water and carrying a ne gative charge on 
the oxygen. The profile of major species of PI was determined by performing a negative mode 
parent i on s can of  a ll i ons pr oducing a f ragment w ith a  m /z of  241, corresponding t o t he 
phosphoinositol he ad gr oup w ith t he l oss of  a  single w ater m olecule.  T he pr ofile of  m ajor 
species o f P S w as de termined by performing a neutral l oss i on scan of al l i ons pr oducing a  
fragment at a  m /z of  8 7 l ess t han t he pa rent i on.  T his s hift c orresponds t o t he l oss of  t he 
phosphoserine he ad group, m inus on m olecule of  H3PO4.  D aughter ion s cans w ere t hen 
performed on the prominent parent ions detected in the parent ion scans and neutral loss scan to 
verify that these species do indeed correspond to PE, PI, and PS respectively and to determine 
the corresponding lengths of the fatty acid side chains. 
Finally, to compare the occurrence of the same lipid species in both hAECs and bAECs, 
spectra from standard l ipid extractions of both cell types (Section 2.2.3) were compared across 
the m/z range of 250-950 in the negative ion mode and 400-950 in the positive ion mode. 
2.2.4.4  Specificity of the AEC response to exogenously added physiological C16 ceramide 
and nonphysioloigcal C8 ceramide 
Because o f t he eas e of  solubility w ith decreasing fatty a cid chain length, short-chain 
ceramides ( C2-C8) a re f requently us ed i n e xogenous c eramide s tudies, de spite be ing 
nonphysiological. T o assess the va lidity o f thi s mode l a nd to further e xplore the  di stinction 
between ph ysiological a nd non -physiological s pecies of  c eramide and the E C r esponse, we 
subjected bA ECs t o i ncreasing c oncentrations of  e xogenous C 8 and de uterated C 16 ceramide 
(C16-D31 ceramide) and compared cell viability and the ceramide profile.  The synthetic C16-D31 
ceramide h as a m ass 3 1 Da hi gher t han C16 ceramide, allowing f or d istinction by E SI-MS 
between exogenously added and endogenous C16 ceramide in these cells. 
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Stocks of  C 8 and deuterated C16 ceramide ( D31-C16 ceramide) w ere pr epared in pure 
ethanol at a concentration of 5 mg/mL and stored at -20oC.  Prior to use, D31-C16 ceramide stock 
was solublized by sonication in a water bath for 30 minutes.  S tock concentrations of ceramide 
were a dded t o E GM m edium pr e-warmed t o 37 oC a nd w ere e xamined f or pr ecipitation.  
Treatment media was used immediately.   
bAECs w ere c ultured i n 6 -well pl ates ( BD B iosciences) us ing E GM as  de scribed 
previously (Section 2.2. 2).  W hen c ells ha d reached approximately 70 -80% c onfluence, t he 
media was replaced with 2mL of  cont rol or  t reatment media.  Two wells for each treatment at  
each time point were treated with either control EGM; EGM supplemented with C8 ceramide at a 
concentration of  10 µM, 25 µM, or  50 µM; or E GM s upplemented w ith D 31-C16 ceramide at  a  
concentration of 10µM, 25µM, or 50µM.  At each timepoint – 1, 3, 6, 12, 24, 48, and 72 hours -- 
two wells w ere h arvested and extracted for ea ch treatment as  d escribed previously ( Section 
2.2.3) a nd a nalysis w as pe rformed by E SI-MS.  F or each sample, sequential ne gative and  
positive ion mode scans were performed across the m/z range of 250-950.  Levels of C16:0, C24:0, 
and C 24:1 species of  cer amide and C16:0 sphingomyelin w ere c ompared and cell vi ability was 
assessed by trypan blue exclusion.  The experiment was performed four times. 
2.3 RESULTS 
2.3.1 Common phospholipid panel 
ESI-MS/MS revealed a broad distribution of species of PC, PE, PG, PI, and PS in hAECs.  The 
MS-MS spectra are shown in Appendix A and the findings are summarized in Tables 2.1, 2.2,  
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2.3, 2.4, 2.5, a nd 2.6 below.  Fatty acid chain-length composition i s expressed with regards to 
both the diacyl species and the individual species.  T he fatty acid containing the vinyl ether is 
notated by an adjacent “p” in the description of the individual group description.  Interestingly, a 
number of species of plasmalogens – plasmenyl PE – were also identified.  The presence of the 
same pa rent i ons in bA ECs i s c onfirmed b y s ide-by-side comparison b etween M S s pectra o f 
bAECs and hAECs (Appendix B). 
Table 2.1.  Predominant species of phosphatidyl choline (PC) in hAECs by ESI-MS/MS 
Phosphatidyl choline (PC) 
Diacyl species   m/z (M-H)- acyl/acyl 
32:1 Cl- salt 766 14:0/18:1 and 16:0/16:1 
34:2 Cl- salt 792 16:1/18:1 
34:1 Cl- salt 794 16:0/18:1 
36:4   781 16:0/20:4 and 14:1/22:3 
36:2 Cl- salt  820 18:1/18:1 
36:1 Cl- salt  822 18:0/18:1 
 
Table 2.2.  Predominant species of phosphatidyl ethanolamine (PE) in hAECs by ESI-MS/MS 
Phosphatidyl ethanolamine (PE) 
Diacyl species   m/z (M-H)- acyl/acyl 
34:1   716 16:0/18:1 and 16:1/18:0 
36:1   744 16:1/20:0, 16:0/20:1, and 18:0/18:1 
38:4   766 16:0/22:4 and 18:0/20:4 
40:6   791 18:1/22:5 
 
Table 2.3.  Predominant species of plasmenyl PE in hAECs by ESI-MS/MS.  The fatty acid containing the 
vinyl ether is notated by an adjacent “p” in the description of the individual group description. 
Plasmenyl species of PE 
Diacyl species   m/z (M-H)- acyl/acyl 
36:4   721 16:0p/20:4 
28:2   754 16:0/22:2 and 18:1/20:1 
38:5   747 16:0p/22:5 and 18:1p/20:4 
40:6   773 18:1p/22:5 
40:5   775 16:0p/24:5 and 18:0p/22:5 
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Table 2.4.  Predominant species of phosphatidyl glycerol (PG) in hAECs by ESI-MS/MS. 
Phosphatidyl glycerol (PG) 
Diacyl species   m/z (M-H)- acyl/acyl 
32:1   719 14:0/18:1 and 16:0/16:1 
32:0   721 14:0/18:0 and 16:0/16:0 
34:1   747 16:0/18:1 
36:2   773 18:1/18:1 
36:1   775 16:0/20:1 and 18:0/18:1 
 
Table 2.5.  Predominant species of phosphatidyl inositol (PI) in hAECs by ESI-MS/MS. 
Phosphatidyl inositol (PI) 
Diacyl species   m/z (M-H)- acyl/acyl 
28:0   754 14:0/14:0 
30:1   779 14:1/16:0 
36:1   863 18:0/18:1 
38:4   885 18:0/20:4 
40:5   911 18:1/22:4 
40:4   913 18:0/22:4 
 
Table 2.6.  Predominant species of phosphatidyl serine (PS) in hAECs by ESI-MS/MS. 
Phosphatidyl serine (PS) 
Diacyl species   m/z (M-H)- acyl/acyl 
34:1   760 16:0/18:1 and 16:1/18:0 
36:1   788 18:0/18:1 
38:3   812 18:0/20:3 
40:5   836 18:0/22:5 
42:1   871 18:0/24:1 and 18:1/24:0 
 
2.3.2 Ceramide distribution 
MS analysis has allowed us to determine the major species of ceramide present in bAECs grown 
in static (unstrained) culture.  Figure 2.6 shows that C16:0, C24:0, and C24:1 ceramides are the major 
species of ceramides present in these cells.  Results are expressed as mean ± SEM.  Although C2 
ceramides can be found in nature, C4 thorough C12 ceramides are non-physiological and as such, 
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are observed in t race l evels a t o r be low the noi se l evel.  Low, but  s ignificant l evels of   C 14:0, 




Figure 2.6.  C16:0, C24:1, and C24:0 are the major species of ceramide in bAECs.  Results are expressed as a ratio of 
total ion count of ceramide to that of a physiological structural phospholipid (phosphatidyl choline).  P<0.0001 for 




2.3.3 Sphingomyelin distribution 
MS analysis ha s al lowed us t o determine t he m ajor species of  sphingomyelin (SM) present i n 
bAECs grown in static culture.  SM is detectable in the positive mode as a sodium adduct and in 
its native form at different levels and precisions (Figure 2.7).  R esults are expressed as mean ± 
SEM.  The ratio of TIC to 782 PC (C16:0/C18:1) for the unsodiated form of C16:0 SM has a mean of 
0.113 ± 0.033, whereas the mean is 0.311 ± 0.015 for the sodiated form (p<0.005, n=6).  For this 
reason, evaluation of the distribution of SM species was performed for the sodium adduct forms.  
Since s phingomyelin i s s ynthesized f rom c eramide, i t i s not  s urprising t hat t he pr edominant 
species of  S M ( Figure 2 .8) r eflect t he p redominant s pecies o f c eramide in these cel ls ( Figure 
2.6).  The predominant species of SM are the C16:1, C16:0, C20:0, C22:1, C22:0, C24:1, and C24:0 forms 
of SM.  In interpreting the relative abundance of the longer chain SMs, however, it is important 
to r ecall t hat t hese s pecies f all w ithin t he s ame m/z r ange a s m any ot her phos pholipids.  For 
example, sodiated C22:0 SM f alls a t m /z of  7 81, w hich i s onl y one  Da l ess t han s odiated 
C16:0/C18:1 PC, the abundant structural phospholipid against which the SM TIC is normalized.  As 
such, the TIC at m/z 781 represents a mixture of sodiated C22:0 SM as well as sodiated C16:0/C18:1 
PC with naturally occurring isotope variation in carbon atoms.  Normally, the contribution of the 
isotopic f orm of  a l ipid species t o the T IC detected at a given m/z va lue i s r elatively 
insignificant, but in this instance, the normal species of sodiated C16:0/C18:1 PC at m/z 782 i s so 





Figure 2.7.  The sodium adduct of C16:0 sphingomyelin is present in greater abundance than the unsodiated form in 
bAECs in s tatic culture.  R esults are expressed as a r atio of total ion count of ceramide to that of a p hysiological 






Figure 2.8.  C16-24 through C24 are the major species of sphingomyelin in bAECs.  Results are expressed as a ratio of 
total ion count of sphingomyelin to that of a physiological structural phospholipid (phosphatidyl choline).  P<0.0001 




2.3.4 Specificity of response to exogenously added physiological C16 ceramide and 
nonphysiological C8 ceramide 
Exogenous C 8 and D 31-C16 ceramides w ere bot h r apidly t aken up b y b AECs i n s tatic c ulture 
(Figures 2.9.A  and 2.10 .A).  In t hese f igures, l evels of  t he e xogenously a dded c eramides a re 
expressed as the TIC of  ceramide normalized to the TIC of  794 P C.  F or all other f igures, the 
normalized ceramide co ntent of  t reated cells i s ex pressed as a  r atio to the co rresponding 
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normalized ceramide content of control cells, allowing better correlation of data sets.  The data 
shown is the average of two experimental repeats. 
The endogenous ceramide response to exogenous ceramide is very different between C8 
and D31-C16 ceramides. Treatment with exogenous C8 ceramide causes an expected increase in 
bAEC C 16 and C 24 ceramides ( Figures 2.9. B and 2.9 .C) w ith a  c orresponding c oncentration-
dependent decrease in viability (Figure. 2.9.D).  Interestingly, treatment with exogenous C16-D31 
ceramide c auses a  s ustained de crease i n bA EC levels of  e ndogenous C 16 and C 24 ceramides 
(Figures 2.10.B  a nd 2.1 0.C) a nd do es not compromise c ell vi ability ( Figure 2.10 .D).  T hese 
findings were confirmed in cells treated with exogenous synthetic C16 ceramide (not deuterated) 





Figure 2.9.  Exogenous C 8 ceramide i s t aken up b y b AECs, r esulting i n i ncreased i ntracellular C 16 and C 24 
ceramides a nd co ncentration d ependent d ecrease i n viability.  ( A) s hows c hanges i n i ntracellular l evels o f C 8 
ceramide following treatment and (B) shows changes in intracellular C16:0 ceramide following treatment.  (C) shows 
changes in intracellular C24:1 following treatment and (D) shows changes in cell viability by trypan blue exclusion 





Figure 2.10.  Exogenous C16-D31 ceramide is taken up by bAECs, resulting in decreased intracellular C16 and C24 
ceramides, and preserved cellular viability.  (A) shows changes in intracellular levels of C16-D31 ceramide following 
treatment, (B) shows changes in intracellular endogenous C16:0 ceramide following treatment, (C) shows changes in 
intracellular C 24:1 ceramide following tr eatment, and (D) shows c hanges i n cell v iability by tr ypan b lue e xclusion 






2.4.1 Phospholipid profile 
The major species of phospholipids present in hAECs, as listed in Tables 2.1, 2.2, 2.3,  2.4, 2.5,  
and 2.6, show a broad distribution of fatty acid chain lengths within the physiological range (C14-
C24).  It is also interesting to note the abundance of cholesterol, at a m/z of 421 i n the negative 
mode or  409 i n t he pos itive m ode, r epresenting the c hloride and s odium a dducts r espectively 
(Appendix B).  Many of these species have been identified by others as predominant species in 
circulating human blood cells [93]. 
This list is extensive, but not exhaustive.  A s alluded to previously, there are limitations 
to ESI-MS/MS analysis of total lipid pools from cellular extracts.  P arent ion scans based upon 
phospholipid he ad-group c haracteristics ma y reveal mul tiple lipi d species, as is  the  c ase w ith 
plasmenyl PE (plasmalogen of PE) and PE, or PC and SM, which share the same choline head-
group but  di ffer i n s ide c hain c omposition. F urthermore, i dentification of  t he f atty a cid s ide-
chains requires MS/MS analysis in the negative ion mode, which does not always favor species 
of phospholipids or  sphingolipids t hat are de tected more abundantly i n t he pos itive i on mode, 
like PC or SM.     
 Not all lipid species fragment in such a way that a definitive fragmentation pattern can 
be determined, as i s the case for PC in the negative ion mode and PG.  Potential species of  a  
phospholipid may be identified by a parent ion scan, as was the case of our evaluation of PE and 
PI, but  ve rification a nd de termination of  s ide c hain c omposition de pends on pe rforming a  
daughter i on scan on e ach potential t arget, as w as pe rformed in t his s tudy.  A s i s clear i n t he 
numerous spectra exhibited i n Appendix A , it i s not  uncommon when scanning, t o f ind that a  
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single ma ss ion peak is a  mix ture of  not  onl y multiple f atty a cid chain lengths o f the  s ame 
phospholipid, but may also be a mixture of multiple phospholipids.   
Assessment of  the fatty acid pairings relies upon  mathematical calculation based on the 
fragmentation pattern.  Occasionally, peaks corresponding to low abundance of longer fatty acid 
chains a re pr esent, but  a  pr obable phospholipid s tructure c annot b e a ssigned t o t hem.  
Additionally, de pending on t he bond ing pa ttern a nd c arbon chain l ength, not  a ll fatty acid 
fragments are easily detectable at an abundance corresponding to their paired shorter fatty acid 
side-chain.  Thus, f ragmentation efficiencies do exist and vary with chain length.  Sometimes, 
these discrepancies in the fatty acid fragmentation pattern can be accounted for because of low 
levels of  s uggestive f ragmentation pa tterns f or a di fferent phos pholipid.  F or e xample, w hen 
performing a d aughter ion scan for a species of PE, there may be detection of a m/z loss of 50 
suggesting the presence of PC due to loss of a CH3Cl during fragmentation in the negative ion 
mode, revealing the presence of a mixture of phospholipids (PE and PC) corresponding to that 
mass ion, and allowing for assignment of low abundance fatty acids. 
Another potential difficulty in assessing the distribution of fatty acid chain compositions 
is t hat t he w indow of  d etection t hrough t he M S1 de tector m ust be  br oad e nough t o a llow for 
adequate signal intensity following fragmentation.  Between this variability and normal isotopic 
variation i n m olecules, i t i s no t unc ommon to h ave f ragmentation of  lipids c orresponding t o 
adjacent mass ion peaks (i.e. 779 PC with 780 PI) or even possibly to detect fragmentation from 
diacyl combination differing by one double bond, corresponding to a mass shift of two Da.  If the 
target pa rent i s i n be tween t he m :n a nd m :n+1 t otal di acyl compositions, fragmentation may 
reveal a n ove rlapping pattern of a ll c onstituent a cyl/acyl c ombinations, making e xact 
characterization more difficult. 
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When s canning f or hi gher m ass i ons, above m/z 700, t here i s a lso t he pot ential f or 
detection of doubly charged species of cardiolipin.  Cardiolipin is formed by two PG molecules 
sharing the same head-group, allowing for the molecule to contain four fatty acid side-chains and 
up to two negative charges.  The doubly charged form of cardiolipin, not surprisingly, falls in a 
similar m/z range as native PG and may overlap with other phospholipid species. 
Ultimately, the lis t of  p hospholipid species ge nerated is i ndicative of  m ajor s pecies of  
phospholipids, but  t here a re l ikely m any s pecies t hat a re a bsent due  t o some of  t he de tection 
difficulties di scussed a bove.  T o f orm a  m ore c omplete l ist, i t w ould b e he lpful t o pur ify t he 
phospholipids f irst b y T LC ( thin layer c hromatography) to separate lip ids b y the ir c hemical 
properties, and then to perform ESI-MS/MS on the purified lipid pools. 
Although not directly related to the present study of ceramide metabolism, the ability to 
detect and measure species of  plasmalogens by ESI-MS is also an interesting finding.  Several 
species of  pl asmenyl PE w ere f ound du ring t he e valuation of  AEC lipi ds ( Table 2.3 ).  
Plasmalogens are a type of lipid characterized by a vinyl ether at the C1 position on the glycerol 
backbone where the sn-1 moiety is usually a C16:0, C18:1, or C18:0 fatty acid (Figure 2.11).  T he 
sn-2 m oiety i s us ually a pol yunsaturated f atty a cid a nd t he he ad-group is t ypically c holine or  
ethanolamine and the abundance of these forms varies in different tissues [98].  Plasmenyl PE is 
abundant in brain myelin and platelets [93, 98-100], while plasmenyl PC is abundant in cardiac 
muscle and platelets [98].  Cleavage of arachidonic acid (C20:4 fatty acid) from plasmenyl PE in 
platelets s timulated by t hrombin [100] and f rom pl asmenyl P C i n c oronary a rtery endothelial 
cells stimulated by thrombin and hypoxia [101] via phospholipase A2 (PLA2) has been reported.  
Plasmalogens, and particularly plasmenyl PE, have been shown to protect platelet phospholipids 
from oxidative degradation [99]. 
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Thus, the ability to monitor selective changes in both total plasmalogen content as well as 
specific s pecies o f pl asmalogens, f or e xample t hose c ontaining a rachidonic a cid, b y m ass 
spectrometry during suspected mechanisms of endothelial activation, may provide further insight 
into the extent of damage to the lipid functionality of the endothelium.  Given the potential role 
of reactive oxygen species in mechanotransduction, the plasmalogen profile may be affected in 
such a system and may be involved in the contribution of mechanical insults to the endothelium 




Figure 2.11.  Plasmalogens are a t ype o f l ipid ch aracterized b y a vinyl ether at  t he C1 position o n t he glycerol 
backbone w here the s n-1 moiety is  u sually a  C16:0, C 18:1, o r C 18:0 fatty acid.  T he sn-2 m oiety is us ually a  
polyunsaturated fatty acid and the head-group is typically choline or ethanolamine. 
   
 
 65 
2.4.2 Ceramide and sphingomyelin profile 
The predominant physiological forms of ceramide contain fatty acids of C16 to C26 chain length 
[62, 70].  C 16 and C24 ceramides specifically have been implicated in apoptosis [70, 102].  N ot 
surprisingly, the major forms of ceramide detected in AECs by ESI-MS are C16:0, C24:1, and C24:0 
ceramides ( Figure 2.6 ).  T he ov erall p roportions of  ph ysiological s pecies of c eramides i n ou r 
analysis ar e comparable to those observed b y others in human umbilical vein endothelial cells 
(HUVECs) as d etected by HPLC/MS [94].  B ecause of  t heir kno wn biological specificity and 
abundance in both bovine and human AECs, ceramide evaluation for further studies is limited to 
the C16:0, C24:1, and C24:0 species of ceramide. 
One of the potential drawbacks of our technique of detecting ceramides by MS is that the 
chloride a dduct i s m easured.  T he a bility t o form a dducts and to detect t hem b y E SI-MS i s 
sensitive to extraction technique and solvent conditions.  To a lesser extent, this is also a problem 
with sphingomyelin detection, although the unsodiated form can be detected with less reliability 
(Figure 2.7).  As such, variation in aqueous buffer use and cell preparation techniques has been 
limited to reduce that source of variation in this study and ESI-MS analysis is always performed 
with fresh solvent. 
Since ceramide is a building block for sphingomyelin, it is not surprising to see that there 
is a similar prevalence of the same fatty acid chain lengths in ceramide in Figure 2.6 as there is in 
sphingomyelin i n F igure 2.8 .  S pecifically, C16:0 is one  of  t he m ost a bundant f orms of  bot h 
ceramide and sphingomyelin detected.  The proportional abundance of SM in AECs is similar to 
that observed b y others us ing ESI-MS/MS of  human c irculating blood cells [93] and has been 
identified b y ou r group as a  major species of  S M i n other cel l t ypes [95].  As i s discussed in 
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Section 2.3.3, i n the positive ion mode, many of the larger forms of SM fall at adjacent m/z to 
those of a bundant s pecies of  P C, m aking i t di fficult t o di stinguish t he r elative c ontribution of  
naturally occurring sphingomyelin and i sotope species of  PC.  A lthough there would l ikely be  
differences in the fatty acid composition of the PC species and the SM species, fragmented fatty 
acids are not  de tectable in the pos itive mode, in which SM and PC run a t greatest abundance.  
Furthermore, performing MS/MS analysis on every lipid sample generated is tedious and would 
increase the amount of sample needed.  To reduce the contribution of overlap of SM with other 
lipid s pecies, a nd t o m aintain c onsistency o f d etection a cross s ample preparations, onl y t he 
sodium adduct of C16:0 SM, corresponding to m/z of 725, is evaluated in further studies. 
2.4.3 Response to exogenous physiological C16 ceramide and nonphysiological C8 
ceramide 
Because of the ease of solubility with decreasing fatty acid chain length, short-chain ceramides 
(C2-C8) are frequently used in exogenous ceramide studies, despite being nonphysiological. Our 
evaluation of the specificity of the aortic endothelial cell response to both physiological C16 and 
non-physiological C 8 species of c eramide r eveals t hat s hort-chain ceramide i s not  a di rect 
functional substitute for physiological long-chain ceramide, with regards to change in viability 
and intracellular physiological ceramide content (Figures 2.9 and 2.10). 
Treatment with exogenous C8 ceramide causes an expected increase in bAEC C16 and C24 
ceramides (Figures 2.9.B and 2.9.C) with a  corresponding concentration-dependent decrease in 
viability ( Figure 2.9.D).  I nterestingly, treatment w ith exogenous C 16-D31 ceramide caus es a  
decrease in bAEC levels of endogenous C16 and C24 ceramides (Figure 2.10.B and 2.10.C) and 
does not compromise cell viability (Figure 2.10.D).     
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Both C8 and C16-D31 ceramides are taken up rapidly by bAECs in static culture (Figures 
2.9.A and 2.10.A), following thorough washing of the cells pr ior to extraction, suggesting that 
the difference in outcome is not due to difference in uptake kinetics associated with the fatty acid 
chain length or precipitation of the C16 ceramide out of solution prior to treatment. 
Although t he da ta i s not  s hown, t hese s ame f indings w ere obs erved i n b AECs t reated 
with synthetic, non-deuterated C16 ceramide species.  In those initial studies, only the change in 
C24 ceramide species w as vi sible as  well as  t he preservation of cel l vi ability, since exogenous 
and endogenous forms of C16 ceramide could not be distinguished.  The use of D31-C16 ceramide 
has shown that all the major species of ceramide are downregulated following the addition of the 
exogenous ph ysiological s ource of  ceramide, u nlike t he c oncentration-dependant i ncrease i n 
endogenous c eramide and de crease i n vi ability pr eset i n bA ECs f ollowing a ddition of  
nonphysiological C8 ceramide.  
Thus, e xogenous s ources of  C 16 ceramide ar e well t olerated by bA ECs and the da ta 
suggests that bAECs may be capable of converting the exogenous physiological ceramide into a 
more palatable metabolite like SM, S-1-P, or a higher glycolipid, whereas the nonphysiological 
ceramide may not be able to be processed.  This seems especially possible given the reduction in 
endogenous ceramide species relative to untreated control cells (Figures 2.10.B and 2.10.C).  C16 
ceramide ma y also be capable of  autoregulating ceramide s ynthesis in  bA ECs s uch that in 
response to increases in C16 ceramide -- a species with known biological activity -- endogenous 
synthesis of  c eramides may be do wnregulated i n t he absence of  o ther s tress events t o prevent 
inappropriate signaling. 
Furthermore, this data may further support the concept that specificity of fatty acid chain 
length plays a role i n specific activity of di fferent ceramide s pecies.  D ifferent s pecies of  
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ceramide have specific ceramide synthases, each of which is encoded on a different gene.  For 
example, in humans, each of the six longenvity assurance genes, LASS1-6, encodes for ceramide 
synthases tha t s electively utilize specific f atty acid chain lengths between C16 and C 24 and 
different genes m ay be  activated under di fferent ci rcumstances [102].  T his e vidence f urther 
supports t he not ion t hat di fferent c hain l engths of c eramide m ay pl ay d ifferent r oles a nd t hat 
measurement of a single species of ceramide may not be a surrogate for all species of ceramide 
with regards to biological activity. 
The outcome of ceramide signaling is also associated with the site and source of ceramide 
generation within t he c ell.  E xogenous C 16 ceramide ma y not  p artition into the a ppropriate 
intracellular pools to evince a ch ange in viability, whereas C8 ceramide causes rapid generation 
of c eramide, pot entially through removal o f t he C8 chain a nd r eacylation w ith C 16:0 (palmitic 
acid), similar to de novo synthesis [88]. 
If this is indeed the case, it may partially explain the apparent pro-survival outcome for 
exogenous C16 ceramide treatment. Ceramide has also been implicated in autophagy in HUVECs 
following bi nding t o gl ycated c ollagen s ubstrates [94] and i n r esponse t o a  num ber o f 
chemotherapeutic a gents i n cancer cel ls [103, 1 04].  A utophagy i n r esponse t o C 2 ceramide 
occurs rapidly ove r a  few hou rs [103, 104] , consistent w ith the ti meframe of  ceramide 
accumulation and cell death experienced by bAECs in response to C8 ceramide.  In HT-29 colon 
cancer cel ls, C2 ceramide has be en s hown t o pr omote a utophagy b y t he a ccumulation of  
intracellular physiological ceramides, and that autophagy is reduced in the presence of myriocin, 
an i nhibitor of  de novo ceramide synthesis [103].  T hus, i f bA ECs d ownregulate de novo 
ceramide s ynthesis i n r esponse t o e xogenous C16 ceramide s ynthesis w hereas a ddition of  
exogenous C 8 ceramide pr omotes it,  one  mig ht e xpect c ells tr eated with C16 ceramide t o be 
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spared from autophagic death.  Interestingly, the ceramide generation associated with induction 
of autophagy in HUVECs appears to result f rom aSMase activity, not de novo synthesis [94].  
Autophagy m ay be  m odulated b y c eramide a nd i ts m etabolites, i ncluding S -1-P, t hrough 
different pathways, suggesting, as of ten occurs with ceramide, that the  final f ate of  th e cell is  
determined not  b y a  s ingle p athway, but  b y t he s um of  c oncurrent st ress si gnaling pr ocesses 
[104].   
Of c ourse, ou r i nitial s tudies do not  e xplore w hether cell de ath oc curs b y apoptosis, 
autophagy, or  ne crosis, and f urther evaluation o f a poptotic and a utophagic m arkers w ould b e 
necessary, but  t he s imilarity of  out comes i n r esponse t o s hort- and l ong-chain ceramides t o 
autophagy data is intriguing.  Furthermore, when evaluating ceramide data in endothelial cells, it 
is a ppealing to  be lieve tha t a utophagy, a nd n ot j ust a poptosis, m ay contribute t o i mpaired 
endothelial cell function. 
2.5 CONCLUSIONS 
 
Evaluation of  t he phos pholipid a nd s phingolipid pr ofiles of  bA ECs a nd hA ECs c onfirms t hat 
both cell types possess a similar lipid profile.  Examination of the sphingolipid profile confirms 
that C16:0, C24:2, and C24:0 ceramides are the predominant species in AECs and identifies sodiated 
C16:0 SM as  an appropriate measure of  SM by ESI-MS, establishing them as suitable endpoint 
measures for future experiments.  Furthermore, evaluation of the bAEC response to exogenous 
C8 and C 16 ceramides r eveals that bAECs have a  specific regulatory r esponse to physiological 
but not non-physiological ceramides. 
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3.0  THE CERAMIDE RESPONSE TO MECHANICAL CYCLIC STRAIN 
3.1 INTRODUCTION 
The effect of  c yclic s train on the endothelium is  of  pa rticular relevance in the c linical s etting 
because of its involvement in hypertension, vein grafting, balloon angioplasty over-stretch injury 
and pos sibly i ntra-aortic ba lloon pum ping, tissue eng ineering, and atherosclerotic l esions.  As 
discussed in Section 1.2.2, c yclic s train has been shown to influence a  variety o f vascular cell 
functions i ncluding pr oliferation, m igration, apoptosis, m orphology, a nd pr oduction a nd 
secretion of a v ariety o f s oluble m olecules i nherent t o E C f unction.  C hanges i n bi ological 
endpoints may vary biphasicly or linearly in response to strain magnitude [44].  Signaling events 
may o ccur t ransiently or  may be s ustained, de pending on t he s train c onditions [50].  
Furthermore, the endothelium in disease may be  affected not  only by unusually high s train, as 
one would expect to result in injury, but may also experience unusually low strains. This would 
occur as  part of  s tress-shielding of  the endothelium in the case of  arterial s tiffening which can 
occur in any region of the arterial bed, including the aorta.  Arterial stiffness, even in the absence 
of h ypertension, l eads t o i ncreased l eft ve ntricular a fterload a nd decreased coronary ar tery 
perfusion, s uggesting t hat va scular s tiffness c an a lso c ontribute t o c ardiovascular di sease 
progression [105, 106]. 
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Thus, in evaluating the contribution of the mechanotransduction response to cyclic strain, 
it is important to look at not only whether a change occurs in a biological endpoint in response to 
strain compared to static culture, but to evaluate the dose response over time and over a variety 
of s train c onditions.  J.D. H umphrey further e laborates on t he i mportance of  s uch da ta b y 
suggesting that mechanical dose response curves may be as important to understanding vascular 
health a s ph armacological dos e r esponse curves, and points to the limited availability of s uch 
data in the field [105]. 
Changes i n e ndogenous c eramide l evels i n e ndothelial c ells r emains une xplored.  A s 
such, a full assessment of how the dominant forms of ceramide change in response to duration, 
magnitude, a nd f requency of c yclic s train r egimen is impor tant to  e stablish appropriate 
conditions for assessment of the role of ceramide in the mechanotransduction response. 
This chapter will specifically address the second specific aim: 
Determine whether aortic endothelial cell ceramide levels are altered in response to 
uniaxial, cyclic mechanical strain. 
1. Identify the molecular forms of ceramide generated in response to cyclic strain. 
2. Determine whether ceramide signaling in response to cyclic strain involves an early 
response within minutes, suggesting membrane sphingomyelin as the source of 
ceramide generation; a late response after several hours, suggesting de novo ceramide 
generation; or both. 
3. Determine if the duration, frequency, and intensity of cyclic strain affects the 
magnitude and molecular forms of ceramide generated. 
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3.2 METHODS 
3.2.1 Cyclic strain apparatus 
Cyclic uniaxial s tretch was applied to bAECs using a Flexcell FX4000T cyclic tension system 
(Figure 3.1, Flexcell International, Hillsborough, NC).  The use of the FX4000T to apply cyclic 
strain to vascular endothelial cell monolayers has been well documented [107-109].  Briefly, the 
FX4000T is a  computer-regulated bioreactor that can apply cyclic or  s tatic tensile s trains to in 
vitro cell cultures grown on a  deformable s ilicone substrate.  C omputer-regulated valves allow 
for t he application and release o f va cuum pr essure t o the und erside o f t he de formable culture 
substrate, s tretching t he s ubstrate ove r a  rigid l oading pos t s uch t hat a  r eproducible, 
predetermined tensile strain is applied to the cells.  Frequency and magnitude of the cyclic strain 
is set by the user.  A baseplate holds up to four specialty 6-well plates containing the deformable 
substrate as the bottom of each well and applies the same strain regimen to all plates.   
For t hese ex periments, arctangle l oading pos ts w ere us ed to apply uni axial s train to 
BioFlex 6-well culture plates (Flexcell International) factory-coated with ProNectin, a synthetic 
polypeptide c ontaining m ultiple r epeats of  the R GD bi nding s equence of  fibronectin.  
Fibronectin was chosen because it is commonly found as a component of the extracellular matrix 
supporting va scular e ndothelial c ells [110].  F urthermore, f ibronectin i s r ecruited f rom t he 
plasma during tissue injury [110], making i t an appropriate substrate for a  model of  biological 





Figure 3.1.  The F X4000T s ystem (lower le ft) applies cyclic s train/stretch to in vitro cell c ultures grown o n a  
deformable s ilicone substrate.  The computer ( the FlexCentral controller) controls valves in the FlexLink module, 
applies and releases vacuum pressure to the underside of the culture plates fitted with a deformable culture substrate 
that ar e p ositioned o n t he b aseplate.  S tretching t he s ubstrate o ver a  r igid lo ading p ost a pplies a r eproducible, 
predetermined tensile strain that is applied to the cells (far right).  Frequency and magnitude of the cyclic strain is set 
by the user.  T he baseplate holds up to four specialty 6-well plates (top center) containing the deformable substrate 
as the bottom of each well and applies the same strain regimen to all plates.  An arctangle loading post (upper left) is 
used in each well to apply uniaxial strain to the cells.  Figure adapted from www.flexcelliint.com. 
 
 
3.2.2 Panel of cyclic strain conditions 
To fully explore how bAEC ceramide levels change in response to the addition of cyclic uniaxial 
strain, a variety of strain regimens were employed.  The panel of conditions is detailed in Table 
3.1 and tests how ceramide changes in response to isolated variation of duration, magnitude, and 
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frequency of cyclic strain.  Each pairing of strain frequency and magnitude represents a different 
experiment.  Three independent repeats were generated for each experiment and each experiment 
was performed twice such that n=6 for each time-point. 









Duration 10% 1 Hz 0.5, 1, 3, 6, 12, 24, 
48, 72 
Cessation 10% 1 Hz Strain applied for 24 
hrs, then evaluation 
at 1.5, 3, 6, and 12 
hrs post-strain 
Magnitude 3%, 6%, 10%, 12% 1 Hz 0.5, 1, 3, 6, 12, 24, 
48, 72 
Frequency 6% 0.5 Hz, 1 Hz,  
1.5 Hz, 2 Hz 
0.5, 1, 3, 6, 12, 24, 
48, 72 
 
For initial studies of changes in ceramide in response to strain, bAECs were exposed to 
10% c yclic uni axial s train a t a  f requency of  1 Hz.  T hese c onditions a re w idely us ed i n t he 
literature [44, 50, 52, 54].  Time-points of 0.5, 1, 3, 6, 12, 24, 48, and 72 hrs were chosen so that 
both e arly a nd l ate c hanges i n c eramide, s uggestive of  s phingomyelin h ydrolysis or  de novo 
synthesis r espectively, c ould be  e xplored.  To determine w hether cha nges i n ceramide l evels 
require constant application of cyclic strain, cyclic uniaxial strain was applied to bAECs for 24 
hours (10%, 1 Hz) and changes in ceramide over time following cessation of strain were studied. 
The c yclic s train r egimens w ere chos en to reflect a b road r ange of  ph ysiological and 
pathophysiological conditions.  W e e xamined t he c eramide response of  bA ECs t o 
subphysiological ( 3%), normal ph ysiological ( 6%), a nd hi gh ph ysiological s train i ntensities 
(10% and 12%) [44, 50, 52] , all at 1Hz frequency.  T o explore the ceramide response to varied 
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frequency, bAECs were subjected to cyclic strain at 6% intensity, which is a normal physiologic 
value [44, 52], but with varied frequency ranging from 0.5Hz (below physiological, representing 
a heart rate of 30 bpm), 1Hz (normal physiological, representing a heart rate of 60 bpm), 1.5Hz 
(high ph ysiological, r epresenting a  he art r ate of  90 bpm ), a nd 2 Hz ( abnormally hi gh 
physiological, representing a heart rate of 120 bpm). 
The FX4000T s ystem i s capable of  t esting up t o four plates at a  time a t a s ingle s train 
frequency a nd m agnitude.  T hus, t o t est f our di fferent s train f requencies, f our s eparate 
experiments had to be performed.  For each time-point, three isolated repeats were generated and 
each experiment was performed twice such that n=6. 
To evaluate more than four time-points per experiment, a system of cycling 6-well plates 
through t he ba seplate was a dopted.  P rior evaluation of  c hanges i n t he t otal l ipid pr ofile of  
bAECs i n static cul ture revealed that t here w ere ne gligible cha nges i n C16 and C 24 species of  
ceramide over t ime (data not  shown).  T o rotate the plates through the baseplate, as the plates 
being ha rvested for t ime-points be tween 0.5 and 6 hr s were r emoved from the baseplate, n ew 
plates were installed on the baseplate to be harvested for the later time-points.  The contribution 
of the minimal change in ceramide levels prior to the onset of strain in the plates that are added 
to the baseplate later is minimized by using these plates for the latest time points at which there 
are substantially larger time increments between time-points (12-24 hr intervals between the later 
time-points c ompared t o 0.5 -3 hr int ervals be tween the e arlier time -points).  T his pr ocess i s 




Table 3.2.  Explanation of plate rotation system. 
Time (hr:min) Process 
00:00 Plates 1-4 loaded on baseplate, plates 5-8 in incubator 
00:30 Plate 1 r emoved f rom ba seplate f or 0.5 hr  t ime-point, pl ate 5 
loaded on baseplate 
01:00 Plate 2 removed from baseplate for 1 hr time-point, plate 6 loaded 
on baseplate 
03:00 Plate 3 removed from baseplate for 3 hr time-point, plate 7 loaded 
on baseplate 
06:00 Plate 4 removed from baseplate for 6 hr time-point, plate 8 loaded 
on baseplate 
12:30 Plate 5 r emoved from baseplate for 12 hr  time-point (12 hrs total 
strain time) 
25:00 Plate 6 r emoved from baseplate for 24 hr  time-point (24 hrs total 
strain time) 
51:00 Plate 7 r emoved from baseplate for 48 hr  time-point (48 hrs total 
strain time) 
78:00 Plate 8 r emoved from baseplate for 72 hr  time-point (72 hrs total 
strain time) 
 
3.2.3 Cell culture for cyclic strain time-course experiments 
For each cyclic strain experiment, two vials of bAECs (2x106 total live cells) were thawed and 
passed i nto t hree T-75 flasks c ontaining E GM ( Section 2.2.2) .  W hen c ells a chieved 80% 
confluence, they were pa ssed into seventeen BioFlex P roNectin-coated 6-well pl ates us ing the  
same t echnique as  de scribed in Section 2.2.2.   F or s train c essation e xperiments, onl y eight 
BioFlex P roNectin plates w ere s eeded with cells.  F or t he i nitial be nchmark assessment of  
ceramide response t o cyclic s train, only t wo BioFlex P roNectin plates were s eeded with cells.  
The m edia w as r eplaced w ith 2 m L E GM on t he f irst da y a fter pl ating a nd every t wo da ys 
thereafter.  W hen the cells achieved 80% confluence, after approximately four to five days, the 
 77 
media was replaced with 2 m L fresh EGM, warmed to 37oC.  The plates were then returned to 
the humidified incubator @ 37oC, 5% CO2 for 2 hours to allow the cells to adjust to the media 
exchange prior to loading the plates on the baseplate of the FX4000T strain apparatus. 
3.2.4 Sample collection and preparation of lipid extractions 
3.2.4.1  Benchmark assessment of ceramide response to cyclic strain 
To de termine w hether c yclic s train affects w hole-cell l evels of  C 16:0, C 24:1, a nd C 24:0 
ceramides,  one  pl ate of  b AECs, pr epared a s de scribed i n S ection 3.2.3,  w as l oaded ont o t he 
FX4000T b aseplate and e xposed t o 10%  s train a t 1 H z f or 24 hr s.  An i dentical pl ate of  
unstrained bA ECs i ncubated i n t he s ame hu midified i ncubator as t he one  c ontaining t he 
FX4000T (37oC, 5% C O2) s erved as t he pa ired control.  A t t he end of  the s train pe riod, cells 
were imme diately h arvested and the lipi ds were ex tracted as de scribed in Sections 2.2.2 a nd 
2.2.3.  C ell c ount a nd vi ability b y t rypan bl ue e xclusion w ere also assessed as de scribed in 
Section 2.2.2 to assure cell survival.   
For each extraction, two wells were pooled during harvest, allowing for the preparation 
of t hree s eparate repeats of  e ach time-point p er plate.  E ach pa ir of  wells ( one s ample) w as 
harvested and processed using separate pipets, conicals, and cell count/viability assessments to 
ensure t hat t hey w ere t ruly i ndependent s amples.  T his t echnique w as e mployed i n a ll strain 
experiments. 
An ESI-MS scan across the m/z range of 250-950 in the negative mode was performed 
and C16:0, C24:1, and C24:0 ceramide levels were measured and normalized to C16:0:C18:1 PC (m/z 
of 794) as described in Section 2.2.4.3.  Statistical significance of the change in ceramide species 
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was determined by a paired t-test comparing the strained cells to the unstrained controls using 
Prism Version 4. 
3.2.4.2 Cessation of strain 
To de termine whether c hanges i n c eramide r equired c ontinuous a pplication of  c yclic 
strain, four pl ates of  b AECs, pr epared as de scribed i n S ection 3.2.3, were l oaded ont o t he 
FX4000T ba seplate a nd e xposed t o 10%  s train a t 1 H z f or 24 hr s.  F our i dentical pl ates o f 
unstrained bA ECs i ncubated i n t he s ame humidified i ncubator as t he one  c ontaining t he 
FX4000T ( 37oC, 5%  C O2) s erved a s t he pa ired c ontrols.  A t t he e nd o f t he s train pe riod, a ll 
plates were removed f rom the baseplate and returned to the incubator in static culture.   C ells 
were harvested and the lipids were extracted as described in Section 2.2.2 and 2.2.3 at 1.5, 3, 6 , 
and 12 h rs post-strain.  F or each plate, three independent r epeats w ere ge nerated and the 
experiment was performed twice.   
The extractions were timed so that the chloroform:methanol was added to the cells at the 
indicated time-points.  This e nsured that the  li pid extraction reflected the lipi d levels a t tha t 
period of time following the cessation of strain.  Because the total lipid extraction process takes 
approximately one hour, it was not possible to generate a true 0 hr time-point for comparison; the 
1.5 hr time-point is equivalent to the extraction process utilized in all other experiments in this 
study. 
Consecutive ESI-MS scans across the m/z range of 250-950 in the negative and positive 
ion modes were performed.  C16:0, C24:1, and C24:0 ceramide, sphingosine (m/z of 299), and S-1-P 
(m/z of 379) levels were measured in the negative ion mode scan and C16:0 sphingomyelin levels 
were m easured i n t he pos itive i on m ode s can.  T he T ICs of  t hese s phingolipid s pecies w ere 
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normalized to C16:0:C18:1 PC (m/z of 794 in the negative mode and 782 in the positive ion mode) 
as described in Section 2.2.4.3.  Statistical significance of the change in sphingolipid species was 
determined by a pa ired t-test comparing the strained cells to the unstrained controls using Prism 
Version 4. 
3.2.4.3  Variation of duration of strain 
To determine how whole-cell levels of C16:0, C24:1, and C24:0 ceramides vary over time in 
response to cyclic s train, eight pl ates of  b AECs, pr epared as de scribed in Section 3.2.3, w ere 
loaded onto the FX4000T baseplate and exposed to 10% strain at 1 H z, using the plate rotation 
scheme outlined in Table 3.2.  N ine identical plates of unstrained bAECs incubated in the same 
humidified incubator that contains the FX4000T (37oC, 5% CO2) served as the paired controls.  
One control plate was harvested immediately after the initial loading of the strain apparatus as a 
0 hr control time-point.  At 0.5, 1, 3, 6, 12, 24, 48, and 72 hrs, a strained and a control plate were 
each harvested and the lipids were extracted as described in Sections 2.2.2 and 2.2.3.  Cell count 
and viability by trypan blue exclusion were also assessed as described in Section 2.2.2 to assess 
cell survival.   
For each extraction, two wells were pooled during harvest, allowing for the preparation 
of t hree s eparate r epeats of  e ach time-point p er plate.  E ach pa ir of  wells ( one s ample) w as 
harvested and processed using separate pipets, conicals, and cell count/viability assessments to 
ensure that they were truly independent samples. 
Consecutive ESI-MS scans across the m/z range of 250-950 in the negative and positive 
ion modes were performed.  C16:0, C24:1, and C24:0 ceramide, sphingosine (m/z of 299), and S-1-P 
(m/z of 379) levels were measured in the negative ion mode scan and C16:0 sphingomyelin levels 
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were m easured i n t he pos itive i on m ode s can.  T he T ICs of  t hese s phingolipid s pecies w ere 
normalized to C16:0:C18:1 PC (m/z of 794 in the negative mode and 782 in the positive ion mode) 
as described in Section 2.2.4.3.  Statistical significance of the change in sphingolipid species was 
determined by a pa ired t-test comparing the strained cells to the unstrained controls using Prism 
Version 4. 
Data r egarding changes i n s phingomyelin, s phingosine, a nd S -1-P ar e pr esented in 
Chapter 4. 
3.2.4.4  Variation of magnitude of strain 
To determine how whole-cell levels of C16:0, C24:1, and C24:0 ceramides vary over time in 
response t o di fferent m agnitudes of  cyclic s train, a s et of  four s eparate ex periments w as 
performed.  E ach experiment w as pe rformed us ing t he s ame f requency (1 H z), but  di fferent 
strain magnitudes – 3%, 6%, 10%, or 12%.  E ach experiment was performed twice and yielded 
three isolated repeats per experiment. 
All e xperiments us ed the s ame m ethod a s t hat de scribed i n S ection 3.2.4.3.  F or e ach 
experiment, one control plate w as ha rvested immediately after the  ini tial loading o f the  s train 
apparatus as a 0 hr  control t ime-point.  At 0.5, 1,  3, 6, 12, 24,  48, a nd 72 hrs, a strained and a 
control plate were each harvested and the lipids were extracted as described in Sections 2.2.2 and 
2.2.3.  C ell c ount a nd vi ability b y t rypan bl ue e xclusion w ere also assessed as de scribed in 
Section 2.2.2 to assess cell survival.   
Consecutive ESI-MS scans across the m/z range of 250-950 in the negative and positive 
ion modes were performed.  C16:0, C24:1, and C24:0 ceramide, sphingosine (m/z of 299), and S-1-P 
(m/z of 379) levels were measured in the negative ion mode scan and C16:0 sphingomyelin levels 
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were m easured i n t he pos itive i on m ode s can.  T he T ICs of  t hese s phingolipid s pecies w ere 
normalized to C16:0:C18:1 PC (m/z of 794 in the negative mode and 782 in the positive ion mode) 
as described in Section 2.2.4.3. Statistical significance of the change in sphingolipid species was 
evaluated by one-way ANOVA with a Bonferroni posttest using Prism Version 4. 
Data r egarding changes i n s phingomyelin, s phingosine, a nd S -1-P ar e pr esented in 
Chapter 4. 
3.2.4.5  Variation of frequency of strain 
To determine how whole-cell levels of C16:0, C24:1, and C24:0 ceramides vary over time in 
response t o di fferent frequencies of  cyclic s train, a s et of  f our s eparate experiments w as 
performed.  E ach experiment w as pe rformed us ing t he s ame s train magnitude ( 10%), but  
different strain frequencies – 0.5 Hz, 1 H z, 1.5 H z, and 2 H z.  Each experiment was performed 
twice and yielded three isolated repeats per experiment. 
All e xperiments us ed the s ame m ethod a s t hat de scribed i n Section 3.2.4.3.  F or e ach 
experiment, one control plate w as ha rvested immediately after the  ini tial loading o f the  s train 
apparatus as a 0 hr  control t ime-point.  At 0.5, 1,  3, 6, 12, 24,  48, a nd 72 hrs, a strained and a 
control plate were each harvested and the lipids were extracted as described in Sections 2.2.2 and 
2.2.3.  C ell c ount a nd vi ability b y t rypan bl ue e xclusion w ere also assessed as de scribed in 
Section 2.2.2 to assure cell survival.   
Consecutive ESI-MS scans across the m/z range of 250-950 in the negative and positive 
ion modes were performed.  C16:0, C24:1, and C24:0 ceramide, sphingosine (m/z of 299), and S-1-P 
(m/z of 379) levels were measured in the negative ion mode scan and C16:0 sphingomyelin levels 
were m easured i n t he pos itive i on m ode s can.  T he T ICs of  t hese s phingolipid s pecies w ere 
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normalized to C16:0:C18:1 PC (m/z of 794 in the negative mode and 782 in the positive ion mode) 
as described in Section 2.2.4.3.  Statistical significance of the change in sphingolipid species was 
evaluated by one-way ANOVA with a Bonferroni posttest using Prism Version 4. 
Data r egarding changes i n s phingomyelin, s phingosine, and S -1-P ar e pr esented in 
Chapter 4. 
3.3 RESULTS  
3.3.1 Benchmark assessment of ceramide response to cyclic strain 
With the addition of 10% cyclic strain at 1 Hz for 24 hours, bAECs undergo a marked increase in 
intracellular accumulation of C16:0, C24:1, and C24:0 ceramides (Figure 3.2).  All data are presented 
as mean ± SEM, with n=5.  In the strained cells, normalized levels of C16:0 ceramide were 2.34 ± 
0.14 compared to 1.14 ± 0.20 in control cells; normalized levels of C24:1 ceramide were 3.15 ±  
0.25 compared to 1.36 ± 0.29 in control cells; and normalized levels of C24:0 ceramide were 2.51 
± 0.25 c ompared to 1.14  ±  0.21  in control cells.  S tatistical s ignificance was achieved in each 
comparison ( p<0.005).  Thus, i n r esponse t o 24 hour s of  10%  c yclic u niaxial s train a t 1 H z 
frequency, all t hree of  t he m ajor s pecies of  ceramide ex perience at l east a t wo-fold increase 





Figure 3.2.  Cyclic s train c auses i ncreases i n C16, C 24:1, a nd C 24:0 ceramides.  b AECs were s ubjected t o 10% 
uniaxial, c yclic s train, 1 Hz for 2 4h. R esults ar e ex pressed as  mean ±  S EM o f t he r atios o f t otal i on co unts for 
specific ceramide species to that of phosphatidyl choline (PC).  * = p<0.005 (n=5) 
 
 
3.3.2 Cessation of strain 
Following cessation of strain, the ceramide changes initially seen are rapidly lost, suggesting that 
strain-induced ceramide changes only occur while the cell is actively being strained (Figure 3.3).  
The same is true for changes in the metabolite sphingomyelin (SM).  Changes in sphingosine and 
S-1-P were not  s ignificant.  B y 12 hou rs, a  small, but  s ignificant increase in ceramide species 
relative to control is again observed.  The normalized ceramide or metabolite content of strained 
cells is expressed as a r atio to the corresponding normalized ceramide or metabolite content of 




Figure 3.3.  Ceramide and sphingomyelin changes are lost upon cessation of strain.  bAECs were subjected to 10% 
uniaxial strain, 1Hz for 24 hrs.  Cells were harvested and processed such that the time of lipid extraction occurred at 
1.5, 3, 6, or 12 hrs following cessation of strain.  The total ion count of the species of interest was normalized to PC 
and the data shown expresses the ratio of the strained group to matched controls (mean ± SEM).  ( A) shows how 
ceramide i ncreases ar e l ost f ollowing s train ces sation an d ( B) shows h ow cer amide m etabolite ch anges v ary 
following strain cessation (only sphingomyelin demonstrated a statistically significant initial c hange compared to 
control).  * = p<0.05 (n=3) 
 
 
3.3.3 Variation of duration of strain 
When cells are exposed to 10% cyclic s train at 1 Hz, the time response reveals that whole-cell 
ceramide levels are not constant over time (Figure 3.4).  Although the lack of cellular synchrony 
between experiments complicates the  s tatistical evaluation of the  early t ime points, the results 
still s uggest the  pr esence of  a n early rise in ceramide w ithin the f irst f ew hour s a s w ell a s a  
prolonged rise in ceramide levels over the first few days.  This observation is in agreement with 
the time scale of ceramide generation in response to other cellular stresses.  T hese observations 
in the cyclic strain model will be confirmed later with studies using pharmacological inhibitors 
against de novo synthesis a nd S M h ydrolysis t o e lucidate t he s pecific c ontribution of  t hese 
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pathways to total ceramide accumulation.  Results for C24:1 and C24:0 ceramide are comparable to 
those of C16 ceramide.  The normalized ceramide content of strained cells is expressed as a ratio 
to the corresponding normalized ceramide content of  the matched unstrained control.  N one of 
the data were statistically significant (p≤0.05), although most data points were trending towards 




Figure 3.4.  Time s cale of ceramide accumulations s uggests the contribution o f both ear ly membrane-associated 
ceramide production and late de novo ceramide synthesis.  bAECs were subjected to 10% uniaxial strain, 1Hz for 0-
72h. and harvested at time points shown for lipid extraction and ceramide analysis.  As previously, total ion count of 




3.3.4 Variation of magnitude of strain 
When bAECs were exposed to different strain magnitudes from 3%-12%, all at a frequency of 1 
Hz, it should be noted that the previously described early and late ceramide responses can still be 
observed in a ll but  th e 3%  s train intensity (subphysiological) ( Figure 3.5 ).  T he da ta a lso 
suggests t hat above or  below a  nor mal ph ysiological l evel of  6 % s train, t hat bA ECs e xhibit 
elevated levels of C16:0 and C24:1 ceramides, particularly within the first 24 hours.   
The nor malized ceramide cont ent of  s trained cel ls i s ex pressed as a r atio to the 
corresponding normalized ceramide content of the matched unstrained control.  None of the data 
were s tatistically s ignificant ( p≤0.05), although many data points were trending towards 





Figure 3.5.  Ceramide regulation is tuned to strain intensity.  Above or below normal physiological strain intensity 
(6%), b AECs e xhibit e levated C 16 (A) a nd C 24 ceramide l evels ( B an d C).  Also o bserve t hat at  al l b ut t he 
subphysiological s train i ntensity ( 3%), t he p reviously d escribed ear ly an d l ate cer amide r esponses ap pear t o b e 
involved.  bAECs were exposed to 3, 6, 10, or 12% strain at 1Hz for up to 72hrs with harvest and lipid extraction for 
ceramide analysis performed at time points shown between 30 m in and 72 h rs. The total ion count of ceramide is 
normalized to that of PC and the data shown is expressed as a ratio of the strained group to the control.  (n=5) 
 
 
3.3.5 Variation of frequency of strain 
At 6% c yclic s train, va riation of  s train frequency between 0.5 H z and 2  Hz did not  appear t o 
affect long-term ceramide accumulation compared to a frequency of 1 Hz (Figure 3.6). 
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The nor malized ceramide cont ent of  s trained cel ls i s ex pressed as a r atio to the 
corresponding normalized ceramide content of the matched unstrained control.  None of the data 
were s tatistically s ignificant ( p≤0.05).  The data shown are the average of four experimental 




Figure 3.6.  Ceramide levels do not vary with frequency at 6% cyclic strain.  bAECs were exposed to 6% strain at 
0.5, 1, 1.5, or 2 Hz for up to 72 hrs with harvest and lipid extraction for ceramide analysis performed at time points 
shown b etween 3 0 min a nd 7 2 hr s. ( A) s hows c hanges i n C 16:0 cer amide l evels, ( B) s hows ch anges i n C24:1 
ceramide, and (C) shows changes in C24:0 ceramide.  As previously, total ion count of ceramide is normalized to that 





3.4.1 Application and cessation of cyclic strain 
Evaluation of a single time-point and strain regimen on bAECs – 10% strain at 1 Hz for 24 hrs – 
reveals t hat all t he m ajor s pecies o f ce ramide d o change i n response to  uni axial c yclic s train 
(Figure 3.2).  When discussing a change in a signaling molecule like ceramide, the next natural 
question is to ask whether the observed increases in ceramide require the continuous application 
of strain to maintain the change, or whether an initial period of application sets the cells down a 
committed path of signaling events, such that removal of the strain stimulus would not change 
the resulting outcome.   
To test this, we exposed bAECs again to the same regimen of cyclic strain for 24 hou rs 
and, at the end of this period, removed the plates from the strain apparatus and returned them to 
static culture.  Interestingly, the initial elevations in ceramide were quickly lost upon removal of 
the strain stimulus (Figure 3.3), as were any changes in sphingomyelin.  T his suggests that the 
observed ceramide signaling requires active straining of the cells and that removal of the strain 
stimulus returns the cells to the unstrained state. 
Considered i n t he c ontext of  m echanotransduction, t his f inding m akes s ense.  If a  c ell 
encounters an increase in the local forces being applied to it (i.e. acute hypertension or vein-to-
artery grafting), it needs to trigger appropriate signaling pathways in response.  O nce the strain 
stimulus is removed (i.e. return to normotension or remodeling of the vessel to compensate for 
increased s train), pr olonged s ignaling, pa rticularly ceramide s ignaling, could be de trimental to 
the cell survival. 
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This data also stresses the importance of consistent experimental technique and potential 
introduction of experimental error in this type of experiment.  The first time-point chosen for the 
strain cessation e xperiments i s 1.5 hr s, which i s s lightly l onger t han t he a mount o f t ime 
necessary t o disassemble t he s train apparatus, harvest t he cel ls, and extract t he l ipids, and as 
such, c losely represents the t echnical c onditions of a  s tandard l ipid e xtraction a s us ed i n t his 
body of work.  By three hours, the detectable change in ceramide is lost, which means that it is 
absolutely critical to employ consistent technique with regards to the timing of the extraction and 
potentially even the person performing the extraction. 
It s hould be not ed that t here is  a  s mall but  s ignificant inc rease in ceramide r elative to 
control by 12 hrs post-strain, although this difference is considerably less than that observed at 
1.5 hr s pos t-strain.  Between 6  and 12  hours following cessation of s train, the t ypical c ellular 
alignment observed in response to strain is lost, as observed by light microscopy, indicating that 
the cells are changing their orientation and potentially their integrin profile as well.  This process 
may require an increase in ceramide to participate in lipid rafting to facilitate integrin and focal 
adhesion r earrangement.  F urther s tudies of  l ipid r aft content a nd focal a dhesions f ollowing 
cessation of  s train w ould be  ne cessary t o confirm t his pos sibility a s it c annot be  p roved b y 
changes in the whole-cell lipid profile. 
It is  w orth noting tha t one of  the  pot ential di fficulties e xpected with the us e of  the  
Flexcell F X4000T is  the  f act tha t s train is not  uni formly a pplied across the  e ntire c ulture 
substrate of  the B ioFlex pl ate, onl y a cross t he r egion ov er t he l oading post.  T hus, w e m ay 
encounter s ome de gree of va riability of  c eramide de tected ba sed upon t he di stribution a nd 
homogeneity of cells across the strained surface compared to regions on the periphery.  During 
culture, bAECs and hAECs tend to grow most heavily in the centers of the wells in the region 
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that i s pos itioned ove r t he l oading pos t, w hich somewhat m inimizes t he c ontribution of  t hese 
nonhomogeneous strain regions around the periphery of the well.  The BioFlex plate, which has 
the culture adhesion surface across the entire well, was chosen for these experiments rather than 
the similar UniFlex plate, which has the cul ture adhesion surface only in a d efined rectangular 
region over t he ar ctangle l oading pos t, be cause i t w as f elt t hat t he c ontribution of  a dhesion 
matrix c omposition a ffecting a ny c ells t hat pe rsist i n g rowing on t he u ncoated r egions of  t he 
UniFlex pl ate ( i.e. cellular s tress a ssociated with c ulture on the unt reated silicone me mbrane) 
was potentially greater and less controlled from experiment to experiment than the contribution 
of uneven strain distribution towards the periphery of the BioFlex plate.   
Another pot ential pr oblem w ith t he F X4000T s ystem i s t hat a  s mall a mount of  m edia 
evaporation is to be expected in the s trained cultures compared to the s tatic controls.  E Cs are 
sensitive to preconditioning of their microenvironment and prefer to be grown at a specific ratio 
of c ell d ensity to  me dia vol ume.  T his ma kes it di fficult to offset eva poration with a l arger 
culture volume or exchanging the media of the system, which as introduced cellular stresses, can 
be expected to affect ceramide expression.  It should be noted, however, that any contribution to 
cellular s tress f rom evaporation in t he s train apparatus or  uneven s train di stribution across t he 
membrane a re encountered in all s train experiments and will thus  be  r outine a cross tr eatment 
conditions in comparisons of strain parameters by lipid profile. 
3.4.2 Variation of time, magnitude, and frequency of cyclic strain over time 
To examine whether ceramide generation due to cyclic strain is indicative of an early response, 
suggesting m embrane-associated c eramide formation f rom s phingomyelin; a  l ate r esponse, 
suggesting de novo synthesis; or both types of responses, bAECs were subjected to 10% uniaxial 
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cyclic strain, 1Hz with lipid extractions for ceramide analysis performed after 0.5, 1, 3, 6, 12, 24, 
48, a nd 72  hrs of s train ( Figure 3.4 ).  A lthough t he l ack of  cellular s ynchrony be tween 
experiments complicates the statistical evaluation of the early time points, the results still suggest 
the presence of an early rise in ceramide within the first few hours as well as a prolonged rise in 
ceramide levels over the first few days.  This observation is in agreement with the time scale of 
ceramide generation in response to other cellular stresses.  Very interestingly, the data within the 
first 6 hours suggests that there may be two rises in ceramide at 0.5 and 3 hours, suggesting that 
there m ay even be  t wo s ignaling e vents oc curring w ithin t his pe riod.  The pr esence of  t wo 
ceramide i ncreases within that time frame s uggests t he pos sible i nvolvement of  t wo di fferent 
sphingomyelinases. 
These observations in the cyclic strain model will be confirmed in Chapter 4 with studies 
using pharmacological inhibitors against de novo synthesis and SM hydrolysis to e lucidate the 
specific contribution of these pathways to total ceramide accumulation. 
When the s ame time -course w as r epeated but s train magnitude w as v aried to reflect 
subphysiological ( 3%), normal ph ysiological ( 6%), a nd hi gh ph ysiological s train i ntensities 
(10% a nd 12% ), a ll at 1H z f requency, s imilar time -dependant i ncreases i n ceramide w ere 
observable for al l regimens except the 3% strain intensity (Figure 3.5).  If the time response is 
indeed reflective o f t he pr esence of  an early c eramide i ncrease due  t o m embrane-associated 
sphingomyelin h ydrolysis whereas t he l ater, prolonged increase i n ceramide may be  due  to de 
novo synthesis, this f inding suggests that a threshold level of  s train may be necessary to  e licit 
sphingomyelin hydrolysis.  Being that ECs do not  align perpendicular to strain below 5% strain 
magnitude, it may be possible that either this early ceramide increase is caused by or is necessary 
for c ell a lignment.  O f c ourse, f urther e xperiments us ing i nhibitors to c eramide s ynthetic 
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pathways a t ph ysiological s train levels as  w ell as  ex periments ex amining w hether i ncreasing 
endogenous ceramide, p otentially t hrough ba cterial S Mase, at s ubphysiological s train l evels 
would be necessary to determine whether the lack of the early ceramide response at 3% strain is 
associated with the failure of cells to align. 
When viewing the change in ceramide levels in response to change in strain magnitude 
(Figure 3.5), it is  also interesting to consider that the data suggests that subphysiological (3%) 
and high physiological (10% and 12%) magnitudes of strain show a greater increase in ceramide 
relative to that occurring in response to normal physiological s train (6%).  T his would suggest 
that endothelial cells require a  certain amount of  strain to achieve optimum growth conditions, 
but t hat e levation be yond t hat poi nt c an be  ha rmful t o t he c ell.  O ne would e xpect levels of  
ceramide generated to have s omething of  a l inear r esponse t o increasing s train such that cel ls 
exposed t o 3%  s train would ha ve l ower ceramide l evels t han cells exposed to 6%  s train.  
However, if one considers that ECs align to reduce net intracellular stress, one might expect to 
see an increase in a cellular stress signaling molecule like ceramide in a cell that was unable to 
accomplish this goal without alignment, hence the relative increase in ceramide in cells exposed 
to 3% strain compared to 6% strain. 
These f indings regarding 3% s train are particularly interesting in the context of  arterial 
stiffness as sociated with cal cified at herosclerotic pl aques and  pr ogressive v ascular di sease.  If 
one defines endothelial cell health in terms of the activity of cellular stress signaling pathways, 
reduction in cellular strain in the wrong population of ECs (aortic ECs), may be as detrimental as 
an e levation i n s train.  This obs ervation s hould a lso be  considered i n the c ontext of  t issue 
engineered va scular conduits i n w hich m aintenance o f a n i ntact a nd nor mally functioning 
endothelium is necessary for conduit success [42]. 
 94 
Of course, when considering strain magnitude, which is also reflective of pulse pressure, 
it is important to consider that these findings utilize aortic ECs, and that different results might 
be observed in ECs of microvascular or venous origin reflective of phenotypic differences. 
Variation of  c yclic s train f requency a cross a r ange t o i nclude 0.5  Hz ( below 
physiological, representing a heart rate of 30 bp m), 1 Hz (normal physiological, representing a 
heart rate of 60 bpm), 1.5 Hz (high physiological, representing a heart rate of 90 bpm), and 2 Hz 
(abnormally high physiological, representing a heart rate of 120 bpm), all maintaining a normal 
physiological strain magnitude of 6% does not appear to affect long-term ceramide accumulation 
(Fig. 3.6).  In the context of normal arterial conditions, this suggests that a change in heart rate at 
a normal blood pressure is less detrimental than an increase in blood pressure at a nor mal heart 
rate.  
Another c linical s ituation t hat c ould be  modeled us ing t he e xisting F X4000T s ystem 
would be  t o e valuate 3%  s train a t 2 H z.  T his r egimen w ould m odel t he va sculature dur ing 
cardiogenic s hock i n w hich a  p atient e ncounters h ypotension a nd t achycardia.  It w ould b e 
interesting to see whether such conditions resulted in a further change in ceramide compared to 
3% strain at 1 Hz, particularly if changes in ceramide signaling in the arterial circulation result in 
endothelial activation and production of soluble factors that could affect the microvasculature, all 
potentially contributing t o t he e nd s tage or gan a nd va scular d ysfunction e ncountered b y t hese 
patients.  
Of cour se, there a re s everal experimental limita tions to consider when evaluating these 
frequency findings.  T he ability to generate experimental strain magnitude and frequency in the 
FX4000T s train a pparatus i s l imited b y t he a bility t o ge nerate a n appropriate va cuum and t o 
shuttle a ir t hrough t he system a s v acuum i s a pplied a nd r eleased a t the unde rside of  t he 
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deformable culture substrate membrane.  Thus, in order to generate higher magnitudes of strain, 
one is limited to a lower range of frequencies.  Similarly, when generating higher frequencies of 
strain, one is limited to lower strain magnitudes.  Initial assessment revealed that 6% strain could 
be achieved at 2 Hz, but that 10% strain could not.  It is very possible that at high physiological 
strains s uch a s 10 or  12 %, t hat elevated strain frequency m ay pr oduce a cha nge i n ceramide 
levels w ithin t he c ell.  T his w ould c orrespond t o t he c linical oc currence of  a pa tient w ith 
hypertension and high heart rate. 
At hi gh f requencies a nd hi gh m agnitudes, t he de formable culture s ubstrate on the 
BioFlex plates may also experience some amount of creep over time, which would have resulted 
in a reduction in the strain magnitude encountered by the cell.  Creep describes the tendency of a 
material to permanently deform over time in response to a stress, and in this case would suggest 
a ba llooning of  the de formable membrane over t ime causing the application of  the same force 
over a greater surface area to result in lower strain magnitudes.  While endothelial cells strained 
at or  a bove 6 % di d r etain their a lignment, suggesting tha t a  m agnitude of  a t le ast 5%  w as 
maintained under these conditions, it is possible, particularly at the later time points of 48 and 72 
hrs, that the true strain encountered by the cells was less than the intended strain, which may in 
part account for the closeness of many of the variables at the 72 hr time-points in Figures 3.5 and 
3.6.  E valuation of the deformation properties of the substrate membrane alone over time at the 
various strain regimens employed would be necessary to confirm or deny the possible influence 
of creep at the later experimental time-points. 
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3.4.3 Statistical considerations 
The time -course da ta presented i n t his c hapter f requently s how s trong evidence t owards 
conclusions, but fail to achieve statistical significance of p≤0.05.  Often, this is reflective of the 
low numbers of experimental repeats presented, as may be the case with the strain frequency data 
for which results express only three or  four da ta repeats.  T he number o f t imes an experiment 
was performed is described in the methods, whereas the results describe the number of times an 
experiment was analyzed by mass spectrometry. 
At the earliest time-points occurring within six hours, lack of  synchrony of cells across 
experiments and even between two wells on the same plate may contribute to subtle differences 
in ceramide detected.  Ceramide levels detected in whole cell extracts represent a snapshot of the 
sum of  t he contributions of  a ll ceramide bi osynthetic a nd m etabolic p athways.  If a t ransient 
spike in signaling occurs fifteen minutes sooner or later in one sample than in other samples, it 
will potentially increase the sample variation at two time-points.  T hus, in describing the early 
ceramide s ignaling increases that appear to occur at  30 minutes and 3 hour s, caution has been 
used.  E specially a t t he 30 -minute time -point, t he a mount of  c eramide detected i s l ikely t he 
trailing shoulder of a ceramide spike that has occurred prior to 30 m inutes, which is consistent 
with the timeframe of membrane-associated sphingomyelin hydrolysis, particularly by nSMase.   
Some researchers choose to compensate for lack of cellular synchrony by serum starving 
the cells prior to introducing the cellular stress, but since serum starvation is a cellular stress in 
itself and can affect ceramide levels, this method was not employed in these studies so that the 
results we present describe only the effects of cyclic strain on ceramide generation and not that 
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associated with serum withdrawal.  To partially reduce the contribution of culture variation from 
well to well within the same plate, two wells were always combined for each lipid extraction. 
Additionally, t o nor malize t he da ta p resented t o a ccount f or s ignal va riation be tween 
mass s pectrometry runs a nd t o a djust f or cell count a nd vol ume a cross s amples, r atios w ere 
frequently employed, and at times, ratios of ratios.  Ratios are inherently asymmetrical, making a 
t-test, for example, somewhat ambiguous. 
Finally, w hen di scussing w hole-cell l evels of  a m olecule act ive i n signaling, it is  
important t o c onsider t hat functionally significant and statistically significant are not  
synonymous.  A dvocates of  t he dos e-response a pproach t o a nalyzing m echanotransduction 
signaling s upport a f ocus on f unctional s ignificance be yond j ust s tatistical s ignificance [105].  
Since t he i mpact of  cer amide on cell f ate i s d ependent on the s ite and source of  cer amide 
generation, it is important to recognize that functionally relevant differences may be reflected by 
a s tatistically s mall i ncrease.  P rior s tudies have s hown t hat a therosclerotic t issue ha s 
approximately 1.5 -fold increase i n ceramide compared to normal a rterial t issue b y w et w eight 
[2].  This is consistent with the fold increase in ceramide observed at later time-points illustrated 
in F igures 3.2 a nd 3.4 .  T hus, t rue va lidation o f t he c eramide da ta pr esented r ests i n l inking 
ceramide changes to biological outcomes in cyclically strained ECs. 
3.5 CONCLUSIONS 
Cyclic, uniaxial strain applied at a variety of magnitudes (3% - 12%) and frequencies (0.5 Hz - 2 
Hz) r epresenting va riation f rom s ubphysiological t o e levated, p athophysiological s tates of  
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arterial s train conditions, demonstrates tha t C 16:0, C 24:1, a nd C 24:0 ceramides ar e el evated in 
bAECs i n r esponse t o c yclic s train.  F urthermore, a pplication of  c yclic strain i s ne cessary t o 
sustain elevated c eramide le vels; r emoval of  the  s train stimulus results i n a  r apid r eturn t o 
ceramide l evels comparable t o t hose s een i n un strained c ontrol c ells.  Evaluation of  t he t ime 
response suggests that bAECs exhibit an early and a late ceramide signaling event, suggestive of 
the involvement of  both hydrolysis of membrane-associated sphingomyelin as well as  de novo 
synthesis in ceramide generation. 
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4.0  CERAMIDE BIOSYNTHESIS AND METABOLISM DURING CYCLIC STRAIN 
4.1 INTRODUCTION 
The da ta pr esented in Chapter 3 indicate t hat cer amide i s g enerated in response t o cyclic, 
uniaxial s train.  Ceramide represents a central molecule in sphingolipid signaling and biology, 
and can be generated through de novo synthesis or through hydrolysis of sphingomyelin or other 
complex sphingolipids [63, 64].  Ceramide as well as its metabolites, like S-1-P, are biologically 
active and the ultimate fate of a cell is believed to be determined by the net effect of the activity 
of al l these pathways in response to a s tress [65].  In particular, the con cept of  the ba lance of  
ceramide and S-1-P activity acting as a rheostat to push a cell towards death or survival has been 
proposed [80].  B oth c eramide a nd S -1-P ha ve be en s hown t o c ause a utophagy.  Ceramide 
generated by SM hydrolysis induces an autophagic death while S-1-P was associated with a pro-
survival type of autophagy [104]. 
The time-course response of ceramide in bAECs in response to cyclic strain described in 
Section 3.3.3 and supported in Section 3.3.4 suggests that ceramide generation has an early and a 
late response, suggesting that both SM hydrolysis and de novo synthesis are at  work.  There is 
evidence t hat bot h neutral S Mase, active i n t he pl asma m embrane, and acidic SMase, 
predominant in lysosomes but capable of translocating to the plasma membrane, may be active in 
ECs in response to s tressors [62, 82, 83] .  The appearance o f a s pike in ceramide l evels at  30 
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minutes a nd a gain a t 3 hours s uggests t hat bot h a SMase and nS Mase m ay be responsible for 
early ceramide signaling.   
The finding that continuous application of cyclic strain is necessary to maintain elevated 
ceramide l evels (Section 3.3.2) , s uggests t hat regulation of  ceramide synthesis i s l inked t o 
mechanosensing.  Thus, SM hydrolysis and de novo synthesis may work together to regulate and 
maintain the ceramide signaling response to cyclic strain. 
To test t his h ypothesis, more ex tensive eva luation of cha nges i n major ce ramide 
metabolites like  s phingosine and S-1-P a s w ell as h ydrolysable s phingolipids like  S M w ill be  
necessary.  To specifically assess the roles of SM hydrolysis and de novo synthesis of ceramide 
in the EC response to strain, inhibition of the appropriate enzyme pathways will be necessary. 
This chapter will specifically address the third specific aim: 
Determine which ceramide biosynthetic pathways are activated upon exposure of aortic 
endothelial cells to cyclic, uniaxial strain and determine the abundance of ceramide 
metabolites. 
1. Determine if levels of sphingomyelin, sphingosine, and sphingosine-1-phosphate are 
altered in response to cyclic strain. 
2. Determine the effects of inhibitors of de novo ceramide synthesis and hydrolysis of 
sphingomyelin to ceramide, on cyclic strain-induced ceramide levels. 
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4.2 METHODS 
4.2.1 Response of sphingosine, S-1-P, and sphingomyelin to cyclic strain 
Studies of changes in whole-cell levels of sphingosine, S-1-P, and sphingomyelin in bAECs were 
performed concurrently with evaluation of ceramide level changes in response to the varied time, 
magnitude, and frequency regimens described in Table 3.1.  Thus, the experimental methods are 
outlined in Section 3.2. 
During E SI-MS an alysis, consecutive s cans ac ross t he m /z r ange of  2 50-950 i n t he 
negative and positive ion modes were performed.  In addition to C16:0, C24:1, and C24:0 ceramides, 
sphingosine (m/z of 299), and S-1-P (m/z of 379) levels were measured in the negative ion mode 
scan and C16:0 sphingomyelin levels were measured in the positive ion mode scan.  The TICs of 
these sphingolipid species were normalized to C16:0:C18:1 PC (m/z of  794 in the negative mode 
and 782 in the positive ion mode) as described in Section 2.2.4.3.  S tatistical significance of the 
change in sphingolipid species was determined by paired t-test comparing the  s trained cells to  
the unstrained controls for the benchmark assessment at 24 hrs, following 10% strain at 1 Hz and 
by one-way ANOVA with a Bonferroni posttest for magnitude and frequency data using Prism 
Version 4. 
4.2.2 Selective inhibition of aSMase, nSMase and de novo ceramide synthesis  
Three pha rmacological i nhibitors w ere e mployed t o s electively i nhibit h ydrolysis of  a cid or  
neutral sphingomyelinase or de novo ceramide synthesis.  T he inhibitors and the concentrations 
used are d escribed i n Table 4.1.  M anumycin A  pr epared f rom Streptomyces parvulus, 
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desipramine, a nd L-cycloserine w ere pur chased from S igma.  M anumycin A ( hereafter cal led 
manumycin) i s maintained as a  s tock 5 m g/mL solution in pure e thanol.  D esipramine and L-
cycloserine are both stored as powders and were prepared as 1 mM stocks in EGM medium and 
were sterile filtered through a syringe filter (Fisher Scientific).  All media containing inhibitors 
were pr epared f resh i mmediately pr ior t o us e.  T he c oncentrations us ed w ere c hosen be cause 
they w ere pr eviously d emonstrated i n pi lot s tudies t o be  t he hi ghest c oncentration c apable of  
eliciting inhibitory function in hAECs during 10% cyclic s train at 1 H z without compromising 
cell viability by trypan blue exclusion. 
Table 4.1.  Inhibitors of ceramide synthesis 
Inhibitor Ceramide synthetic 
pathway blocked 
by inhibitor 




Manumycin A SM hydrolysis nSMase 2 µM 
Desipramine SM hydrolysis aSMase 50 µM 




hAECs were chosen for the inhibitor experiments because future experiments assessing 
direct EC functionality i n r esponse t o pe rturbation of  ceramide s ignaling will be  pe rformed in 
hAECs due to the expanded clinical relevance of the human cell source as well as the increased 
availability of commercial immunoassays for human cell systems.  While some of these assays 
could be done in bovine cells, relying upon species cross-reactivity, it was more logical to switch 
to human cells for the inhibitor studies. 
For each inhibitor experiment, two vials of  hAECs (2x106 total l ive cel ls) were thawed 
and passed into three T-75 f lasks containing EGM (Section 2.2.2) .  W hen cells achieved 80% 
confluence, they were passed into sixteen BioFlex ProNectin-coated 6-well plates using the same 
technique a s de scribed i n S ection 2.2.2.  F or s train c essation e xperiments, onl y e ight B ioFlex 
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ProNectin plates were seeded with cells. The media was replaced with 2 mL EGM on the first 
day after plating and every two days thereafter. 
When the ce lls a chieved 80%  c onfluence, a fter a pproximately four t o five da ys, t he 
media in fifteen of the  pl ates w as r eplaced with 2 mL/well f resh untreated EGM or  E GM 
containing 2 µM manumycin, 50 µM desipramine, or 1 mM L-cycloserine, pre-warmed to 37oC.  
Two wells r eceived unt reated E GM and t wo w ells r eceived E GM c ontaining t he i nhibitor of  
interest.  The media in the sixteenth plate was replaced with 2 mL/well untreated EGM, the cells 
were immediately h arvested, and the l ipids were extracted, pool ing two wells pe r s ample as  a 
pre-treatment control as described in Sections 2.2.2 and 2.2.3.  Cell count and viability by trypan 
blue exclusion were also assessed as described in Section 2.2.2 to assure cell survival.   
The f ifteen treated pl ates w ere t hen r eturned to the hum idified i ncubator @  37 oC, 5 % 
CO2 for 2 hour s f or m anumycin s tudies a nd f or 3 hour s f or de sipramine a nd L-cycloserine 
studies t o a llow f or f ull e nzyme i nhibition pr ior t o l oading t he pl ates o n t he ba seplate o f t he 
FX4000T strain apparatus. 
To determine how whole-cell levels of C16:0, C24:1, and C24:0 ceramides vary over time in 
response to cyclic strain in the presence of inhibitors to aSMase, nSMase, and de novo synthesis, 
seven pl ates of  t he i nhibitor pr e-treated hA ECs w ere l oaded ont o t he F X4000T ba seplate and  
exposed t o 10%  s train a t 1 H z, us ing t he pl ate rotation s cheme out lined in T able 3 .2.  S even 
identical pl ates of  uns trained i nhibitor pr e-treated hA ECs i ncubated i n t he s ame hum idified 
incubator containing the FX4000T (37oC, 5% CO2) served as the paired controls.  One inhibitor 
pre-treated control pl ate w as ha rvested immediately after th e ini tial loa ding of  th e s train 
apparatus as a 0 hr control time-point.  At 0.5, 1, 3, 6, 12, 24, and 48 hrs, a strained and a control 
plate were each harvested and the lipids were extracted as described in Sections 2.2.2 and 2.2.3.  
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Cell count and viability by trypan blue exclusion were also assessed as described in Section 2.2.2 
to assure cell survival.   
For each extraction, both wells containing either the control media or the inhibitor-treated 
media were pooled during harvest.  As a result, each experiment yielded only one experimental 
repeat with a matched control.  Each inhibitor experiment was performed three separate times. 
Consecutive ESI-MS scans across the m/z range of 250-950 in the negative and positive 
ion modes were performed.  C16:0, C24:1, and C24:0 ceramide levels were measured in the negative 
ion mode scan and C16:0 sphingomyelin levels were measured in the positive ion mode scan.  The 
TICs of these sphingolipid species were normalized to C16:0:C18:1 PC (m/z of 794 in the negative 
mode and 782 in the positive ion mode) as described in Section 2.2.4.3. 
4.3 RESULTS 
4.3.1 Response of sphingosine, S-1-P, and sphingomyelin to cyclic strain 
4.3.1.1  Benchmark assessment of sphingosine, S-1-P, and sphingomyelin to cyclic strain 
After 24  hr s o f 10%  c yclic s train at 1 Hz, onl y s phingosine and s phingomyelin s howed 
significant changes in bAECs, both resulting in decreases (Figure 4.1).  Results are expressed as 
the ratio of TIC to PC.  All data are presented as mean ± SEM, with n=5.  After 24 hours of 10% 
cyclic s train a t 1 Hz, s phingosine l evels dr opped f rom 0.120  ±  0.015  t o 0.0783 ±  0.0090  
(p=0.046) and sphingomyelin levels dropped from 0.326 ± 0.008 to 0.282 ± 0.010 (p=0.013).  As 
shown in Figure 3.3, changes in sphingomyelin levels following cessation of strain rapidly return 
to ba seline, c omparable t o t he f indings s hown f or ceramide c hanges.  T his s uggests t hat 
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sphingomyelin/ceramide metabolism is intimately linked to mechanical strain.  In Figure 3.3, it 
should be noted that the sphingosine levels at 1.5 hrs following cessation of strain, also strained 
for 24 hrs at 10% strain at 1 Hz, show an initial increase in sphingosine levels relative to control, 
whereas the benchmark data taken immediately following cessation of  s train shows a  decrease 




Figure 4.1.  Cyclic strain causes decreases in sphingosine and sphingomyelin, but not S-1-P.  bAECs were subjected 
to 10% uniaxial, cyclic strain, 1Hz for 24h. Results are expressed as mean ± SEM of the ratios of total ion counts for 




4.3.1.2  Response of sphingosine, S-1-P, and sphingomyelin to variation in magnitude and 
frequency of strain 
Because the responses of sphingomyelin, S-1-P, and sphingomyelin to cyclic strain over 
time do not  f ollow a  s tandard r esponse pa ttern, as c eramide s pecies do,  t he t ime r esponse of  
these sphingolipids will not be expressed separately, but will instead be discussed in the context 
of strain magnitude and frequency. 
4.3.1.2.1  Metabolite response to variation of strain magnitude 
When bA ECs w ere e xposed t o di fferent s train m agnitudes f rom 3% -12%, a ll a t a  
frequency of 1 Hz, it should be noted that each sphingolipid metabolite varies distinctively and 
not all follow a standard dose or time response to strain intensity.  At all magnitudes except 10%, 
bAECs appear to experience a reduction in sphingosine, as seen in figure 4.2.A.  This reduction 
is particularly evident a t la ter timepoints in the 12-72 hr  range.  S -1-P l evels do not  appear to 
experience a cons istent change ov er t ime (Figure 4.2. B), but  t he p resence of clear r esponse 
curves at a ll s train m agnitudes s uggest a t ransient e arly ( <3 hr s) and i ntermediate (12-24 hr s) 
elevation in S-1-P levels.  Only SM  (Figure 4.2.C) appears to demonstrate a consistent reduction 
in r esponse t o s train a t all but  t he s ubphysiological s train i ntensity ( 3%); t his phe nomenon i s 
particularly pronounced at the high physiological strain intensity of 12%. 
The nor malized s phingolipid c ontent of  s trained c ells i s e xpressed a s a  r atio t o t he 
corresponding normalized sphingolipid content of the matched unstrained control.  N one of the 





Figure 4.2.  Sphingolipid metabolites of ceramide show some variation in response to cyclic strain magnitude.  At 
all magnitudes except 10%, bAECs appear to experience a reduction in sphingosine (A).  S-1-P levels do not appear 
to experience a consistent change over time, but the response curves at all strain magnitudes suggest a transient early 
(<3 h rs) an d i ntermediate ( 12-24 hr s) e levation i n S -1-P l evels ( B).  O nly SM ( C) appears t o d emonstrate a 
consistent reduction in response to  s train a t a ll but the subphysiological s train intensity (3%); this phenomenon i s 
particularly pronounced at the high physiological strain intensity of 12%.  bAECs were exposed to 3, 6, 10, or 12% 
strain at 1Hz for up to 72 hrs with harvest and l ipid extraction for sphingolipid analysis performed at t ime points 
shown between 30 minutes and 72 hours. The total ion count of each sphingolipid metabolite is normalized to that of 
PC and the data shown is expressed as a ratio of the strained group to the control.  (n=5) 
 
 
4.3.1.2.2  Metabolite response to variation of strain frequency 
At 6% cyclic strain, variation of strain frequency between 0.5 Hz and 2 Hz did not appear 
to affect long-term changes in sphingosine, S-1-P, or sphingomyelin compared to a frequency of 
1 Hz (Figure 4.3). 
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The nor malized ceramide cont ent of  s trained cells i s ex pressed as a r atio to the 
corresponding normalized ceramide content of the matched unstrained control.  None of the data 
were s tatistically s ignificant ( p≤0.05).  The data shown are the average of four experimental 




Figure 4.3.  Sphingolipid metabolites do not vary with frequency at 6% cyclic strain.  bAECs were exposed to 6% 
strain a t 0 .5, 1,  1.5, or  2 H z for u p t o 7 2 h rs with ha rvest a nd l ipid e xtraction f or s phingosine, S -1-P, an d S M 
analysis pe rformed a t t ime p oints shown be tween 30 minutes a nd 72 hours. ( A) shows c hanges in s phingosine 
levels, (B) shows changes in S-1-P, and (C) shows changes in sphingomyelin levels.  As previously, total ion count 
of sphingolipid metabolite is normalized to that of PC and the data shown is expressed as a ratio of the strained 
group to the control.  (n=3-4) 
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4.3.2 Selective inhibition of aSMase, nSMase and de novo ceramide synthesis 
4.3.2.1  Inhibition of aSMase 
Pretreatment of  hA ECs w ith de sipramine, a n i nhibitor of  a SMasem, prior t o a nd 
concurrently with e xposure t o 10%  c yclic s train a t 1 H z, blocks t he e arly, but  not  t he l ate 
increase in ceramide associated with 10% cyclic strain at 1 Hz (Figure 4.4).  The C16:0, C24:1, and 
C24:0 ceramide i ncrease t ypically encountered at 3 hrs i s abrogated in response t o desipramine 
treatment, however the prolonged ceramide increase normally encountered at later timepoints is 
still present and even seems to be elevated for all major ceramide species.  Sphingomyelin levels 






Figure 4.4.  Desipramine inhibition of aSMase blocks only the early ceramide increase.  (A) shows changes in C16:0 
ceramide, (B) shows changes in C24:1 ceramide, (C) shows changes in C24:0 ceramide, and (D) shows changes in 
sphingomyelin.  hAECs were pretreated with 50 µM desipramine for 3 hrs prior to exposure to 10% cyclic strain at 
1Hz for up to 48 hrs, maintaining desipramine in the culture medium.  Cells were harvested for lipid extraction for 
ceramide analysis at time points shown between 30 minutes and 48 hours. As previously, total ion count of ceramide 
or sphingomyelin is normalized to that of PC and the data shown is expressed as a ratio of the strained group to the 




4.3.2.2 Inhibition of nSMase 
Pretreatment of  hA ECs w ith m anumycin A , an i nhibitor of  nS Mase, prior t o a nd 
concurrently w ith e xposure t o 10%  c yclic s train a t 1 H z, blocks t he v ery early and the l ate 
increase in ceramide associated with 10% cyclic strain at 1 Hz (Figure 4.5).  The C16:0, C24:1, and 
C24:0 ceramide increase typically encountered at about 30 minutes to 1 hr is abrogated, as well as 
the pr olonged ceramide i ncrease t ypically encountered at l ater t ime-points.   I nterestingly, i t 
appears that a small increase in ceramide at 3 hrs is still present for all species of ceramide, even 
during m anumycin treatment.  S phingomyelin le vels a re s ubstantially decreased following 





Figure 4.5.  Manumycin A inhibition of nSMase blocks both early and late ceramide increases.  (A) shows changes 
in C16:0 ceramide, (B) shows changes in C24:1 ceramide, (C) shows changes in C24:0 ceramide, and (D) shows changes 
in sphingomyelin.  hAECs were pretreated with 2 µM manumycin A for 2 hrs prior to exposure to 10% cyclic strain 
at 1Hz for up to 48 hrs, maintaining manumycin A in the culture medium.  Cells were harvested for lipid extraction 
for ceramide analysis at time points shown between 30 minutes and 48 hours.  As previously, total ion count of 
ceramide or sphingomyelin is normalized to that of PC and the data shown is expressed as a r atio of the strained 




4.3.2.3 Inhibition of de novo ceramide synthesis 
Pretreatment of  hAECs with L-cycloserine, an i nhibitor of  de novo ceramide synthesis, 
prior t o a nd c oncurrently with e xposure t o 10%  c yclic s train a t 1 H z, blocks onl y t he l ate 
increase in ceramide associated with 10% cyclic strain at 1 Hz (Figure 4.6).  The C16:0, C24:1, and 
C24:0 ceramide increase typically encountered between 30 minutes and 3 hrs is still present, but 
the pr olonged c eramide i ncrease i s m arkedly reduced be low even uns trained c ontrol l evels.  
Sphingomyelin l evels a re s ubstantially d ecreased f ollowing L-cycloserine treatment a s w ell.  





Figure 4.6.  L-cycloserine inhibition of de novo ceramide synthesis inhibits late, but not early ceramide 
accumulation.  (A) shows changes in C16:0 ceramide while (B) shows comparable changes in C24:1 ceramide and (C) 
shows comparable changes in C24:0 ceramide.  ( D) shows changes in sphingomyelin.  h AECs were pretreated with 
1mM L -cycloserine for 3 h rs pr ior t o e xposure t o 10%  cyclic strain a t 1 Hz for u p t o 48 h rs, maintaining L-
cycloserine in the culture medium.  Cells were harvested for l ipid extraction for ceramide analysis at  t ime points 
shown between 30 minutes and 48 hours. As previously, total ion count of ceramide or sphingomyelin is normalized 





4.4.1 Sphingosine and cyclic strain 
Evaluation of a single time-point and strain regimen on bAECs – 10% strain at 1 Hz for 24 hrs – 
reveals that onl y s phingomyelin a nd s phingosine s how a  c hange relative t o uns trained c ontrol 
cells, bot h e xhibiting de creases (Figure 4.1) .  In F igure 3.3 , i t s hould be  not ed t hat t he 
sphingosine levels at 1.5 hrs following cessation of strain, also for 24 hrs at 10% strain at 1 Hz, 
shows an initial increase in sphingosine levels relative to control, whereas the benchmark data 
taken immediately following cessation of strain shows a de crease (Figure 4.1).  T he question is 
then how these conflicting data should be viewed.  As discussed in Section 3.4.1, the 1.5 hr post-
strain t imepoint l ipid extraction ( addition of  c hloroform a nd m ethanol) i s pe rformed a t 
approximately the same time following removal from the s train apparatus as the s tandard lipid 
extractions described in the rest of this study, so one would expect agreement of the data.   These 
are separate experiments performed on separate occasions and the variability may reflect Type I 
error indicating that the change in sphingosine at this timepoint may not actually exist.   
Alternatively, the reduction in sphingosine with strain relative to control, as seen in the 
benchmark assessment, may be lost very quickly following cessation of strain, more quickly than 
even the changes in ceramide or sphingomyelin.  The total time to extraction of a standard lipid 
extraction as performed in the benchmark experiment is approximately 1 hour, whereas the total 
time between cessation of strain and actual extraction for the first strain cessation time-point is 
1.5 hours.  Being that sphingosine is an intermediate between ceramide and protective S-1-P, it is 
possible t hat dur ing s train, s phingosine i s ut ilized r eadily t o generate S -1-P to shift the  c ell 
towards a  m ore pr otective phe notype, but  t hat upon r emoval of  t he strain s timulus, S -1-P 
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generation slows and sphingosine levels back up, resulting in the increase relative to control seen 
at 1.5 hr s in the strain cessation experiment.  T his explanation is supported by the observations 
that sphingosine shows a reduction across most time-points at all strain magnitudes (Figure 4.2) 
and frequencies (Figure 4.3) tested. 
4.4.2 S-1-P and cyclic strain 
When c onsidering s phingosine c hanges, c hanges i n S -1-P m ust be  com pared as w ell, since 
sphingosine is an intermediate in the metabolism of ceramide to S-1-P.  If one tries to look at net 
change i n S-1-P a cross s train r egimen m agnitudes, t here doe s not  a ppear t o be a s tatistical 
significance (Figure 4.2.A).  However, looking at the time-response of each frequency together, 
it is clear that at all strain magnitudes tested, bAECs experience an early spike in S-1-P, followed 
by a reduction, followed by a second, more sustained rise.  T hese patterns generally follow the 
pattern of ce ramide i ncrease ove r t ime i n response t o strain and may r epresent conv ersion of  
increased ceramide to S-1-P, potentially as a protective mechanism.  V ariation of  frequency at 
6% strain does not appear to affect S-1-P levels (Figure 4.3.A).   
Taken together with the sphingosine data, it appears that during active strain, sphingosine 
is r eadily ut ilized and does not  r emain as an intermediate.  Whether it is  be ing ut ilized in the 
conversion of S-1-P to ceramide or in the conversion of ceramide to S-1-P cannot be determined 
from t hese s tudies, but  i t i s pr obable t hat bot h pa thways o ccur w ithin E Cs dur ing s train, 
potentially as part of the theorized sphingolipid rheostat [80]. 
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4.4.3 de novo synthesis of ceramide 
Synthesis of  ce ramide b y the de novo pathway, which usually o ccurs ov er a  pe riod of  s everal 
hours as  a l ate response to cellular s tress, has been shown in response to a  number of  cellular 
stresses i ncluding T NF-α, i onizing r adiation, and c hemotherapeutic agents a nd h as be en 
implicated in apoptosis [63, 65, 70, 75]. 
When L-cycloserine is introduced into culture concurrent with 10% cyclic strain at 1 Hz, 
hAECs e xhibit t he c haracteristic e arly i ncrease i n c eramide t hrough 3 hr s, but  a fter 6 hr s, t he 
ceramide r esponse i s co nsiderably de pressed co mpared to strain alone and even compared t o 
unstrained control cells (Figure 4.6).  This suggests that the late ceramide response, as expected, 
is a ssociated with de novo synthesis.  F urthermore, s phingomyelin levels i n hA ECs a re 
substantially reduced w ith a ddition of  L -cycloserine dur ing s train relative to strain alone, 
suggesting tha t S Mase activity is  s till f unctional a nd tha t inhi bition of de novo synthesis o f 
ceramide reduces the level of available sphingomyelin (Figure 4.6.D). 
4.4.4 Sphingomyelin and cyclic strain 
The s phingomyelin r esponse t o c yclic s train i s a rguably t he m ost s traight-forward of t he 
metabolite r esponses t ested. T he s tandard ceramide r esponse t o t ime, a s s hown in F igure 3.4 , 
appears to have two early spikes in ceramide generation prior to 1 hr and again at approximately 
3 hrs, followed by a sustained increase in ceramide after 12-24 hrs.  Based on these findings, we 
hypothesized t hat s phingomyelin h ydrolysis w as r esponsible f or t he e arly c eramide i ncrease 
while de novo ceramide synthesis was responsible for the late ceramide increase.   
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Addition of  m anumycin A , a n i nhibitor of  ne utral S Mase, dur ing 10%  strain a t 1 H z 
causes an early and immediate de crease i n all of  t he m ajor s pecies of  ceramide as w ell as  an 
absence of t he l ate ceramide r esponse (Figure 4 .5).  Interestingly, there is  s till a  s pike in all 
ceramide s pecies m easured occurring at  3 hrs.  T his s uggests t hat t he i nitial cer amide s pike 
occurring pr ior t o 1  ho ur i s due  t o h ydrolysis of S M b y nS Mase i n t he pl asma m embrane, 
consistent with the notion of initiation of mechanotransduction signaling at the membrane.  This 
is a lso c onsistent w ith t he f inding t he nS Mase a ctivity i s obs erved i n r esponse t o e levated 
pressure/flow in an is olated lung graft mod el [82, 83] .  T he pr esence of  t he 3 h r s pike i n 
ceramide e ven w ith t he a ddition t he nS Mase i nhibitor, a s w ell as t he continued r eduction i n 
sphingomyelin compared to strain alone, suggests that there is a second early ceramide response, 
probably due to another form of SMase and that nSMase activity accounts for a relatively small 
amount of  S M h ydrolysis ( Figure 4.5) .  H owever, t he a bsence of  t he l ate c eramide r esponse 
following ma numycin A tr eatment s uggests th at c eramide s ignaling resulting f rom nSM ase 
hydrolysis is necessary for the later de novo synthesis of ceramide.  If de novo synthesis is indeed 
blocked b y t he i nhibition of  nS Mase-associated hydrolysis of  s phingomyelin to ceramide, the 
pronounced reduction in sphingomyelin seen in Figure 4.5.D may be due to a  reduction in the 
available sphingomyelin caused by a reduction in available ceramide without de novo synthesis.  
Further s tudies a ssessing the functional activity of enz ymes a ctive i n the de novo biosynthetic 
pathways would be necessary to confirm this observation.  However, it is important to recognize 
that m anumycin A  i s a lso a  know n i nhibitor of  t he R as pa thway b y way o f i nhibiting R as 
farnesyl t ransferase.  It ha s be en pr oposed t hat s ome of  t he R as i nhibitory a ctivities of  
manumycin A  m ay be  attributable t o nS Mase i nhibition [111].  T o c onfirm tha t nSM ase is  
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responsible f or obs erved appa rent ch anges i n de novo synthesis, i t w ould be  h elpful t o r epeat 
these experiments using other known inhibitors of nSMase like scyphostatin. 
The da ta f rom e xperiments us ing de sipramine, a n i nhibitor of  a SMase, clarify t hese 
findings.  W hen desipramine is added to hAEC culture during 10% strain at 1 Hz, the ceramide 
spike at 3 hrs is abrogated for all major species of ceramide, but the late response is still present 
and is actually more pronounced than in hAECs exposed to 10% strain alone (Figure 4.4).  This 
suggests that the 3 hr spike in ceramide is attributable to aSMase hydrolysis of sphingomyelin, 
potentially a fter l ysosomal tr anslocation to the me mbrane, but tha t c eramide s ignaling f rom 
aSMase doe s not  af fect de novo ceramide s ynthesis.  W hen one  l ooks a t t he ve ry m eager 
sphingomyelin c hanges i n response t o a SMase i nhibition ( Figure 4 .4.D) r elative t o t he 
pronounced changes in sphingomyelin in response to manumycin (Figure 4.3.D), it appears that 
the ma jority of S M h ydrolysis obs erved i n r esponse t o c yclic s train i s a ttributable t o a SMase.  
The relevance of this finding in the setting of the endothelial response to mechanical stresses is 
supported by studies that have shown that ceramide signaling by aSMase-mediated hydrolysis of 
sphingomyelin are ne cessary for eN OS act ivity [73, 74 ].  A lthough t he r elationship be tween 
eNOS a ctivity a nd c eramide dur ing c yclic s train i s not  tested i n t his b ody of  w ork, i t i s a n 
intriguing target for future experiments. 
In the bAECs exposed to 6%, 10%, and 12% s train, sphingomyelin shows a  prolonged 
reduction r elative t o un strained c ontrols, s uggesting t hat s phingomyelin h ydrolysis oc curs a t 
physiological and high physiological levels of  s train, whereas a t 3 % s train ( subphysiological), 
there is actually an elevation in sphingomyelin relative to unstrained controls.  At 3% strain, the 
major s pecies of  cer amide di d not ex hibit t he cha racteristic ear ly i ncrease i n ceramide at  
approximately 3 hrs that was observed in response to 6%, 10%, and 12% strain.  Taken together 
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with the inhibitor studies, this information is very interesting.  Recalling that the ceramide spike 
at 3 hr s appears to be a result of  aSMase hydrolysis of  SM, i t i s possible that aSMase act ivity 
requires a strain threshold to occur.  It is intriguing, since the apparent lack of aSMase activity at 
3 hrs occurs in cells exposed to 3% strain, which do not  align perpendicular to s train, to think 
that aSMase activity is  e ither required for a lignment, or  that a lignment i s required for aSMase 
activity.  Certainly, in the context of integrin rearrangement and formation of focal adhesions in 
conjunction w ith c ellular a lignment, i t s eems l ikely t hat one  w ould e xpect a n i ncrease i n 
ceramide enriched membrane domains to facilitate reorganization and clustering of receptors or 
adhesion m olecules, po tentially t hrough a SMase.  a SMase t ranslocation t o t he m embrane 
accompanying t he f ormation of cer amide-enriched m embrane dom ains i n r esponse t o C D95 
ligand stimulation has been shown in bAECs [62].   
As with ceramide, sphingosine, and S-1-P, sphingomyelin does not  appear to vary with 
changes in strain frequency at 6% strain (Figure 4.3.D).  As discussed previously (Section 3.4.2), 
due to limitations of the Flexcell FX4000T system, it is not possible to impose a strain regimen 
at 2 H z us ing a  s train m agnitude hi gher t han 6% .  A t hi gher s train m agnitudes, hi gher 
frequencies might affect ceramide generation and consequently sphingomyelin h ydrolysis, in a  
more profound manner, but these s tudies do not  suggest that s train frequency affects ceramide 
synthesis. 
4.5 CONCLUSIONS 
Cyclic, uniaxial strain applied at a variety of magnitudes (3%-12%) and frequencies (0.5 Hz – 2 
Hz) r epresenting va riation f rom s ubphysiological t o e levated, p athophysiological s tates of  
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arterial strain conditions, demonstrates that whole-cell levels in sphingosine and sphingomyelin 
are reduced in bAECs in response to cyclic strain.  As with ceramide, continuous application of 
cyclic uniaxial strain is necessary to maintain these changes and removal of the strain stimulus 
causes sphingosine and sphingomyelin levels to return to baseline.  B ased on s imilarly shaped 
curves f or t he S -1-P r esponse t o s train ove r t ime c ompared t o c eramide, i t a ppears t he 
sphingosine, as an i ntermediate, i s be ing ut ilized in conversion of  ceramide to S -1-P and vi ce 
versa during strain.  Sustained reduction in sphingomyelin levels suggests that sphingomyelin is 
being h ydrolyzed t o f orm c eramide dur ing s train.  S imilar t o c eramide f indings, va riation o f 
strain frequency at a s train magnitude of 6% does not appear to alter levels of sphingosine, S-1-
P, or sphingomyelin. 
Studies of  s elective i nhibition of  a SMase, nS Mase, a nd de novo synthesis of  ceramide 
reveal that all three enzymes are involved in the ceramide response to cyclic strain, as shown in 
Figure 4.7 .  N eutral S Mase h ydrolysis of  s phingomyelin oc curs w ithin t he f irst hour  o f s train 
application a nd a ppears t o be  ne cessary f or t riggering t he s ustained de novo synthesis of  
ceramide following strain.  Acid SMase hydrolysis of sphingomyelin occurs at approximately 3 
hours after the onset o f strain and may represent the majority of SM h ydrolysis that occurs in 
response to strain.  Finally, de novo synthesis of ceramide seems to begin after 6 hrs of strain and 
appears to be predominantly responsible for the prolonged ceramide response observed after 12-
24 hours of cyclic strain. 
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Figure 4.7.  The cer amide r esponse t o c yclic s train involves the g eneration of  c eramide f rom bot h t he de novo 
synthetic pathway and from hydrolysis of sphingomyelin to ceramide by nSMase and aSMase. 
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5.0  CLOSING DISCUSSION 
5.1 RESTATEMENT OF THE BIOLOGICAL PROBLEM 
The purpose of this body of research was to examine the virtually unexplored and critical role of 
the lipid microenvironment, particularly with regards to ceramide signaling, in aortic endothelial 
cells in response to cyclic strain within and beyond the physiological range, so as to gain a better 
understanding of  t he events w hich m ay ul timately contribute t o e ndothelial a ctivation and 
dysfunction and to eventual atherosclerosis.   
Cyclic strain, acting circumferentially through the wall of the blood vessel, in addition to 
hydrostatic pressure acting radially, and fluid shear stress, acting longitudinally in the direction 
of bl ood f low a re t he major m echanical f orces e ncountered b y bl ood vessels i n r esponse t o 
pulsatile bl ood f low [43].  T ogether, t hese f orces i nfluence t he e ndothelium a nd i ts a bility t o 
maintain appropriate vascular permeability, tone, and hemostasis, and to regulate inflammation 
and remodeling in health and disease.  During mechanical injury or disease states, blood vessels 
may encounter a bnormal l evels of  m echanical f orces, which can alter e ndothelial a nd s mooth 
muscle c ell f unction, which in turn may c ontribute to the f ormation of atherosclerotic le sions 
[43-45].   
Clinically, cyclic s train i s a ssociated w ith h ypertension, ve in gr afting, ba lloon 
angioplasty over-stretch injury and possibly intra-aortic balloon pumping, tissue engineering, and 
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formation of  atherosclerotic l esions.  A therosclerotic l esions t end t o d evelop i n r egions of  
elevated strain, including s ites of  ve in to artery grafting [42, 51 ].  T hus, a n i mproved 
understanding of  how  aberrant m echanical f orces t rigger dysfunction a nd i nflammation i n t he 
vasculature has the potential to greatly improve our understanding of vascular disease pathology 
and etiology. 
The m eans b y w hich cells c onvert m echanical f orces i nto bi omolecular r esponses i s 
known as mechanotransduction [46].  N umerous possible mechanisms for mechanotransduction 
have been proposed, including ion channels, G-proteins, MAPKs, integrins and focal adhesions, 
the cytoskeleton, and reactive oxygen species [44, 45, 47] .  While it is  debated which of these 
mechanisms i n the t rue mechanosensor i n the vascular s etting, it is  ve ry lik ely tha t s everal o f 
these processes are activated concurrently.   
Ceramide, t he c entral molecule i n s phingolipid bi osynthesis, i s w idely know n t o 
participate in stress signaling in response to a multitude of cellular stress stimuli pertinent to the 
vascular setting, including cytokines (TNF-α, IFN-γ, IL-1β, e tc.), l ipopolysaccharide, ox idized 
LDL, va rious c hemotherapeutic a gents, i onizing i rradiation, he at s tress, i schemia/reperfusion, 
and nitric oxide [2, 61, 63, 65, 72]  and has been implicated in signaling through many versatile 
targets including MAPKs, JNK, and caspases, amongst others [63, 67] .  D epending on t he site 
and source of synthesis, ceramide can participate directly in signaling or can assist in signaling 
through i ts i nvolvement i n l ipid r afting [2, 62] , l eading t o c ell pr oliferation, di fferentiation, 
growth, or arrest [61]. 
Furthermore, ceramide and its m etabolites h ave be en found i n elevated levels i n 
atherosclerotic lesions [2, 81], and areas of lesion development have exogenous and endogenous 
sources o f s phingomyelinases a nd sphingomyelin, c apable o f c ontributing t o ceramide 
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generation t hrough s phingomyelin h ydrolysis [2, 71, 81] .  W ithin t he c ontext of  v ascular 
inflammation and activation, ceramide introduced f rom e xogenous s ources as w ell a s 
endogenously through the hydrolysis of sphingomyelin has been shown to trigger Weibel-Palade 
body exocytosis in endothelial cells [26]. 
Despite t he br eadth of  i ts s ignaling pot ential a nd i nfluences on  cell f ate, the r ole o f 
ceramide signaling remains largely unexplored in the context of mechanotransduction.  Ceramide 
has t he pot ential t o be  i nvolved i n a ll a spects of  m echanotransduction, w hether t hrough 
involvement in plasma me mbrane d ynamics and lipid rafting to facilitate coa lescence of  
membrane p roteins a nd r eceptors, pa rticularly i n t he c aveolae, f or signaling a nd s ignal 
amplification [62]; through direct or indirect activation of protein kinases [63, 65, 67] ; through 
its ability to self-associate into lipid channels and to aid in the proper formation of ion channels 
[62, 85]; and through the ability of ceramide to generate reactive oxygen species and vice versa, 
suggesting its  potential r ole in signaling amplification [62, 67, 86] .  Furthermore its  hi storical 
implication in the development of  inf lammation, cellular s tress, and endothelial cell activation 
make i t a ve ry l ikely l ink between mechanical t rauma and eventual de velopment of  va scular 
disease. 
5.2 RESTATEMENT OF THE HYPOTHESIS AND REVIEW OF EXPERIMENTAL 
DESIGN 
Our c entral h ypothesis is tha t m echanical, uniaxial c yclic s train results i n an increase i n 
intracellular ceramide in vascular endothelial cel ls, which participates in signaling necessary to 
propagate m echanotransduction r esponses t o c yclic s train, pot entially c ontributing t o e arly 
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events i n t he de velopment of  e ndothelial d ysfunction a nd t he f ormation of  a therosclerotic 
lesions.   
To t est t his h ypothesis w e be gan b y de fining t he phos pholipid a nd s phingolipid 
environment of aortic endothelial cells by a detailed mass spectrometric analysis to establish the 
foundation for a more in-depth study of ceramide signaling.  W e then explored the response of 
aortic endothelial c ells t o exogenous sources of  C8 and C 16 ceramides, representing species of  
nonphysiological and physiological fatty acid chain lengths respectively, to test the specificity of 
the endothelial cell response to different species of ceramides. 
We t hen set out to thoroughly e valuate ho w c eramide a nd its  me tabolites -- namely 
sphingosine, S -1-P, a nd s phingomyelin -- change i n r esponse t o a  p anel of  ph ysiological a nd 
pathological strain conditions with regards to magnitude and frequency over time.  Sphingosine 
and S -1-P w ere chos en because t he i ntracellular ba lance be tween ceramide and S-1-P activity 
has been suggested as a determining factor -- a sphingolipid rheostat -- for whether a cell’s fate 
favors s urvival (S -1-P) or  d eath (ceramide) [80].  S phingomyelin w as c hosen be cause i ts 
hydrolysis i s a r eady source of ceramide a nd it is  a  p rominent s phingolipid involved in lipid 
rafting and cell signaling [65, 66, 71].   
Then, to further define the place of  ceramide s ignaling within the mechanotransduction 
response t o c yclic s train, t hrough t he us e of  pha rmacological i nhibitors t o a cid 
sphingomyelinase, ne utral s phingomyelinase, a nd de novo ceramide s ynthesis, we eva luated 
which biosynthetic pathways appeared to be activated in response to strain and we examined the 
accumulation of s elect me tabolites w ith known biological a ctivity in the va scular 
microenvironment.   
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5.3 SUMMARY OF RESULTS AND DISCUSSION 
In C hapter 2,  w e established t he s phingolipid a nd phos pholipid m icroenvironment t hrough an 
extensive mass spectrometric analysis.  The list of phospholipids in Tables 2.1, 2.2, 2.3, 2.4, 2.5, 
and 2.6 reveal that the major species of phospholipids present in AECs show a broad distribution 
of fatty aci d chain lengths w ithin the ph ysiological r ange ( C14-C24).  B y na ture of  limita tions 
inherent i n ESI-MS/MS analysis of  whole-cell lipid extractions, this lis t is not  absolute and is 
only indicative of major species present, as discussed in Section 2.4.1.   
In addition t o e xpected phos pholipids l ike P C, P E, P G, P I, a nd P S, w e a lso f ound 
abundant cholesterol and a number of species of PE plasmalogens, which possess a vinyl ether at 
the C1 position on the glycerol backbone instead of the typical ether linkage connecting the fatty 
acid.  As such, plasmalogens are particularly susceptible to attack by reactive oxygen species at 
the vinyl ether linkage (Figure 2.11), thereby conferring anti-oxidant function by causing them to 
be es pecially effective in protecting ot her m embrane phos pholipids a nd c omponents f rom 
oxidative damage in platelets [99].  Plasmenyl PE and plasmenyl PC are also cleaved by PLA2 to 
release arachidonic acid in coronary artery ECs stimulated by thrombin and hypoxia [101].  The 
ability to detect and monitor changes in specific plasmalogen species by ESI-MS may prove to 
be an insightful tool in future studies assessing the extent of damage to lipid functionality in the 
endothelium, pa rticularly with r egards t o t he potential r ole of  r eactive ox ygen s pecies i n 
mechanotransduction, as well as in evaluating the initiation and progression of vascular disease. 
In assessing the sphingolipid profile of  AECs, we established that C16:0, C24:1, and C24:0 
species of  c eramide ar e abundant and easily d etectable b y ESI-MS in both bovine and human 
AECs.  Evaluation of the profile of sphingomyelin species present revealed species with a broad 
distribution of length of the non-sphingoid fatty acid side-chain.  C16:0 sphingomyelin was found 
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to be abundant and easily detectable.  By nature of its lower mass than the abundant species of 
PC de tected i n t he pos itive i on m ode, it is  r elatively is olated on the M S s pectrum.  T hese 
properties e stablished C 16:0 sphingomyelin a s a  suitable m easure of  s phingomyelin a ctivity i n 
ECs.  T hese s tudies also established C16:0, C 24:1, and C24:0 ceramide; C 16:0 sphingomyelin; a nd 
sphingosine and S-1-P as the panel of sphingolipids to be measured in all further endothelial cell 
experiments in this study. 
Because o f t he eas e of  solubility w ith decreasing fatty a cid chain length, short-chain 
ceramides ( C2-C8) a re f requently us ed i n e xogenous c eramide s tudies, de spite be ing 
nonphysiological. Our evaluation of the specificity of the aortic endothelial cell response to both 
physiological C16 and non-physiological C8 species of ceramide reveals that short chain ceramide 
is not  a  di rect f unctional s ubstitute f or t he ot her, bot h w ith r egards t o c hange i n vi ability and 
intracellular physiological ceramide content (Figures 2.9 and 2.10). 
Treatment with exogenous C8 ceramide causes an expected increase in bAEC C16 and C24 
ceramides with a corresponding concentration-dependent decrease in viability (Figure 2.9), while 
treatment with exogenous C16-D31 ceramide causes a decrease in bAEC levels of endogenous C16 
and C 24 ceramides and does not c ompromise c ell vi ability ( Figure 2.10).  T hus, e xogenous 
sources of C16 ceramide are well tolerated by bAECs and the data suggests that bAECs may be 
capable o f c onverting th e e xogenous ph ysiological c eramide int o a mor e pa latable me tabolite 
like SM, S-1-P, or a higher glycolipid, whereas the nonphysiological ceramide may not be able 
to be processed and is instead deacylated and reacylated to form longer-chain ceramides.  T his 
seems es pecially possible g iven the r eduction in endogenous c eramide s pecies r elative t o 
untreated control cells following treatment with exogenous C16-D31 ceramide (Figure 2.10).  C16 
ceramide m ay al so exhibit f eedback i nhibition of ceramide s ynthesis i n bA ECs s uch t hat i n 
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response t o increases i n C16 ceramide, a  s pecies w ith know n bi ological a ctivity, endogenous 
synthesis of  c eramides may be do wnregulated i n t he absence of  other s tress events t o prevent 
inappropriate signaling. 
This data may further support the concept that specificity of fatty acid chain length plays 
a r ole i n specific a ctivity of  di fferent ceramide s pecies.  D ifferent s pecies of  ceramide are 
associated with distinct ceramide synthases, each of which is encoded on a different gene.  For 
example, in humans, each of  the s ix longevity assurance genes, LASS1-6, encode for ceramide 
synthases t hat s electively utilizes s pecific f atty acid chain lengths be tween C16 and C 24 and 
different genes m ay be  activated under di fferent ci rcumstances [102].  T his e vidence f urther 
supports t he not ion t hat di fferent c hain l engths of c eramide m ay pl ay d ifferent r oles a nd t hat 
measurement of a single species of ceramide may not be a surrogate for all species of ceramide 
with regards to biological activity. 
The outcome of ceramide signaling is also associated with the site and source of ceramide 
generation within t he c ell.  E xogenous C 16 ceramide ma y not  p artition into the a ppropriate 
intracellular pools to evince a ch ange in viability, whereas C8 ceramide causes rapid generation 
of long-chain ceramide, potentially through removal of  the C8 chain and reacylation with C16:0 
(palmitic acid), similar to de novo synthesis. 
The a bility o f e ndothelial c ells t o r espond t o extracellular s ources o f s phingolipids i s 
highly a pplicable i n t he vascular s etting w here endothelial c ells are e xposed t o s phingolipids 
circulating in serum or  associated with extracellular lipi d-protein c omplexes, a nd pool s o f 
sphingolipids within atherosclerotic lesions. 
To fully explore how endothelial cells r espond to cyclic s train, a s eries of  ex periments 
was pe rformed t o test h ow ce ramide l evels va ry in bA ECs i n response t o a v ariety o f s train 
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regimens e ncompassing s ubphysiological t hrough ph ysiological s train c onditions e ncountered 
within the a rterial va sculature, each assessing the t ime r esponse t hat accom panies s elective 
variation of  t he m agnitude a nd frequency o f strain. F urther e xperiments i n hA ECs, us ing 
selective inhi bitors a gainst de novo ceramide synthesis or  h ydrolysis of  s phingomyelin t o 
ceramide by acidic or neutral sphingomyelinases, clarified many of these findings.  
A feature of the ceramide response to cyclic strain by bAECs over the first 72 hrs, which 
was conserved across normal physiological and pathophysiological strain magnitudes at all strain 
frequencies t ested, was the pr esence of  a t wo-part e arly r ise in ceramide w ithin the f irst f ew 
hours as well as a prolonged rise in ceramide levels over the first few days (Figures 3.4, 3.5, and 
3.6).  T he inhibitor studies performed in hAECs revealed that the very early rise in ceramide at 
30 minutes corresponds to nSMase hydrolysis of SM to ceramide, while the second early rise in 
ceramide at 3 hr s c orresponds t o a SMase h ydrolysis of  S M t o c eramide.  T he l ate, pr olonged 
response occurring after 12 hrs and lasting for the remainder of the 72 hr  experiment was found 
to be  due  t o de novo ceramide s ynthesis (Figure 4.7) .  V ery i nterestingly, w hen nSMase w as 
inhibited, the c ells e xperienced ne ither th e ini tial s pike in ceramide generation, nor the  la ter 
prolonged response, suggesting that nSMase-associated ceramide signaling may be necessary to 
initiate de novo synthesis.  Thus, we propose that ceramide signaling due to nSMase and aSMase 
hydrolysis of  s phingomyelin t o c eramide a nd de novo ceramide s ynthesis pl ays a role i n t he 
mechanotransduction t o c yclic s train, a lthough f urther s tudies a re ne eded t o de termine how  






Figure 5.1.  Ceramide i s i nvolved i n t he mechanotransduction response t o cy clic s train an d i s g enerated f rom 
hydrolysis of sphingomyelin to ceramide by both nSMase and aSMase, as well as by the de  novo synthetic pathway.  




More plainly, this data suggests that the initial ceramide signaling event due to nSMase 
activity occurring a t the  onset of  s train, a nd localized to the pl asma m embrane appe ars t o be 
necessary to stimulate de novo synthesis that may be necessary for the cell to mount a sustained 
mechanotransduction response to cyclic strain.  Thus, nSMase activity at the plasma membrane, 
where sphingomyelin is abundant in caveolae and in lipid rafts necessary for receptor and surface 
molecule arrangement, may be critical to the initial steps of mechanotransduction, either through 
the direct action of ceramide signaling, or through the role of ceramide in lipid rafts to enhance 
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receptor c oalescence.  This phe nomenon ha s a lso be en pr oposed i n s tudies of  e levated 
pressure/flow in isolated lung grafts [82, 83]. 
The f inding t hat nS Mase i s a ctivated i n r esponse t o c yclic s train f urther s upports t he 
hypothesis that ceramide signaling in ECs in response to cyclic strain contributes to early events 
leading to EC dysfunction.  Ceramide generated by nSMase activation in hAECs has been shown 
by others to cause exocytosis of Weibel-Palade bodies [26], a hallmark of endothelial activation, 
which may over time contribute to endothelial dysfunction [23]. 
Interestingly, the early ceramide response, particularly that occurring at 3 hrs, appears to 
be absent in the response to 3% strain (subphysiological), while being present at all higher strain 
magnitudes tests (6-12%).  If the t ime response i s indeed reflective of  the presence of  an early 
ceramide increase due to membrane-associated sphingomyelin hydrolysis, this finding suggests 
that a threshold level of strain may be necessary to elicit sphingomyelin hydrolysis.  B eing that 
ECs do not align perpendicular to strain below 5% strain magnitude, it may be possible that this 
early ceramide i ncrease i s either caused by o r is  necessary for c ell a lignment w ithin this time 
period.  T he 3 h r peak in ceramide, which we have shown is associated with aSMase activity, 
may r eflect ei ther t ranslocation of l ysosomal aS Mase t o the cel l m embrane t o participate i n 
membrane r eceptor co alescence [62] necessary f or s ignaling o r t o facilitate integrin 
rearrangement dur ing a lignment.  A lternatively, it ma y represent th e invol vement of  the  
sphingolipid s alvage pa thway, w hich r ecycles s phingolipids like s phingomyelin or  
glucosylceramide to sphingosine which may then be converted to S-1-P or to ceramide [88].  The 
transience of this peak in the higher strain magnitude suggests that aSMase is being employed to 
assist in a specific transient membrane event, rather than a b asal metabolic function of the cell, 
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further s trengthening t he not ion t hat a SMase-mediated ceramide generation is s pecifically 
associated with strain alignment. 
The A EC r esponse to subphysiological s train is  s till c linically r elevant, s ince va scular 
disease is also characterized by regions of arterial stiffness occurring in any region of the arterial 
bed including the aorta and across calcified a therosclerotic l esions.  If o ne de fines endothelial 
cell he alth in terms o f t he a ctivity of c ellular s tress s ignaling pathways, r eduction in cellular 
strain i n t he w rong pop ulation of  E Cs ( aortic E Cs), m ay be  a s de trimental a s an e levation i n 
strain.  T hus, t he a bsence of  a SMase-associated ceramide s ignaling i n ECs e xperiencing a  
reduction i n s train m agnitude i n t he a orta o r across a therosclerotic l esions, m ay r esult i n 
endothelial d ysfunction w hich c ould a ffect va scular c ells bot h l ocally a nd i n the di stal 
circulation, pot entially c ontributing t o t he g ross pathological m anifestations of  c ardiovascular 
disease. 
Variation of strain frequency (0.5 Hz – 2 Hz) at a normal physiological strain magnitude 
(6%) yielded less variation in ceramide and ceramide metabolite regulation than did variation of 
strain magnitude (3%-12% at a physiological frequency (1 Hz).  In the context of normal arterial 
conditions, this suggests that a change in heart rate at a normal blood pressure is less detrimental 
than an increase in blood pressure at a normal heart rate. 
One of  t he other ve ry i nteresting findings o f t he c yclic s train s tudies i s t he not ion that 
continuous a pplication of  c yclic s train i s r equired t o m aintain c hanges i n c eramide, 
sphingomyelin, and sphingosine and that removal of the strain stimulus causes the cell to rapidly 
return t o s phingolipid l evels c ommensurate with uns trained c ontrol c ells ( Figure 3.3 ).  T his 
further strengthens the link between ceramide signaling and the act of mechanosensing.   
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Considered i n t he c ontext of  m echanotransduction, t his f inding m akes s ense.  If a  c ell 
encounters an increase in the local forces being applied to it (i.e. acute hypertension or vein-to-
artery grafting), it needs to trigger appropriate signaling pathways in response.  O nce the strain 
stimulus is removed (i.e. return to normotension or remodeling of the vessel to compensate for 
increased s train), pr olonged s ignaling, pa rticularly ceramide s ignaling, c ould be  de trimental t o 
the c ell s urvival.  T his further strengthens t he o bservations f rom t he exogenous ce ramide and 
inhibitor s tudies tha t E Cs a ppear to tightly regulate c eramide s ynthesis a nd that c eramide 
signaling employs some measure of autoregulation. 
Cyclic s train, at a ll m agnitudes (Figure 4.2)  a nd f requencies (Figure 4.3)  t ested 
encountered an S-1-P response curve similar in shape to that observed for ceramide, showing a 
brief e arly s pike i n S -1-P a nd a  s econd l ater r ise, s uggesting t hat S -1-P i s be ing m odulated 
concurrently w ith ceramide, potentially as a protective m echanism as  pa rt of  t he t heorized 
sphingolipid rheostat [80].  C eramide generation has be en associated with both apoptosis [61] 
and a utophagy [94, 103 , 104] , w hile S -1-P ha s be en associated with cell s urvival [80] and 
protective autophagy [104]. 
The concept of autophagy in the setting of cyclic strain is interesting.  For our studies, we 
monitored cell vi ability throughout a ll e xperiments a nd f ound t hat vi ability w as pr eserved i n 
response t o a ll s train r egimens e mployed, c onsistent w ith s tudies b y ot hers l eading s ome t o 
speculate that cyclic strain confers a protective effect to ECs and SMCs [44, 52, 53].  Autophagy 
in H UVECs f ollowing binding of  glycated c ollagen s ubstrates i s dependent on aSMase [94].  
The pr esence of  t he aSMase-associated peak in cer amide s ignaling i n bAECs and hAECs i n 
response to cyclic s train a t ph ysiological l evels be gs t he que stion of  w hether a utophagy m ay 
occur in these cells as part of the response to cyclic strain.  Of course, a cell need not be dead in 
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order t o ha ve a berrant cell f unction a nd autophagy, which i s potentially l inked t o c eramide 
signaling, may p rovide some i nsight i nto m echanical i nduction of  e ndothelial a ctivation a nd 
dysfunction. 
5.4 STUDY LIMITATION AND FUTURE DIRECTIONS 
The da ta pr esented r eveal g reat i nsight i nto how  c eramide va ries i n A ECs dur ing t he t ime 
response to mechanical cyclic strain and makes large steps towards defining the ceramide dose 
response t o s train i n A ECs.  F urthermore, t he e valuation of  changes in l evels of  c eramide 
metabolites, l ike s phingosine a nd S -1-P, a nd hi gher s phingolipids l ike s phingomyelin t aken 
together with inhibitor studies exploring SM hydrolysis and de novo ceramide synthesis, begin to 
shed l ight on  t he m echanism of  c eramide generation i n r esponse t o s train a nd i nto how  i t i s 
utilized.  C omparison of these findings with known ceramide activity in other cell systems and 
disease m odels s uggests t hat c eramide generation m ay contribute t o pro-inflammatory a nd 
dysfunctional cell phenotypes associated with cellular stress, not to be confused with mechanical 
stress in this definition. 
What is  c learly mis sing from the se s tudies is  a di rect relationship of ceramide to a 
cellular stress phenotype in response to cyclic strain, particularly through repetition of inhibitor 
studies i n s train m odels, l ooking a t bi ological e ndpoint a ssessments.  T o pr ove t hat c eramide 
signaling i n E Cs dur ing s train de finitively contributes t o a n activated p henotype, i t w ould be  
helpful a nd ne cessary t o r epeat t hese e xperiments l ooking f or m arkers of E C a ctivation, l ike 
vWF and IL-8 release associated with Weibel-Palade body exocytosis, which has been shown to 
be t riggered b y bot h e xogenous c eramide a s well a s e ndogenous c eramide f rom nS Mase 
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activation [26].  Likewise, an assessment of how ceramide regulation affects the standard model 
of endothelial cell function – NO production – would be essential.  To explore whether ceramide 
contributes to a pro-inflammatory state in this system with an eye towards the eventual onset of 
atherosclerotic l esion f ormation, one  s hould s tudy i nflammatory m olecules l ike T NF-α or 
HMGB1 and adhesion molecules traditionally associated with monocyte recruitment, like MCP-
1.  C orrelations of  c eramide s ignaling a nd S Mase a ctivation i n E Cs i n r esponse t o s train 
compared to other disease models makes a strong argument for further study of whether cyclic 
strain induces autophagy in endothelial cells.  As such, it would be helpful to examine traditional 
markers of autophagy like Beclin-1 or LC3 spots. 
Further validation of the roles that SMase hydrolysis and ceramide signaling play in the 
membrane m ay pr ove t o be  m ore pr oblematic.  O ne can easily s tudy ho w t he abs ence of  S M 
hydrolysis a ffects i ntegrin r earrangement, t hrough us e of  i nhibitors a gainst a cid or  ne utral 
SMases and histological staining for specific integrins, but it is harder to prove its involvement in 
response to strain without r eal-time vi sualization of the  cell dur ing s train on a microscope-
mounted strain system.  Ideally, ceramide a ccumulation at the  s ite of  int egrins dur ing 
rearrangement would be able to be visualized with fluorescent antibodies against ceramide and 
SMases. 
This bod y of work also doe s not  m ake an effort t o s pecifically describe w hich o f t he 
numerous mechanisms proposed for mechanotransduction is the “correct” method, nor is it our 
intention t o do s o.  I t does s eem l ikely t hat c eramide pl ays a  critical r ole in lipid rafting 
associated with integrins and focal adhesions, as well as  to perhaps perform second messenger 
signaling.  As such, it would help to clarify the function of ceramide in the mechanotransduction 
response b y e xamining how i nhibition of  S Mases a nd de novo synthesis dur ing s train a lters 
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traditional signaling pathways, particularly MAPKs which are also modulated by ceramide.  In 
particular, nSMase is associated with signaling through ERK1/2 to promote a pro-inflammatory 
phenotype, whereas aSMase is assicated with signaling through JNK to promote a pro-apoptotic 
phenotype [112].  Both of these pathways have been implicated in endothelial activation [25] and 
in m echanotransduction [44].  T hus, di fferent sources of  c eramide generated i n r esponse t o 
cyclic s train may contribute to di fferent aspects of the mechanotransduction response to cyclic 




Figure 5.2.  Different sources of ceramide generated in response to cyclic strain may contribute to different aspects 





In assessing the importance of ceramide signaling in the mechanotransduction response, 
it w ould be n ecessary as w ell t o examine t he direct i mpact of  t he va rious cer amide ev ents 
observed (nSMase a ctivation, a SMase a ctivation, a nd l ate de novo synthesis) on cellular 
alignment in ECs.  Although not reported in the results, during experiments, cells pretreated with 
manumycin A  appear, b y visual i nspection, t o f ail t o a lign w ith 10%  s train initially, a lthough 
they do eventually a lign b y 24 hour s, w hich i s pot entially a  ve ry i nteresting f inding.  This 
observation suggests t hat cer amide s ignaling as  a r esult of  nS Mase a ctivity i s ne cessary f or 
alignment to occur.  However, it should be noted that manumycin A is also a known inhibitor of 
the Ras pathway by way of inhibiting Ras farnesyl transferase.  It has been proposed that some of 
the R as inhi bitory a ctivities of  ma numycin may be a ttributable to nSMase inhi bition.  I t is  
unclear whether nSMase inhibition occurs in parallel to Ras inhibition or  upstream to i t [111].  
Initial pi lot s tudies to quantify c ellular a lignment dur ing s train in the p resence of  ma numycin 
were di sappointing, ow ing t o t he t oxicity of  m anumycin t o t he c ells a t levels capable of  f ull 
nSMase inhibition, especially when cells were grown at the subconfluent levels needed for clear 
alignment a ssessment b y computer-assisted a nalysis of  m orphology.  It w ould be  he lpful t o 
repeat these experiments us ing another inhibitor of nSMase (i.e. scyphostatin), and to evaluate 
alignment in the context of a confluent monolayer, since this represents the most physiologically 
relevant culture condition for ECs.   
Finally, it would be necessary to evaluate the overall role of  ceramide as  a c ontributing 
factor t o t he de velopment of  a therosclerotic l esions i n a n in vivo model.  A polipoprotein E  
(apoE)-deficient mice are a common animal model of atherosclerosis.  Interestingly, two studies 
performed by others appear to validate the role of ceramide in atherosclerosis progression.   
 139 
M. Sugita et al, i n a study examining whether o ne of  t he ant iatherogenic properties of  
statins is the ability of that drug class to inhibit protein farnesylation, treated apoE-deficient mice 
with manumycin A, which i s a known inhibitor of Ras farnesyltransferase as  well as  nSMase.  
Their results showed that fatty streak lesions at the aortic sinus in mice treated with manumycin 
were onl y 42% o f t he s ize of  t hose i n unt reated a poE-deficient mic e a nd that the α-smooth 
muscle actin-positive area in the lesion was reduced to 29% of that in the untreated group [113].  
While their results may be due specifically to inhibition of Ras farnesyltransferase, the possible 
function of nSMase inhibition, particularly in the strain setting of the aorta, may also play a role.  
Furthermore, nSMase has been show to stimulate Weibel-Palade body exocytosis in hAECs [26], 
strengthening t he i dea t hat nS Mase a ctivity c ontributes t o E C a ctivation a nd e ventual 
dysfunction prior to the onset of atherosclerosis.  Our own study showed that nSMase-associated 
ceramide signaling seems to be required for later de novo ceramide synthesis as well, which may 
help to propagate prolonged mechanotransduction responses.   
Similar findings have been reported following inhibition of de novo ceramide synthesis in 
vivo.  M . H ojjati et al. treated apoE -deficient m ice w ith m yriocin, a n i nhibitor of  s erine 
palmitoyl-CoA t ransferase, and therefore de novo ceramide s ynthesis, s howing a  r eduction i n 
atherosclerotic lesion size of 42% and 39% at the aortic root compared to control in mice fed a 
normal and high fat diet, and reduction in aortic lesion sizes en face of 36% and 37% in the same 
groups [114].  C onsidered t ogether w ith t he m anumycin s tudy i n a poE-deficient mic e, this 
argues strongly t hat pr olonged c eramide pr oduction due  t o de novo synthesis in ECs ma y 
contribute to ultimate progression of atherosclerotic lesions. 
In s tudying the vascular microenvironment, i t i s also important to consider that smooth 
muscle cel ls as  w ell as  E Cs enc ounter t he s ame c yclic s train forces and contribute t o the 
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formation of atherosclerotic lesions.  Although they do not encounter the same soluble sources of 
sphingolipids as ECs because of  their separation from circulating blood, they do e ncounter the 
same intralesional sources of  ceramide and ceramide metabolites.  Thus, to properly assess the 
role of ceramide and its metabolites in atherogenesis and in response to cyclic strain, it would be 
very helpful to compare the response of SMCs to ECs by repeating the same studies in this cell 
type. 
Likewise, experiences in vein to artery grafting and vessel stenosis argue that in addition 
to examining the ceramide response due to cyclic strain in arterial ECs, we should pursue studies 
of how  c eramide c hanges i n ve nous E Cs w here the c eramide r esponse m ay pr ove t o be  even 
more pronounced. 
5.5 CLOSING REMARKS 
These studies ha ve el ucidated the t ime s cale of t he ce ramide response and the ceramide 
biosynthetic and  m etabolic pa thways t hat o ccur dur ing t he early r esponse t o cyclic s train.  
Ceramide s ignaling oc curs as a  r esult of  di stinct s ignaling e vents a ssociated with nSMase, 
aSMase, and de novo ceramide synthesis.  The nSMase signaling event appears to be necessary 
for the later de novo event to occur.  The EC response to cyclic strain appears to be sensitive to 
strain magnitude, resulting in ceramide elevation at levels both above and below physiological 
strain magnitudes, suggestive of a wide variety of arterial pathological states.   
These findings help to elucidate the early events in the mechanotransduction response to 
cyclic strain and represent a step towards bridging our understanding of the relationship between 
mechanotransduction and inflammation as it relates to endothelial cell activation and dysfunction 
 141 
and vascular disease.  Establishment of the involvement of the ceramide biosynthetic pathway in 
endothelial cells and the vascular environment provides us with new biomarkers and therapeutic 




ESI-MS/MS ANALYSIS OF PHOSPHOLIPIDS IN AORTIC ENDOTHELIAL CELLS 
The ESI-MS/MS analysis of the total phospholipid profile in hAECs described in Section 2.2.4.3 
yielded a wealth of information about the predominant species of PC, PE, plasmenyl PE, PG, PI, 
and PS present in hAECs.  T hese spectra are presented in this appendix.  Daughter ion spectra 
are l abeled t o s how w hich f ragments c orrespond t o f atty a cid s ide-chains, a llowing for 
determination of  t he a cyl/acyl composition of  e ach species shown in Tables 2.1, 2.2, 2,3.  2.4, 





Figures A.A and A.B:  (A) shows t he full ne gative i on mode scan f or h AECs.  (B) shows the f ull positive ion 
modes scan for hAECs. 
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 Figures A.C and A.D: (C) shows the parent ion scan of all ions producing a fragment with m/z of 196 indicating 




Figures A.E and A.F.  (E) shows the daughter ion scan of the parent at a m/z of 721, identified in (C).  (F) shows 




Figures A.G and A.H.  (G) shows the daughter ion scan of the parent at a m/z of 766, identified in (C).  (H) shows 
the daughter ion scan of the parent at a m/z of 791, identified in (C). 
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Figures A.I and A.J.  (I) shows the parent ion scan of all ions producing a fragment with m/z of 241 indicating PI 
species.  (J) shows the daughter ion scan of the parent at a m/z of 754, identified in (I). 
 148 
 
Figures A.K and A.L.  (K) shows the daughter ion scan of the parent at a m/z of 780, identified in (I).  (L) shows 
the daughter ion scan of the parent at a m/z of 863, identified in (I). 
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Figures A.M and A.N.  (M) shows the daughter ion scan of the parent at a m/z of 885, identified in (I).  (N) shows 
the daughter ion scan of the parent at a m/z of 912, identified in (I). 
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Figures A.O and A.P.  (O) shows the neutral loss scan of all ions producing a fragment at m/z of 87 less than the 
parent, indicating PS species.  (P) shows the daughter ion scan of the parent at a m/z of 760, identified in (O). 
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Figures A.Q and A.R.  (Q) shows the daughter ion scan of the parent at a m/z of 788, identified in (O).  (R) shows 
the daughter ion scan of the parent at a m/z of 812, identified in (O). 
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Figures A.S and A.T.  (S) shows the daughter ion scan of the parent at a m/z of 836, identified in (O).  (T) shows 
the daughter ion scan of the parent at a m/z of 871, identified in (O). 
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Figures A.U and A.V.  (U) shows the daughter ion scan of the parent at a m/z of 719, identified in (A).  (V) shows 
the daughter ion scan of the parent at a m/z of 721, identified in (A). 
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Figures A.W and A.X.  (W) shows the daughter ion scan of the parent at a m/z of 747, identified in (A).  (X) shows 
the daughter ion scan of the parent at a m/z of 773, identified in (A). 
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Figures A.Y and A.Z.  (Y) shows the daughter ion scan of the parent at a m/z of 775, identified in (A).  (Z) shows 
the daughter ion scan of the parent at a m/z of 794, identified in (A). 
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Figures A.AA and A.AB.  (AA) shows the daughter ion scan of the parent at a m/z of 820, identified in (A).  (AB) 




ESI-MS VERIFICATION OF SIMILARITY OF LIPID PROFILE BETWEEN HUMAN 
AND BOVINE AORTIC ENDOTHELIAL CELLS 
To confirm t hat t he s ame s pecies of phos pholipids a nd s phingolipids i dentified i n hA ECs are 
also present in bAECs, the full positive and negative ion mode spectra were compared following 
ESI-MS analysis of identically performed lipid extractions from both cell types.  These spectra 
are presented in this appendix.  For ease of comparison, the spectra have been expanded so that 
each figure shows a  m/z range of  50  uni ts unless otherwise specified.  T he negative ion mode 
scan covers the m/z range of 250-950 to include sphingosine (m/z of 299) and S-1-P (m/z of 379) 
in addition to the usual phospholipids and sphingolipids detected in the m/z range of 400-950.  
The pos itive i on scan covers t he m /z r ange o f 400 -950.  F or e ach figure, the t op s pectra 
corresponds to hAECs and the bottom panel corresponds to bAECs.   
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Figure B.B.  ESI-MS comparison of hAECs and bAECs in the negative ion mode across the m/z range of 300-350. 
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Figure B.C.  ESI-MS comparison of hAECs and bAECs in the negative ion mode across the m/z range of 350-400. 
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Figure B.D.  ESI-MS comparison of hAECs and bAECs in the negative ion mode across the m/z range of 400-450. 
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Figure B.E.  ESI-MS comparison of hAECs and bAECs in the negative ion mode across the m/z range of 450-500. 
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Figure B.F.  ESI-MS comparison of hAECs and bAECs in the negative ion mode across the m/z range of 500-550. 
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Figure B.G.  ESI-MS comparison of hAECs and bAECs in the negative ion mode across the m/z range of 550-600. 
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Figure B.H.  ESI-MS comparison of hAECs and bAECs in the negative ion mode across the m/z range of 600-650. 
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Figure B.I.  ESI-MS comparison of hAECs and bAECs in the negative ion mode across the m/z range of 650-700. 
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Figure B.J.  ESI-MS comparison of hAECs and bAECs in the negative ion mode across the m/z range of 700-750. 
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Figure B.K.  ESI-MS comparison of hAECs and bAECs in the negative ion mode across the m/z range of 750-800. 
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Figure B.L.  ESI-MS comparison of hAECs and bAECs in the negative ion mode across the m/z range of 800-850. 
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Figure B.M.  ESI-MS comparison of hAECs and bAECs in the negative ion mode across the m/z range of 850-900. 
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Figure B.N.  ESI-MS comparison of hAECs and bAECs in the negative ion mode across the m/z range of 900-950. 
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Figure B.O.  ESI-MS comparison of hAECs and bAECs in the negative ion mode across the m/z range of 250-950. 
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Figure B.P.  ESI-MS comparison of hAECs and bAECs in the positive ion mode across the m/z range of 400-450. 
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Figure B.Q.  ESI-MS comparison of hAECs and bAECs in the positive ion mode across the m/z range of 450-500. 
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Figure B.R.  ESI-MS comparison of hAECs and bAECs in the positive ion mode across the m/z range of 500-550. 
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Figure B.S.  ESI-MS comparison of hAECs and bAECs in the positive ion mode across the m/z range of 550-600. 
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Figure B.T.  ESI-MS comparison of hAECs and bAECs in the positive ion mode across the m/z range of 600-650. 
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Figure B.U.  ESI-MS comparison of hAECs and bAECs in the positive ion mode across the m/z range of 650-700. 
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Figure B.V.  ESI-MS comparison of hAECs and bAECs in the positive ion mode across the m/z range of 700-750. 
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Figure B.W.  ESI-MS comparison of hAECs and bAECs in the positive ion mode across the m/z range of 750-800. 
 181 
 
Figure B.X.  ESI-MS comparison of hAECs and bAECs in the positive ion mode across the m/z range of 800-850. 
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Figure B.Y.  ESI-MS comparison of hAECs and bAECs in the positive ion mode across the m/z range of 850-900. 
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Figure B.Z.  ESI-MS comparison of hAECs and bAECs in the positive ion mode across the m/z range of 900-950. 
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